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ABSTRACT OF THE DISSERTATION
Characterization of Human Gut Microbiota Dynamics Using Model Communities in
Gnotobiotic Mice
by
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Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2013
Professor Jeffrey I. Gordon, Chair
The human gut is colonized by a diverse array of microbes, collectively referred to as the microbiota. The microbiota’s complexity poses significant challenges in characterizing the rules dictating its assembly, inferring the functional roles of its component species, and understanding how
communities sense and respond to changes in their habitat. We developed defined, representative
model communities comprised of sequenced human gut bacteria that could be characterized in a
highly controlled manner in gnotobiotic mice, plus a suite of scalable molecular tools for assaying
community properties. These tools were first used to evaluate how the microbiota is impacted by
probiotic bacterial strains found in fermented milk products (FMP). Introduction of a consortium
of five FMP strains resulted in only minimal changes in the structural configuration of a 15-member model microbiota. However, RNA-Seq and follow-up mass spectrometry revealed numerous
functional responses, many related to carbohydrate metabolism. Results from a study performed
in monozygotic twin pairs confirmed many of our observations in the model microbiota, showing
that lessons learned from preclinical models can inform the design and interpretation of human
studies. In a second set of experiments, we evaluated the impact of food on both a model community and its constituent taxa by feeding gnotobiotic mice oscillating diets of disparate composixiii

tion. In addition to prompt and reversible structural reconfigurations suggesting rules-based diet
effects, we noted consistent, staggered changes in the representation of many functions within the
metatranscriptome related to carbohydrate and amino acid metabolism. One prominent community member, Bacteroides cellulosilyticus WH2, was identified as an adaptive forager that tailors
its versatile carbohydrate utilization strategy to the dietary polysaccharides available. The specific
carbohydrates that trigger expression of many of this organism’s 113 predicted polysaccharide
utilization loci were identified by RNA-Seq analysis during in vitro growth on 31 distinct carbohydrate substrates, aiding our interpretation of in vivo RNA-Seq and high resolution proteomics
data. These results offer insight into how gut microbes adapt to dietary perturbations, both at a
community level and from the perspective of a well-adapted symbiont with exceptional saccharolytic capabilities, and illustrate the value of studying defined models of the human gut microbiota.
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“In the vernacular of the times, we must unite and confront these microbes with a non-negotiable
demand to increase our time of usefulness to them. Mankind should no longer die of infectious
diseases; hospitals can be made infection-free; we should live in peaceful coexistence with ‘our
microbes,’ and they should contribute positively to our continued health and well-being.”
-T. D. Luckey (1972)
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Chapter 1

Introduction
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The human gut microbiota: a metabolic organ of substantial complexity
Host-microbial mutualism in the human gastrointestinal tract
While nearly every surface of the human body is colonized with microbes, the greatest density
of microorganisms is found within the distal colon (1011-1012 CFUs/ml) [1]. Other, more proximal sites in the gut, including the stomach and duodenum, are also inhabited by microbes, but in
smaller numbers (<103 to 104 CFUs/ml). The prevailing thought among ecologists today is that this
population of microbes, collectively referred to as the human gut ‘microbiota’, represents one of
the earth’s most dynamic and densely-populated ecosystems [2]. If one assumes that the human
body consists of approximately 1013 cells (as postulated by Theodosius Dobzhansky in 1970, [3])
and that the human gut harbors some 1014 microbial cells (as calculated by T.D. Luckey in 1972,
[1]), it becomes clear that the sum of microbial cells inhabiting each of us exceeds our ‘own’ number of H. sapiens cells by an order of magnitude. Going one step further, the number of distinct
microbial genes within the collective genomes of these microbes (the human gut ‘microbiome’) is
estimated to exceed our human genome’s gene content by perhaps as much as 100-fold. Thus, we
are living amalgamations of both microbial and non-microbial cells, whose biological operations
are inextricably linked with one another in a finely tuned mutualism.
Humans and microbes have co-evolved [4]. In exchange for the shelter we provide them,
our gut microbes carry out important functions that the proteins encoded by our own human genes
cannot perform. Recent comparative studies of humans, non-human primates, and other mammals
have found that each species’ microbiota is tailored to include symbionts with traits well-suited
to the host’s anatomy, diet, and other biological parameters [5,6]. And, the results of microbiota
transplantation studies in mice and zebrafish suggest that there is selection within a host for those
microbes well-suited to a particular habitat [7]. While the human genome is probably not changing very quickly over modern timescales, the conditions in which people live and operate, and
the environmental factors shaping our gut communities, are changing at a rapid pace. Thus, if we
are to understand the complexities of our biology and how we are evolving as a species, we must
2

understand who our microbial symbionts are and how our relationship with them is affected by the
changing ways we live, eat and interact.
Phylogenetic diversity and interpersonal variation
Substantial advances in sequencing technology over the last ten years have allowed microbial
ecologists to greatly expand the breadth and depth of culture-independent (metagenomic) surveys
of the human gut [8]. As the per nucleotide cost of DNA sequencing has dropped precipitously, at
rates even exceeding those predicted by Moore’s Law, researchers have seized on the opportunity
to enumerate the microbial diversity in a number of human populations differentiated by many
metrics (e.g., geography, health status, cultural tradition). Collectively, the results of these studies
provide us with our most comprehensive understanding yet of the incredible diversity that exists in
the gut, highlighting both similarities and differences that exist between individuals [9,10].
The intestine is home to species from all three domains of life, though it is dominated by the
Bacteria. Representatives of at least 14 bacterial phyla have been identified in human fecal samples
to date, including Bacteroidetes, Firmicutes, Proteobacteria, Actinobacteria, Verrucomicrobia,
Fusobacteria, Tenericutes, Lentisphaerae, TM7, Cyanobacteria, Synergistetes, Spirochaetes, SR1,
and Deinococcus-Thermus [11]. When more resolved levels of taxonomy are considered, the number of bacterial phylotypes that colonizes human beings increases dramatically. One helpful, previously proposed analogy for visualizing the phylogenetic structure of the gut microbiota suggests
that a community can be represented as a grove of palm trees with long trunks (one tree per bacterial phyla), each trunk topped with fans representative of divergent lineages of related bacteria, and
each fan comprised of leaflets representative of individuals strains [4]. This illustration emphasizes
that a great deal of bacterial diversity in the gut exists at the strain level. Although bacteria are
without question the dominant constituents of the gut ecosystem, this microbial menagerie also
includes representatives from two other domains (Archaea and Eukaryota), as well as viruses (bacteriophage). However, our understanding of non-bacterial diversity in the gut is in its infancy, and
only a small number of studies addressing this area have been reported so far [12-14].
3

Results from some of the deepest surveys suggest that a typical healthy human is colonized by approximately 100-150 bacterial phylotypes [10]. Comparisons of these many bacterial
phylotypes across individuals suggest that each of us is also colonized with a unique assemblage
of species [15]. Efforts in recent years to identify a subset of species that reside in all human beings that might constitute a ‘core microbiota’ at the phylogenetic level have not been successful,
suggesting it is likely that many different configurations of gut phylotypes can achieve stable or
quasi-stable equilibria, presumably because of functional redundancy between different strains/
subspecies. These observations suggest that the human gut microbiota’s ‘alpha diversity’ (i.e., the
number of distinct microbial organisms observable within an individual) and ‘beta diversity’ (i.e.,
the degree of differentiation between individuals) are both quite high. The total species diversity
within human guts, typically represented by ‘gamma diversity’ (the product of alpha and beta diversity measures), is therefore quite significant. This staggering complexity presents those studying the gut microbiota in human subjects with significant challenges as they attempt to compile
generalizable principles about the system and its constituents.
Despite the exceptional diversity described above, there are common themes in community
structure and composition when comparing the microbiota of different individuals. For example,
although at least 14 bacterial phyla have been observed in human fecal samples, the overwhelming majority of bacteria hail from just two: the Bacteroidetes and the Firmicutes (collectively, taxa
from these two phyla constitute approximately 95% of adult gut communities based on recent
surveys) [11]. Representatives of the Proteobacteria and Actinobacteria are also common, but are
typically observed in low numbers (i.e., <3%) in healthy adults. Although microbes common to
all human communities have proven elusive, some individual taxa and related groups of taxa are
observed on a regular basis in a large proportion of individuals. One example is Clostridium cluster XIVa of the Firmicutes, which has been suggested to account for as much as 60% of the total
mucosa-associated microbiota [16]. This cluster includes a number of species (e.g., Ruminococcus
torques, Ruminococcus obeum, Clostridium symbiosum) that have been detected consistently in
different subjects from large-scale surveys of the human fecal microbiota [10]. The incidence of
4

some particular species from the genus Bacteroides is also quite high in gut surveys. Some of the
most common representatives include Bacteroides ovatus, Bacteroides vulgatus, and Bacteroides
caccae, though there are many others as well. Of those bacteria hailing from the phylum Actinobacteria, Collinsella aerofaciens appears to be most prevalent. A confounding factor in accurately
deciphering the representation of different bacterial taxa among humans representing different
ages, physiological states, and geographic regions/cultural traditions is the lack of methodological
standards in microbiota research. Studies may rely on different methods for extracting microbial
DNA from samples, different PCR primers and cycling conditions to amplify different regions of
the 16S rRNA gene used as a phylogenetic marker, different sequencing platforms, and different
bioinformatics tools to deal with artifacts (sequencing errors, chimeras) arising from amplicon
sequencing. Nevertheless, consistent similarities (and differences) between healthy gut communities such as those described above are important for the researcher to consider when attempting to
build experimental models of the healthy human gut microbiota.
Microbial contributions to human physiology and metabolism
The previously described diversity of our gut microbes (and their genes) affords them a central role
in our physiology and metabolism [17]. These microbes encounter innumerable substrates (e.g.,
dietary compounds, drugs, host molecules, and microbial metabolites, to name a few), and these
compounds enter the intestinal ecosystem in a number of ways (orally, as components of biliary
and mucosal secretions, or through the circulatory system). This multiplicity of compounds and
routes of introduction makes characterizing the biotransformation of different molecules by gut
microbes especially challenging.
One way the gut microbiota benefits its human host is by salvaging energy from compounds that we are incapable of efficiently processing with our own metabolic machinery [18].
Bacteroides spp., for example, are known for their substantial capacity to degrade and ferment a
broad range of plant-derived polysaccharides and oligosaccharides found within our diets, as well
as host-derived glycans (e.g., mucin). Gut microbes are thought to liberate energy from some5

where between 20 and 70 g of carbohydrates per day, suggesting that their impact on the extraction
of calories from food could be significant [19]. As gut microbes disassemble poly- and oligosaccharides, they ferment their constituent subunits, generating a number of short-chain fatty acids
(SCFA; e.g., acetate, propionate, and butyrate) and other end-products (e.g., lactate, succinate, and
formate) [20]. In addition to serving as important sources of energy for a subset of host cells (e.g.,
colonocytes), these SCFA also stimulate epithelial renewal and facilitate the absorption of salt and
water in the distal gut [17]. Unfortunately, little is currently known about which microbes within
these complex communities are responsible for degrading particular dietary substrates.
In addition to strongly influencing macronutrient processing in the distal gut, the microbiota also impacts how we process a host of smaller molecules that are exogenously as well as endogenously derived. Several examples of gut microbial biotransformation of orally administered
drugs have been documented, including the inactivation of digoxin by Eggerthella lenta [21] and
the deglucuronidation of the chemotherapeutic irinotecan by microbial beta-glucuronidases [22].
Gut microbes are also known to play an important role in the deconjugation of bile acids, ensuring efficient reabsorption of free bile acids from the ileum and colon and the loss of only around
5% of all bile acids in feces [23]. Finally, the microbiota plays an important role in the synthesis
of some vitamins. Previous work has shown that while adults maintained on a diet low in vitamin
K do not develop deficiencies even after several weeks, the administration of antibiotics that have
activity against gut microbes significantly impacts the host’s ability to carry out processes requiring vitamin K [24]. Experiments in conventionally-raised and germ-free rats have demonstrated
that gut microbial synthesis of biotin is sufficient to meet the animals’ requirements [25]. As with
macronutrient processing, a detailed understanding of how individual components of the microbiota cooperate and compete to process and synthesize micronutrients and other small molecules
is currently lacking. New approaches to studying the microbiota that reduce the complexity of the
system while preserving the way in which it operates should allow us to monitor the activities of
individual members so that we can better understand the roles played by key taxa and the metabolic guilds of which they are members.
6

Though beyond the scope of this dissertation, it is important to note that gut microbes
are also known to play a key role in shaping features of the innate and adaptive immune systems
[26]. Some gut microbes prevent colonization of the intestine by pathogens or other allochthonous
(transient) microbes by colonizing mucosal surfaces and/or secreting antimicrobial peptides. Others have been shown to exert strong influences on specific subsets of immune cells. For example,
researchers have reported that members of the genus Clostridium induce the regulatory lineage of
CD4+ T cells (Tregs) in mice [27]. And still other work has implicated reduced diversity of the
microbiota, especially during infancy, with increased rates of atopy [28]. Although there have been
a small number of cases in which specific human gut microbial lineages have been tied to immune
phenotypes, further dissection of these important and complex interactions is needed.
The need for representative models of the human gut microbiota
Although the importance of studying the gut microbiota in human subjects is undeniable and has
resulted in many important insights, such studies are limited in several ways and present challenges that can be overcome by studying animal models of the human microbiota. First, it is logistically difficult, expensive and time-consuming to study the microbiota in recruited human subjects.
Animal studies (e.g., in mice) are by comparison relatively inexpensive, require shorter amounts
of time, and are easier to plan and oversee. The expense and logistical challenges of human studies also typically restricts researchers from carrying out experiments in large cohorts, restricting
the amount of biological replication that can be built into a study, as well as the number of times
large-scale human studies can be replicated. Small, unrepeated human studies may not provide the
statistical power required to work out complex relationships in a system whose biological signals
may be faint and noisy. Studies in animal models, by comparison, are much more amenable to
replication. In contrast with human subjects, animals can also be maintained in habitats where
environmental variables such as diet can be tightly controlled, along with important host parameters such as genotype, age, and health status. Additionally, longitudinal studies of the human gut
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microbiota have in nearly every case been limited to analyses of feces, whereas studies of model
human microbiota in animals allow for sampling along the length of the gut at the time of sacrifice.
The complexity of the human microbiota makes it extremely difficult to define and characterize relationships between different taxa and between taxa and ecosystem parameters. For example, if we assume that in a microbiota comprised of 500 distinct taxonomic groups, all components
interact with one another, there would be 124,750 distinct pairwise combinations of relationships
to characterize. Experimental models of the microbiota, on the other hand, can intentionally reduce
this complexity while preserving the key features of the microbiota. A calculation similar to the
one above in which a model microbiota of 15 taxa are considered yields a more manageable 105
distinct pairwise interactions between community members. Additionally, our ability to precisely
manipulate the composition of the microbiota in humans to test particular hypotheses is extremely
limited; such manipulations are usually restricted to the administration of antibiotics whose microbial targets constitute a broad range of organisms. Taken together, the many advantages of animal
studies argue strongly for the development of representative models of the human microbiota
in mice whose characterization can complement and inform research in human subjects (e.g.,
by generating/testing hypotheses, by helping to define effect sizes, by identifying surrogate and
mechanism-based biomarkers, etc.).
Creating a defined system: model communities of sequenced human gut microbes
Colonization of germ-free mice with complex, undefined communities[29]
Germ-free (GF) mice can be colonized with microbial communities of different origins and degrees of complexity at defined stages of host development. When such colonizations are performed using one or more known microbial species, the resulting animals are often described as
‘gnotobiotic’ (from the Greek roots gnostos for ‘known’ and bios for ‘life’), though technically
the term applies to GF animals as well. The microbial communities used as inocula in gnotobiotic
experiments can be harvested from any number of habitats, including various body sites of con8

ventionally-raised mice with defined genotypes and physiological phenotypes of interest. These
communities can be introduced into GF recipients (possessing a desired genotype) to determine
how much of a donor’s phenotype is transferrable to the resulting ‘conventionalized’ mice via their
microbiota. If partial or complete phenotypic transfer occurs, follow-up studies can be performed
in order to define the composition of the donor community, the mechanisms by which the donor
community impacts host physiology, and how the recipient affects the transplanted microbiota/
microbiome. These types of studies have typically been performed using gut contents [30], but in
principle could be extended to communities harvested from any body habitat.
Procedures for transplanting human fecal microbial communities into GF mice to generate
‘humanized’ mouse models have been developed by members of our laboratory [31]. A remarkable
portion of human fecal microbial community diversity can be transferred in this fashion even when
a donor specimen has been frozen at -80°C for several years. Past studies suggest that all bacterial
phyla, up to 90% of class-level and genus-level taxa, and 60-90% of species-level phylotypes in a
given human donor’s sample can be identified in recipient gnotobiotic mice when the 16S rRNA
gene is sequenced from fecal DNA. While some human gut taxa may be refractory to transplantation, these results seem to suggest that a large number of the most prevalent human gut microbes
may be capable of colonizing Mus musculus. Once engrafted, the transplanted human microbial
communities are remarkably stable, can be reliably transmitted across generations of animals and
exhibit well defined and reproducible biogeographical features along the length of the mouse gut
[31]. Efficient intergenerational transfer of transplanted human fecal microbiota also allows the
microbiota and the host’s innate/adaptive immune system to co-evolve beginning at birth in ‘second generation’ mice.
‘Humanized’ gnotobiotic mice can be used for proof-of-mechanism studies that cannot
be readily conducted in humans where potentially confounding variables, including variations in
host genotype, diet, and antibiotic consumption are notoriously difficult to control. As such, they
are a powerful model for conducting first-generation experiments whose goal is to determine if
microbes influence a host phenotype or physiological parameter of interest.
9

Like any experimental model, humanized gnotobiotic mice are subject to limitations.
When studying a biological system, it is obviously important to have as complete an understanding as possible of its components and parameters. Unfortunately, a researcher colonizing germ-free
mice using a human fecal suspension is typically unable to discern the exact identities of all the
microbes within the donor community, even using the most sophisticated metagenomic and 16S
rRNA gene sequencing techniques available today. The level of taxonomic resolution that can
be achieved when sequencing these donor communities is in fact the same as for the researcher
studying the microbial composition of human feces, and the same is true for the sequencing of
fecal communities from humanized mice. In some cases, 16S rRNA gene-based identification of
taxa can achieve species-level resolution, but often only genus (or higher) levels of classification
are possible when microbes hail from taxonomic clades where few representatives have been sequenced. This ‘fuzziness’ when assigning identities to microbes also negatively impacts our ability
to accurately estimate the alpha, beta, and gamma diversity present in gnotobiotic recipients of
human gut microbiota transplants. Additionally, genome information is often lacking for microbes
transplanted from complete (uncultured) human communities. This lack of genomic data limits our
ability to make predictions about the functional capacity of any given constituent of the system, as
well as the ways in which it might interact with other microbes (and the host). While metagenomic
sequencing of a donor community or the humanized mouse fecal community can provide some information about a community’s genetic potential, it is not yet a substitute for a completely defined
metagenome whose genes can be attributed to specific taxa. Finally, the use of intact human communities to colonize GF mice currently does not allow for targeted manipulation of the donor community’s composition. This inability to intentionally manipulate the membership of communities
before or after their transplantation to GF mice can make testing hypotheses about the operations
of the microbiota and its individual components either incredibly challenging or impossible. Thus,
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while the humanized mouse model provides several important advantages, there is a substantial
need for more defined systems that are more amenable to mechanistic dissection.
Assembling defined, representative model communities in vivo[29]
Thanks to previous and ongoing efforts by many to culture and sequence human gut microbes [3235], an opportunity exists to create representative model human gut communities in gnotobiotic
mice in which the identities of all community members and the sequences of all of their genomes/
genes are completely defined. Members present in these model communities can be selected from
both public and private culture collections based on various criteria relevant to the researcher’s
experimental focus. Reasons for a microbe’s inclusion in a model community might include its
consistent association with specific human physiological or pathophysiological states, its representation in a fecal microbiota that confers a phenotype to recipient germ-free mice when transferred en masse, its representation in healthy individuals, its evolutionary ancestry, its functional
potential as predicted by in silico inspection of its genome, or any number of other criteria. These
defined communities can be used to address a number of basic questions in the field of microbiota
research, among them: (i) to what extent do established species who presumably sequester limiting
space and/or resources exclude potential colonizers and influence community composition; (ii) to
what extent is the dynamic behavior of the microbiota determined by inter- and intra-specific interactions [36]; (iii) what are the genetic predictors of niche overlap; (iv) how robust are assembled
communities to various environmental perturbations; and (v) how do different gut microbes prioritize available resources in a highly competitive environment. The defined nature of model gut
communities comprised exclusively of sequenced microbes allows these questions and others to
be addressed at levels of resolution that are simply not possible in undefined systems.
It is important to emphasize here that the introduction of defined assemblages of microbes
into gnotobiotic mice is by no means a new experimental approach. In the 1960’s, Dr. Russell W.
Schaedler (then at Rockefeller University) was the first to colonize GF mice with panels of bacte-
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ria isolated from healthy conventionally-raised mice [37]. Today, the 8-species ‘altered Schaedler
flora’ (the result of several rounds of improvement to the original ‘Schaedler flora’ [38]) is internationally recognized as the standard microbiota for colonizing neonatal mice kept in the barrier
rooms of all major animal suppliers. In this case, however, the model community’s main utility is
as a means of standardization and ensuring that animals remain pathogen-free.
More recently, simple model communities comprised of 2-3 species have been studied
in germ-free mice in order to explore some of the metabolic interactions that take place between
different microbes (microbe-microbe interactions) and between particular microbes and the host
(host-microbe interactions) [39-42]. The studies described in this thesis have utilized communities
comprised of as many as 15 different sequenced human gut microbes in an effort to more faithfully reproduce many of the key taxonomic and functional features of the human gut microbiota.
Though these communities are significantly more complex and representative of the human microbiota than past systems, further increases in the complexity of model microbiota introduced
into mice and other gnotobiotic hosts are anticipated as we strive to improve our understanding of
this dynamic ecosystem (discussed in Chapter 4). Methodologies for characterizing the structure
and function of these defined models of the gut microbiota, many of which were developed or
improved during the course of this thesis, are described below.
Compiling a molecular tool kit: methods for characterizing model community structure
and function
Profiling community structure and the development of COPRO-Seq
While many parameters of a microbial community can be measured and characterized in order
to better understand its properties, one of the most important is its ‘structure’. Species richness,
species diversity and patterns of species abundance within a microbiota each constitute different
elements of this structure. Measuring changes in gut microbial community structure over time
provides a researcher with insights about how the different populations with the system are re12

sponding to changes in their environment, how they are responding to one another, and how they
are responding to other elements of the larger ecosystem (e.g., changes in host physiology). One of
the earliest aims of this dissertation was to develop a robust, rapid, and cost-effective method for
evaluating the structure of a defined model microbiota comprised of sequenced human gut-derived
bacterial species.
In principle, the structure of a defined microbiota can be assessed in a number of different
ways. Because the genome sequence of each species in a defined community is known, primers
specific to a particular organism can be designed for quantitative PCR (qPCR)-based assays of species abundance, yielding data for one member of the community at a time. However, this approach
is not tractable if the goal is to longitudinally study many microbes in many animals subjected
to multiple experimental treatments. An alternative approach is based on sequencing of the 16S
rRNA gene. However, this type of approach is hampered by known PCR primer biases [43] and
the need for fairly long DNA sequences (which might significantly inflate the cost of evaluating
community structure across large numbers of samples).
At the time this dissertation work began, ‘massively-parallel’ or ‘next-generation’ sequencing was a relatively new technology, and the first commercially-available Illumina sequencers
were entering the market. The first-generation Illumina platform was capable of generating many
millions of short (35 nt) reads – a number that was many orders of magnitude greater than previous
technologies. This significant increase ultimately paved the way for a new approach to defining
the structure of model communities in gnotobiotic mice, a method I dubbed COmmunity PROfiling by Sequencing (‘COPRO-Seq’). COPRO-Seq takes advantage of the fully-defined nature of
the model microbiome to precisely measure the relative abundance of every community member
in a given sample simultaneously. After generating large numbers of short reads from community
DNA using the Illumina platform, each read is quantitatively mapped back to its genome of origin
using a short read aligner. In some cases, because of genetic overlap between microbial species,
reads cannot be assigned unambiguously to a single genome. These reads of unknown origin are
excluded from the analysis. To compensate for their removal, the ‘informative genome size’ (IGS)
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of each genome is calculated and used to normalize the sum of the read counts attributed to each
species in the community. Each genome’s IGS value is calculated by multiplying two values: (i)
the fraction of all k-mers (e.g., 35-mers) that can be derived from a genome’s sequence and occur only once when considering all k-mers within the defined community’s microbiome (i.e., the
fraction of a genome that does not overlap with any other genome in the defined community), and
(ii) the genome’s total length. Dividing the normalized read counts for each species present in the
community by the total normalized read counts in a sample (e.g., feces) results in a comprehensive
profile of community structure that provides the relative abundance of every species detected in
that sample. All calculations are performed in an automated fashion by a workflow implemented
in Perl to ensure reproducibility and to avoid human error. High-throughput sample processing is
achieved by generating barcoded Illumina libraries for each sample and pooling multiple barcoded
libraries on each lane of an Illumina flow cell. By taking advantage of the high yields of the Illumina platform and the known genome sequences of a defined community microbiome, COPRO-Seq
allows a researcher to quantitatively assess the structure of a defined microbiota in many hundreds
or even thousands of samples with exceptional sensitivity (species comprising as little as 0.001%
of a community are typically detectable) in rapid fashion.
Additionally, because COPRO-Seq can quantify the abundance of a taxon based on a relatively small number of species-specific reads (compared to the total number of sequences generated from each sample characterized), it is well-equipped to characterize defined communities
much larger than those studied in this dissertation. Provided all strains in the model community
have a sequenced genome available, it should be possible in the future to enumerate the proportional abundance of hundreds or even thousands of sequenced community members simultaneously. Further details regarding the COPRO-Seq methodology are provided in the study described
in Chapter 2.
Profiling community function using improved methods[29]
Understanding how different gut communities modulate their activities in response to changes in
14

diet, host physiological status, or the introduction of new microbial species is a key step in understanding the operations of the gut microbiota. Microbial RNA-Seq can be used to quantify changes
in community gene expression at high resolution and with substantial dynamic range [44]. In the
case of model communities of sequenced gut microbes, where all species and genes are known,
this high-resolution data can be used to verify gene structure/operons, generate in silico reconstructions of expressed metabolic pathways for each member in the community, and make predictions concerning the metabolic niches of taxa of interest. Functional predictions about community
operations can also be informed by RNA-Seq analyses of individual members grown in monoculture under highly defined conditions (e.g., minimal medium supplemented with systematically varied carbon sources; see Chapter 3 for an example of this approach involving a prominent member
of the gut Bacteroides). In addition, gnotobiotic mice harboring defined collections of sequenced
organisms provide an opportunity to further develop and test methods for extracting and characterizing, by high-performance liquid chromatography-mass spectrometry (LC-MS), the proteins
expressed by their model microbiota. Given accurate gene predictions based on the sequenced genomes of each community member, theoretical peptidomes/proteomes can be calculated in silico,
and peptides detected in community-extracted protein can be mapped back to their proteins of
origin. In collaboration with researchers at Oak Ridge National Laboratories, we have picked up
where early work in two-member model microbiota left off [40] and significantly improved our
methods for characterizing the metaproteomes of model human gut communities comprised of
up to 12 species (see Chapter 3). Finally, targeted and untargeted quantitative mass spectrometry
(MS)-based measurement of metabolites in the gut (as well as other biocompartments) can provide
an even more direct assessment of how community operations change as the result of experimental
perturbations. These MS-based metabolomics methods allow the researcher to characterize the
effects of systematically manipulating the species composition of a model microbiota or perturb-
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ing the activities of key community members [42]. Collectively, these improved systems-level
approaches in metatranscriptomics, metaproteomics, and metabolomics allow for unprecedented
time-series assessments of expressed functions in model communities.
Genetic manipulation of the community metagenome[29]
Community genetics represents another powerful means by which the researcher may dissect the
operations of microbial communities. The addition or removal of particular species prior to gavaging the model microbiota into GF mice constitutes the simplest genetic perturbation that can
be imposed on the system to identify taxa that confer a benefit or detriment to other community
members or the host. Another method for manipulating the gene content of the metagenome is
insertion-sequencing (INSeq), which combines genome-wide transposon mutagenesis with massively parallel sequencing [45,46]. In this approach, complex populations of tens of thousands of
transposon mutants of a given sequenced community member are generated and introduced into
wild-type or genetically manipulated GF mice in the presence or absence of other (sequenced)
microbes. The representation of each mutant in both the input community and each experimental
sample (output community) is determined by targeted, quantitative sequencing of transposon-adjacent chromosomal DNA. Any differences in mutant representation in input versus output communities provide a quantitative measure of the degree to which loss of a gene’s function imposes a
fitness cost on the species of interest within a given experimental framework (i.e., set of selective
pressures). Additionally, the inclusion of a species-specific barcode within the transposon construct used to mutagenize individual community members allows multiple mutagenized species to
be studied simultaneously, permitting assessment of the importance of fitness determinants within
and between multiple species. Thus, by including or excluding species of interest when constructing model communities and by mutagenizing individual members of those communities using a
randomly inserting transposon, a researcher studying model communities can directly determine
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which genes and which species are most important for specific functional features of a microbiota.
This approach proved particularly informative in two studies included here (see Chapter 3, Appendix A).
Studying the system: characterization of communities and specific taxa in contexts relevant
to human health
If one accepts the premise that the microbiota plays an important role in human health, it is reasonable to think that methods for preserving a ‘healthy’ microbiota configuration or driving the
microbiota away from ‘pathological’ states could serve as the basis for new therapeutic modalities.
Developing safe, efficacious microbiome-directed therapies requires a much better understanding
of how human gut communities assemble, operate, and respond to environmental changes over
time. As discussed, characterization of model communities of human gut microbes using molecular tools that leverage the completely defined nature of these systems represents an approach to
achieving this goal of greater understanding. Over the course of this dissertation, I have used these
systems and tools to study the microbiota in two contexts with significant relevance to human
health.
The impact of probiotic interventions on the microbiota
Though the term ‘probiotic’ is one whose definition has evolved substantially over time [47], probiotics are generally described as live microorganisms that when ingested confer a health benefit
to their host. In 1907, Élie Metchnikoff (often referred to as the ‘father of probiotics’) proposed
that ingesting lactic acid bacteria could replace or diminish ‘putrefactive’ bacteria in the human
intestine, normalizing gut function and prolonging human life [48]. Since Metchnikoff’s time, the
market for probiotic foods and supplements has become a booming business as more and more
individuals turn to these products in hopes of improving intestinal health and general well being.
Yet, while a small number of probiotic strains of bacteria have been carefully studied [49], in
most cases we have a poor understanding of the mechanisms by which these bacteria influence
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human health and how their introduction into the gut microbiota influences its operations. Chapter
2 describes a staged ecological ‘invasion’ of a consortium of five strains reputed to have probiotic
properties into the guts of monozygotic twin pairs as well as gnotobiotic mice colonized with a
defined model human gut microbiota. This study of the model community in parallel with human
subjects allowed us to characterize the ways these probiotic microbes influence gut communities
at the level of individual genes and taxa, and resulted in the identification of numerous functional
responses that are shared between humans and mice. Additionally, the results show that model gut
communities can play an important role in identifying biomarkers and mediators of the direct and
indirect effects of probiotics on gut microbiota and their hosts.
The impact of diet change over time
Many studies in recent years have suggested that the well-known idiom ‘you are what you eat’ is
apt not only in terms of general human health, but also applies to the composition of the human microbiota [50-52]. While these studies have contributed significantly to our appreciation of diet as
a paramount environmental factor in shaping the microbiota’s structure and function, further work
is needed to determine how the many interactions between individual microbes and food lead to
diet-induced effects at the community level, how microbes prioritize utilization of different components of our diets, and how microbes carve out metabolic niches that allow them to persist over
time in individuals eating diverse diets. In Chapter 3, we use the model community experimental
framework to evaluate how diet change influences the structure of the microbiota over time, the
dynamics of community’s functional responses to diet change, and metabolic strategies prominent
taxa rely on in a changing nutrient landscape. We then go on to further characterize the carbohydrate utilization of a well-adapted xylanolytic Bacteroides species, the genetic factors that allow it
to utilize diverse simple and complex saccharides, and which of those factors are most important
for in vivo fitness in a host harboring a model human gut microbiota and consuming different diets.
Footnote
The text within some sections of this Introduction includes both direct and revised excerpts from
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a previously published review (see reference [29]). These sections are designated by a reference
number (in superscript) at the end of their titles.
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Abstract
Understanding how the human gut microbiota and host are affected by probiotic bacterial strains
requires carefully controlled studies in humans and in mouse models of the gut ecosystem where
potentially confounding variables that are difficult to control in humans can be constrained. Therefore, we characterized the fecal microbiomes and metatranscriptomes of adult female monozygotic twin pairs through repeated sampling 4 weeks before, 7 weeks during, and 4 weeks after
consumption of a commercially available fermented milk product (FMP) containing a consortium
of Bifidobacterium animalis subsp. lactis, two strains of Lactobacillus delbrueckii subsp. bulgaricus, Lactococcus lactis subsp. cremoris, and Streptococcus thermophilus. In addition, gnotobiotic
mice harboring a 15-species model human gut microbiota whose genomes contain 58,399 known
or predicted protein-coding genes were studied before and after gavage with all five sequenced
FMP strains. No significant changes in bacterial species composition or in the proportional representation of genes encoding known enzymes were observed in the feces of humans consuming
the FMP. Only minimal changes in microbiota configuration were noted in mice after single or
repeated gavage with the FMP consortium. However, RNA-Seq analysis of fecal samples and
follow-up mass spectrometry of urinary metabolites disclosed that introducing the FMP strains
into mice results in significant changes in expression of microbiome-encoded enzymes involved in
numerous metabolic pathways, most prominently those related to carbohydrate metabolism. B. animalis subsp. lactis, the dominant persistent member of the FMP consortium in gnotobiotic mice,
up-regulates a locus in vivo that is involved in the catabolism of xylooligosaccharides, a class of
glycans widely distributed in fruits, vegetables, and other foods, underscoring the importance of
these sugars to this bacterial species. The human fecal metatranscriptome exhibited significant
changes, confined to the period of FMP consumption, that mirror changes in gnotobiotic mice,
including those related to plant polysaccharide metabolism. These experiments illustrate a translational research pipeline for characterizing the effects of FMPs on the human gut microbiome.
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Introduction
Our physiology and physiological differences are not only manifestations of our human genes and
epigenomes but also a reflection of the genes and genetic variations that exist in our resident microbial communities (microbiomes). Our microbiomes contain at least 100 times more genes than
our human genomes (1). Marked increases in DNA sequencing capacity have led to an explosive
increase in the number and types of culture-independent metagenomic studies of intra- and interpersonal variations in human microbial ecology—as a function of our human life cycle, cultural
traditions, and health status (2–7). Long-term goals of this quest to understand the genomic and
metabolic underpinnings of our mutually beneficial relationships with microbes include using our
symbionts as a new class of biosensors and biomarkers of wellness, and devising safe and effective ways to deliberately manipulate the structure and functions of our microbiome to optimize our
health, as well as to treat various diseases.
A necessary starting point for assessing how the structure and functions of the human
microbiome are related to our biology is to characterize the normal variations that occur in these
communities, their gene pools, and their gene expression profiles both within and between individuals. This requires carefully designed studies where potentially confounding variables such as
host genotype, diet, and various environmental exposures can be controlled and systematically
manipulated. Monozygotic (MZ) twins represent one way to constrain some of these variables,
given that they have more similar genotypes and have experienced more similar dietary and other
early environmental exposures than any other combination of individuals. A complementary approach is to use germ-free mice colonized at various points in their life with defined collections of
microbes, with sequenced genomes, that represent major phylogenetic lineages encountered in the
body habitats of human populations of interest. Gnotobiotic mice harboring “synthetic” model human microbiomes, where all component organisms and microbial genes are known, can be reared
under conditions where a number of the variables that confound human studies are extremely well
controlled. Insights gleaned from these gnotobiotic animals can be applied back to humans (8).
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Common intended or unintentional disturbances to our microbiomes include changes in
our diets, consumption of antibiotics, and ingestion of live microbial strains posited to improve
health. The latter include commercially available probiotics that are incorporated into fermented
milk products (FMPs). With increasing regulatory pressure to validate the composition and health
claims of probiotics and “functional” foods, it is particularly important to develop informative
translational medicine pipelines so that proof-of-concept clinical trials can be performed with
validated biomarkers for quantitative phenotyping of subjects and of their responses. The present
study demonstrates one type of approach. It uses adult MZ twin pairs and metagenomic methods
to first define temporal fluctuations in the organismal and gene content and gene expression profiles of their fecal microbial communities as a function of administration of a widely used commercial FMP. It then takes the five sequenced strains present in the FMP and introduces them as a
consortium, at a dose analogous to that experienced by humans, into gnotobiotic mice containing
a model human microbiome composed of 15 sequenced human gut symbionts. Quantitative analyses of temporal changes in the proportional representation of microbial species and genes, and of
microbiome gene expression and metabolism before and after an ecological “invasion” with the
five-member FMP microbial consortium, have provided insights into the ways that FMP strains
and the indigenous model gut community respond to one another. The transcriptional responses
were used as biomarkers to interrogate metatranscriptome data sets obtained from the MZ twins’
fecal specimens.
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Results
Human studies
Study design and assessment of intra- and interpersonal variations in the fecal microbiota of
MZ twin pairs over a 4-month period. Details concerning the seven adult female MZ twin pairs
recruited for this study are provided in table S1. All had been vaginally delivered; none consumed
antibiotics in the 6 months before and during their participation in the present study; none had
a history of gastrointestinal diseases (including irritable bowel syndrome) or any other acute or
chronic medical conditions; none were consuming dietary supplements or probiotics at the time
of enrollment; and none had a history of gluten sensitivity or other food allergies, nor were any
vegans or lacto-vegetarians.
Fresh lots of an FMP were shipped every 2 weeks to the participants’ homes from the same
pilot production facility; strain-specific quantitative polymerase chain reaction (qPCR)–based assays indicated that, at the time of shipment, each gram of the FMP contained on average 3.2 ×
107 genome equivalents (GEs) of Bifidobacterium animalis subsp. lactis (strain CNCM I-2494)
and 6.3 × 107 GEs of Lactobacillus delbrueckii subsp. bulgaricus (CNCM I-1632, CNCM I-1519).
These results were consistent with previous measurements of the number of colony-forming units
(CFU) in a typical cup of the FMP [4.9 × 107 CFU/g (B. animalis subsp. lactis), 8.4 × 107 CFU/g
(L. delbrueckii subsp. bulgaricus)].
Three fecal samples were obtained over the course of a 4-week period before initiation of
FMP consumption (“pretreatment phase”; see Fig. 1A). Each co-twin then consumed two servings of the FMP per day for 7 weeks (breakfast and dinner). Four fecal samples were collected
at defined intervals during this treatment period, whereas two additional samples were collected
during the 4 weeks after cessation of FMP consumption (“posttreatment phase”; Fig. 1A). Participants kept a daily log of their FMP consumption and stool parameters including frequency.
Statistical analyses of this log indicated that, in this population, FMP consumption was associated
with significantly softer stools but no significant changes in stool frequency (see the Supplemen30

tary Material). However, based on existing regulatory criteria, our study of this small cohort was
insufficiently powered to draw clinical conclusions about these stool parameters. Moreover, the
MZ twin population recruited was composed entirely of healthy individuals, so these data cannot
be used to make statements about the impact of FMP consumption on stool softness in unhealthy
patient populations.
All fecal samples collected during the three phases of this study were frozen at −20°C
within 30 min of their passage and maintained at this temperature during overnight shipment to a
biospecimen repository where they were subsequently stored at −80°C before metagenomic analyses. To assess intra- and interpersonal variations in microbial community structure, we performed
multiplex 454 FLX pyrosequencing of amplicons generated from variable region 2 of bacterial
16S rRNA (ribosomal RNA) genes present in fecal DNA. A total of 431,700 sequencing reads
were obtained from 126 fecal samples (3426 ± 2665 sequences per sample; table S2A). Noise due
to PCR and pyrosequencing artifacts was removed from this data set using software incorporated
into the QIIME suite of 16S rRNA analysis tools (9). Denoised reads were binned into specieslevel phylogenetic types (phylotypes), with a species defined as isolates that share ≥97% identity
in their 16S rRNA gene sequence. To ensure even coverage across samples, we subsampled each
of the 126 data sets to 1640 reads per fecal microbiota. A phylogenetic tree was built from one
representative sequence from each phylotype using FastTree’s approximately maximum-likelihood implementation (10) and communities were compared using unweighted UniFrac (11): The
UniFrac metric measures community similarity based on the degree to which their members share
branch length on a reference phylogenetic tree of Bacteria.
To quantify temporal variation in community composition within and between MZ twins,
we generated a matrix of unweighted UniFrac distances for all pairwise comparisons of all 126
fecal samples obtained from the twins in our study. This matrix allowed us to compare any two
fecal communities separated by all possible time intervals between sampling for each individual
in each of the seven twin pairs (Fig. 2A). The results indicated that no matter how far apart in time
sample collection occurred (1 week to 4 months), the phylogenetic distance between communi31

ties from the same individual was less than the distance between communities between co-twins
or unrelated individuals. UniFrac distances between samples harvested from a given individual
increased modestly as a function of time during the 4-month period, although the changes were not
statistically significant (Fig. 2A).
Each sample contained 163 ± 3 (mean ± SEM) observed species-level phylotypes. Four of
the total 1673 phylotypes identified in our data set were found in all 126 samples; all belonged to
the family Lachnospiraceae (order Clostridiales; phylum Firmicutes) and represented 2.5 ± 0.04%
of the 16S rRNA sequences in each sample. We determined that 26.4 ± 0.4% of species-level
phylotypes observed in a given sample were consistently represented in all nine samples from
that individual (Fig. 2B): The family-level taxa to which these species belong consist principally
of Lachnospiraceae, Ruminococcaceae, and Veillonellaceae (phylum Firmicutes); the Bacteroidaceae and Rikenellaceae (phylum Bacteroidetes); and Coriobacteriaceae (phylum Actinobacteria).
Moreover, 13.7 ± 0.2% of the observed phylotypes were represented in all samples from both cotwins (Fig. 2B).
Impact of FMP consumption on fecal bacterial community composition. A qPCR assay disclosed that 1 week after initiation of FMP consumption, the level of representation of B.
animalis subsp. lactis (CNCM I-2494) was 107 cell equivalents per gram of feces; this level was
sustained in all 14 individuals throughout the ensuing 7 weeks of FMP consumption (that is, there
were no statistically significant differences between the 1-, 2-, 4-, and 7-week time points as determined by Friedman test with post hoc correction). The Spearman correlation test revealed no significant effect of human family membership on the levels of B. animalis subsp. lactis during FMP
consumption. Levels fell to below the limits of detection of the assay in all but four participants
within 2 weeks of cessation of FMP consumption (fig. S1); two of these individuals represented a
twin pair, whereas the other two individuals were unrelated to each other.
Co-occurrence analysis (see the Supplementary Material) indicated that with the FMP dosing schedule used, no species-level phylotypes present in the pretreatment microbiota exhibited a
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statistically significant change in their proportional representation in feces in any individual, during or after the period of FMP consumption. In addition, no species-level taxa that were undetected
in the pretreatment period appeared and persisted during and/or after treatment in any individual
[paired t test, analysis of variance (ANOVA)]. It is possible that with even deeper sampling, differences might be revealed in feces or may exist in more proximal regions of the gut. Further details
of this co-occurrence analysis, including the results of tests at the genus and family level, plus
deeper sequencing of a subset of twin pairs are provided in the Supplementary Material.
Effects of FMP consumption on the functional gene repertoire of the fecal microbiome. To determine the effects of FMP consumption on the representation of gene functions in the
microbiome, we performed shotgun sequencing on 48 of the fecal DNA preparations generated
from four of the MZ twin pairs (n = 6 samples per individual; two fecal samples obtained before,
two during, and two after cessation of FMP consumption; see Fig. 1A). Two of these twin pairs
lived together, whereas two pairs lived 3 and 932 miles apart. A 634-Mb data set was generated
(60,863 ± 28,775 sequences per sample; average length, 238 nucleotides; table S2B). A BLASTX
search against version 54 of the Kyoto Encyclopedia of Genes and Genomes (KEGG) GENES database (12–14) yielded a total of 2205 ± 26 (mean ± SEM) KEGG Orthology identifiers (KOs) per
microbiome sample: 64% of the KOs in a given sample (1417 ± 46) were consistently represented
in all 6 samples from that individual; 55% were consistently represented in all samples from both
co-twins; 892 KOs (41% of the total KOs in a given sample) were identified in all 48 samples
forming a core set of shared fecal microbiome-associated functions. Figure 2C provides a visual
representation of this conserved set of 892 KOs: 38% of the 892 belong to six KEGG categories:
“membrane transport,” “carbohydrate metabolism,” “DNA replication and repair,” “amino acid
metabolism,” “translation,” and “metabolism of cofactors and vitamins.”
The proportional representation of KEGG pathways and their component KOs was subsequently calculated for each of the 48 microbiomes. The microbiomes were then subjected to
all possible pairwise comparisons on the basis of these two classification schemes. The results,
quantified using the Hellinger distance metric, disclosed that over time, unlike the UniFrac-based
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16S rRNA comparisons of community bacterial species composition, there was no significant difference in the degree of similarity of microbiome functional profiles for a given co-twin compared
to the degree of similarity that existed between co-twins (that is, intrapersonal variation was not
significantly different from interpersonal variation between co-twins). However, as with the UniFrac results, individual and twin pair microbiomes were significantly more similar to one another
than those from unrelated individuals (Fig. 2D). No KEGG pathways or KOs exhibited a statistically significant change in their relative abundance in response to FMP consumption in any of the
subjects at any of the time points (Student’s paired t test and two-way ANOVA with Bonferroni
post hoc testing).
At this point in our analysis, the human studies indicated that exposure of a healthy individual’s resident gut microbiota to the FMP strains did not produce a detectable perturbation in
fecal bacterial species composition, nor did it have a broad effect on the functional profile of fecal
microbiome genes. To help guide further analysis of the human data sets, we turned to a simplified
in vivo model of the human gut microbiota. We based our selection of model community members
on several criteria. All members of this model community, or their close relatives, would be represented in the fecal microbiota of the MZ twins and other sampled human populations. They would
encompass the three major bacterial phyla present in this host habitat (Firmicutes, Bacteroidetes,
and Actinobacteria) and would have deep draft or finished genome sequences available. Gnotobiotic mice harboring such a model human microbiome would be used to characterize the impact of
FMP strain introduction on the community’s species and microbial gene abundances, as well as
the microbiome’s transcriptional profile, and to ascertain the impact of the model community on
the abundance and gene expression profiles of the FMP strains whose genome sequences were also
known. The knowledge gleaned would then be used to help guide further analysis of the human
fecal microbiome data sets, including microbial RNA-Seq data sets generated from a subset of the
human fecal samples.
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Studies in gnotobiotic mice
Study design. A community of 15 sequenced human gut-derived microbes containing a total of
58,399 known or predicted protein-coding genes was constructed (Fig. 1B and table S3). Figure
S2 uses assigned KOs to provide evidence of the functional similarity of this model human microbiome to a collection of 127 genomes generated from cultured members of the human gut microbiota, a deeply sampled set of fecal microbiomes obtained from 124 unrelated Europeans (1), and
deeply sampled microbiomes from a pair of obese MZ co-twins (15).
Figure 1B presents the study protocol. Two groups of adult 6- to 8-week-old germ-free
C57BL/6J male mice were colonized with a single gavage of the 15-member community (6 ×
106 CFU per member, total of 9 × 107 CFU). Each group (n = 5 animals) was maintained on a
low-fat, plant polysaccharide–rich diet. Fourteen and 15 days after gavage with the 15-member
community, both groups of mice were inoculated with a mixture of the five FMP strains. One
group received a second pair of gavages of the five strains 7 and 8 days later, and a third pair 21
and 22 days after the first inoculation of the FMP consortium (multiple-treatment group). Each
gavage consisted of a community composed of 2 × 107 CFU: 25% (5 × 106 CFU) Streptococcus
thermophilus, 25% B. animalis subsp. lactis, and 25% Lactococcus lactis subsp. cremoris, with
the remaining 25% split between the two L. delbrueckii subsp. bulgaricus strains (12.5% each; 2.5
× 106 CFU per strain). Dosing was based on the following considerations: (i) a daily dose of two
cups of the FMP contains ~1010 CFU of B. animalis subsp. lactis; (ii) assuming ~1014 bacteria in
the human gut, the ratio of the number of input B. animalis subsp. lactis CFU to the human gut
symbiont population is about 10−4; (iii) to maintain this ratio of 10−4 in mice, and assuming 1011 to
1012 organisms in the mouse gut, we administered a total of 107 B. animalis subsp. lactis CFU per gavage period (one period equals two gavages within 24 hours); (iv) the difference in CFU between
the least and the most abundant microbial species in the FMP product remains less than or equal
to twofold during manufacture and storage; therefore, each species in the gavage was represented
at equivalent levels.
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FMPs contain defined collections of microbes, a dairy matrix, and products of microbial
metabolism of this matrix generated during manufacturing and storage. In principle, the dairy matrix and microbial metabolic products could be responsible for some of the effects observed when
humans consume an FMP. Nonetheless, we chose to administer the strain consortium to mice directly by gavage, rather than by giving them the corresponding commercial FMP. This allowed us
to more precisely control dosing. It also allayed concerns about possible unintended colonization
of the gnotobiotic mice with microbial species (other than strains deliberately introduced during
manufacturing) that could be introduced during handling of an FMP before gavage.
The repertoire of carbohydrate-active enzymes in members of the FMP consortium
and model human gut microbial community. The genomes of the five FMP strains in this study
were sequenced, either completely (B. animalis subsp. lactis) or at a deep draft level (other four
strains) for subsequent analyses of their representation in the model community after gavage of
gnotobiotic mice, and so we could define their in vivo patterns of gene expression (table S3).
Analysis of the 48 carbohydrate-active enzyme (CAZyme) families (16) identified in the five
FMP strains and the 126 CAZyme families identified in the 15-member model human microbiota
disclosed that 23 of the 24 CAZyme glycoside hydrolase (GH) families, 11 of the 12 glycosyltransferase (GT) families, 4 of the 4 carbohydrate esterase (CE) families, and 4 of the 8 carbohydratebinding modules (CBMs) represented in the former were also represented in the latter. The FMP
consortium contains only six CAZyme families that were not represented in the model human gut
community. Three of these are associated with L. lactis subsp. cremoris: of these, two are predicted
to play roles in the binding and metabolism of chitin (fig. S3 and table S4). The other three are
from B. animalis subsp. lactis: BALAC2494_01193 encodes a GT39 family mannose transferase
involved in O-glycosylation of proteins; BALAC2494_01288 specifies a predicted β-mannanase
carrying a C-terminal CBM10 module predicted to bind cellulose; BALAC2494_01971 gives rise
to a protein with a CBM23 module predicted to bind mannan.
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Minimal changes in the species representation of the 15-member model human gut
microbiota after introduction of the FMP strain consortium. We used COmmunity PROfiling by Sequencing (COPRO-Seq), a generally applicable method based on highly parallel DNA
sequencing (17), to quantify the proportional representation of each component of the 15-member microbiota and of the FMP consortium in our gnotobiotic mice. Sequencing reads generated
from fecal DNA samples collected before, during, and after introduction of the FMP strains were
analyzed as described in fig. S4A. Briefly, “informative” tags (that is, reads that can be mapped
uniquely to a single genome) were first identified. Informative tags were then summed by species to generate digital “counts” of abundance. In cases where a read could not be assigned with
certainty during COPRO-Seq analysis, it was ignored. To account for this fact, we normalized
species-specific counts using their “informative genome size” (defined as the percentage of all
possible k-mers a genome can produce that are unique multiplied by the total genome length).
Multiplex sequencing using the Illumina GA-IIx instrument yielded sufficient numbers of reads
per sample so that an organism comprising ≥0.003% of the community could be detected: For a
mouse colonized at 1011 to 1012 CFU/ml cecal contents or feces, this represents 106 CFU/ml.
COPRO-Seq produced several notable findings. First, community assembly before introduction of the FMP strains occurred in a highly reproducible manner, both within and between the
two groups of animals (fig. S5A and table S5A). This reproducibility ensured that animals in both
treatment groups harbored communities with structures comparable to one another at the time of
administration of the five-member FMP strain consortium. Second, within 1 week of introducing
the FMP strains, either in a single treatment or in multiple treatments, B. animalis subsp. lactis and L. lactis were detectable in the fecal microbiota (fig. S5B and table S5A). These two species persisted in the gut throughout the study. Importantly, B. animalis subsp. lactis was the most
prominently represented member of the FMP consortium in the model human gut microbiota,
exhibiting a progressive increase in its representation during the 28 days after initial introduction,
and reaching comparable levels in both the single- and the multiple-treatment groups (up to 1.1%;
see fig. S5B). In contrast, S. thermophilus and the two strains of L. delbrueckii subsp. bulgari37

cus were undetectable or intermittently just over the limit of detection in the single- or the multipletreatment groups. Third, as with the MZ twin pairs, introduction of the consortium led to minimal
rearrangements in overall community structure, whether or not the consortium was administered
twice in a 2-day period or on two subsequent occasions (see table S5B for the results of MannWhitney tests of significance for each species at each time point surveyed relative to the time point
just before initial introduction). Collinsella aerofaciens, the lone Actinobacteria in the 15-member
community, showed a significant reduction in its abundance in both treatment groups immediately
after FMP strain introduction (fig. S5C) that persisted through later time points, raising the possibility of a competitive relationship between this organism and B. animalis subsp. lactis, the only
Actinobacteria in the FMP strain consortium.
The Bacteroides thetaiotaomicron component of the 15-member human gut microbiota
was composed of a library of 34,544 randomly inserted transposon mutant strains covering 3435 of
the organism’s 4779 genes (72%). As noted in the Supplementary Material and table S6, by comparing the representation of mutants in fecal samples before and after introducing the FMP strains,
we were able to determine that their presence did not affect the profile of B. thetaiotaomicron’s
genetic determinants of fitness in the distal gut.
Microbial RNA-Seq analysis of the response of B. animalis subsp. lactis to the gut environment and members of the 15-member community to the FMP strain consortium. Moving beyond COPRO-Seq–based structural analysis, we performed microbial RNA-Seq analysis to
determine the functional impact of exposing the established model human community to the FMP
strains and to ascertain which FMP consortium genes are most highly expressed in the intestines of
these animals. B. animalis subsp. lactis attained sufficient abundance in gnotobiotic mice to allow
profiling of its transcriptome at late time points (days 35, 36, and 42). When its in vivo patterns
of gene expression were compared with those documented during mid-log and stationary phase
in MRS medium and in the commercial FMP (see the Supplementary Material and table S7), we
noted that theBALAC2494_00604-BALAC2494_00614 locus, encoding enzymes involved in the
catabolism of xylooligosaccharides (18), was strongly up-regulated in vivo (average across the
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locus; 27-fold at the day 42 time point compared to mid-log phase in MRS monoculture; 128-fold
compared to the FMP; table S7). Xylose is the main building block of dietary hemicelluloses.
Addition of this pentose sugar is also one of the first steps in O-glycosylation of host mucins.
These results support previous observations suggesting that xylooligosaccharides may serve as
potent “bifidogenic factors,” whose consumption increases the densities of Bifidobacteria in the
gut (19, 20).
Ordination of samples and B. animalis subsp. lactis CAZyme gene expression patterns by
correspondence analysis identified additional CAZymes that correlate strongly with the in vivo
state (Fig. 3), including members of families expected to play roles in the degradation of dietary
plant polysaccharides [GH43 (xylan β-xylosidases), GH77 (4-α-glucanotransferases)]. The analysis revealed sets of B. animalis subsp. lactis CAZymes that corresponded well with each growth
condition (that is, MRS medium, commercial dairy matrix, and mice). Within each growth condition, the expressed groups of CAZymes often had related functions (Fig. 3).
We next examined the impact of the FMP strain consortium on expression of genes in the
15-member community. In a “top-down” analysis, genes were binned by function and the community’s metatranscriptome was evaluated in aggregate, ignoring the species from which each
transcript arose. A complementary “bottom-up” analysis allowed us to determine how each species
in the community responded to the introduction of the FMP consortium.
Top-down analysis of the impact of the FMP strains on the community metatranscriptome
revealed significant increases in expression of genes falling within the KEGG categories carbohydrate metabolism and “nucleotide metabolism,” whereas decreases were observed in amino
acid metabolism and “lipid metabolism” (Fig. 4A and table S8). Peak responses in both treatment
groups occurred 3 weeks after the first gavage of the FMP strains, corresponding to the time of
highest representation of B. animalis subsp. lactis in the community.
The genes that exhibited the highest fold change in expression were heavily skewed toward
the KEGG categories carbohydrate metabolism and membrane transport. The latter includes a
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number of adenosine triphosphate–binding cassette (ABC)– and PTS (phosphotransferase system)–type carbohydrate transporters (table S9). When these KEGG category–level responses were
subsequently broken down into KEGG pathways (Fig. 4B), it was apparent that the most significant
responses in the carbohydrate metabolism category involved increases in “starch and sucrose metabolism,” “fructose and mannose metabolism,” and “pentose and glucuronate interconversions.”
Transcript data were subsequently binned by enzyme commission (EC) number. The levels
of mRNAs encoding these ECs at each time point were compared using ShotgunFunctionalizeR,
an R-based statistical and visualization tool originally designed to identify genes significantly enriched or depleted in environmental microbiomes (21, 22). Using this approach, we were able to
determine that the starch and sucrose metabolism pathway response to the FMP strains was driven
by significant up-regulation of genes encoding three enzymes involved in metabolism of dietary
plant polysaccharides: (i) EC 3.2.1.65 (levanase; Fig. 4C), which cleaves 2,6-β-D-fructofuranosidic
linkages in 2,6-β-D-fructans (levans); (ii) EC 3.1.1.11 (pectinesterase), which de-esterifies pectin
to pectate and methanol; and (iii) EC 2.4.1.20 (cellobiose phosphorylase), which uses cellobiose
formed from partial hydrolysis of cellulose as its substrate to generate α-D-glucose-1-phosphate
and D-glucose. The genes encoding these ECs, which catalyze early steps in three entry points
of the starch and sucrose metabolism KEGG pathway, underwent significant increases in their
expression within 24 hours after introduction of the FMP consortium (Fig. 5A). The levels of expression of these genes either increased further (levanase) or were sustained (the other two ECs)
in both the single- and the multiple-treatment groups through the remaining 4 weeks of the experiment (Fig. 5A). The levanase response showed remarkable species specificity: This gene is represented in 8 members of the 15-member community, yet the community’s transcriptional response
is driven almost exclusively by the levanase in Bacteroides vulgatus (BVU_1663; Fig. 4C). In
contrast, the pectinesterase response was distributed across six members of the community (Bacteroides caccae, Bacteroides ovatus, B. thetaiotaomicron, B. vulgatus, Bacteroides WH2, C. aerofaciens), with changes in transcription largely due to pectinesterase genes found in B. ovatus (BACOVA_03576, BACOVA_03581, BACOVA_04902), B. thetaiotaomicron (BT_4109, BT_4110), B.
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vulgatus (BVU_1116), and B. WH2 (BACWH2_3569, BACWH2_3615). Increases in the proportional abundance of cellobiose phosphorylase transcripts reflected the contributions of three community members: Bacteroides uniformis, Eubacterium rectale, and Ruminococcus obeum (table
S8).
The KEGG starch and sucrose metabolism, pentose and glucuronate interconversions,
and “pentose phosphate” pathways process products generated by these three enzymes. Figure
5B shows that many of the other components of these pathways are up-regulated in the 15-member
community when the FMP strain consortium is introduced. ShotgunFunctionalizeR also identified
significant increases in the expression of genes encoding five ECs that participate in the generation
of propionate and succinate: The induction occurred within 24 hours after the FMP strains were
introduced and involved acetate kinase (EC 2.7.2.1; catalyzes a bidirectional reaction between
propanoyl phosphate and propionate), phosphate acetyltransferase (EC 2.3.1.8), methylmalonylCoA (coenzyme A) decarboxylase (EC 4.1.1.41), propionyl-CoA carboxylase (EC 6.4.1.3), and
methylmalonyl-CoA mutase (EC 5.4.99.2, yields succinyl-CoA as its product) (fig. S6). Only a
single treatment with the FMP consortium was required to produce a sustained response involving
the enzymes that can yield propionate (fig. S6).
A breakdown of RNA-Seq reads by the community member genome to which they mapped
revealed that the abundance of a species in the 15-member community did not necessarily correlate with its contribution to the community transcript pool. At the time point sampled immediately
before invasion (day 14), two of the most extreme outliers were B. WH2 [comprised 39.6 ± 1.6%
(mean ± SD) of the community but only contributed 15.4 ± 2% of the raw reads to the total RNASeq read pool] and R. obeum (2.1 ± 0.4% of the community; 18.2 ± 4.4% of the transcript pool)
(fig. S7). These observations indicate that community-level transcriptional responses can be driven
by species representing small fractions of the microbiota.
Our bottom-up analysis is summarized in fig. S8 and table S10, and disclosed early- and
later-responding species. Specifically, there were more significantly highly regulated R. obeum
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transcripts within the community metatranscriptome 1 day after gavage than would be expected
based on its community representation, and more highly regulated R. obeum genes in the comparison between day 14 (just before gavage) and day 15 metatranscriptomes than between day 14
and day 42 metatranscriptomes. In contrast, B. WH2, Clostridium scindens, and B. uniformis were
defined as late responders to the FMP consortium.
Identifying predictive features from the model community metatranscriptome data
using a random forests classifier. Machine learning techniques using the random forests classifier can be applied to metagenomic data (23) to learn a function that maps a set of input values
or predictors (in this case, relative abundance of KEGG categories, KEGG pathways, or ECs in
a community) to a discrete output value (here, the presence/absence of the FMP strains). KEGG
categories, KEGG pathways, and ECs were all able to predict pretreatment/posttreatment status
with low estimated generalization error (KEGG categories, 6.7%; ECs, 13.3%; KEGG pathways,
10.0%). In all cases, these generalization error rates were less than half of the baseline error rate
of 33% (that is, that achieved by always predicting the largest category). There were 11 predictive
and 5 highly predictive KEGG categories, 35 moderately predictive ECs, and 27 predictive and 4
highly predictive KEGG pathways (table S11). The predictive ECs identified using our supervised
classification approach include a number of carbohydrate metabolism–related functions that were
also identified using ShotgunFunctionalizeR in our top-down analysis.
Metabolomic analyses. To evaluate the impact of invasion with the five-member FMP
consortium on microbial-host co-metabolism, we performed untargeted gas chromatography–
mass spectrometry (GC-MS) on urine samples collected at multiple time points (days 0, 14, and
42) from members of the single- and multiple-treatment groups (Fig. 1B). A metabolite profile was
constructed for each urine sample (n = 19) using the spectral abundances of all identifiable metabolites. A total of 198 metabolites met our reverse match score cutoff of 65% and were present in
at least 50% of samples at one or more time points [for an explanation of the reverse match score,
see (24) and table S12]. Comparing day 0 and 14 samples revealed 39 metabolites whose levels
were significantly higher or lower after colonization with the defined 15-member community (see
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table S12A). The changes included decreases in the levels of oligosaccharides we would expect
to be consumed by members of the microbiota [melibiose (87% decline); raffinose/maltotriose
(98%); note that oligosaccharides are by their nature difficult to identify with certainty with the
present, nontargeted GC-MS technique, and our annotations of these metabolites as melibiose and
raffinose/maltotriose are provisional]. The observed 3.4-fold increase in pyrogallol, a polyphenol,
is consistent with the known ability of many gut microbes to cleave these molecules from polyphenols present in dietary plant material. A 4.4-fold increase in taurine after the initial colonization of
mice was also noted, probably a result of microbial deconjugation of taurine from bile compounds.
Table S12B lists urinary metabolites that change significantly after introducing the five
FMP strains (compare day 14 versus day 42 in table S12B). Fructose and xylose were not significantly affected by the introduction of the defined 15-member community but increased significantly after the introduction of the FMP strain consortium (2.3- and 2.9-fold, respectively; Fig. 6,
A and B). Increases in fructose may reflect an enhanced capacity of the community to liberate this
monosaccharide from levan and other polyfructans via levanase-catalyzed reactions. Increases in
xylose might be explained by the additional xylanase activity introduced by B. animalis subsp.
lactis (Fig. 3) or, alternatively, by the induction of microbiome genes encoding xylan-degrading
enzymes (for example, BACOVA_04387and BACOVA_04390, which were up-regulated 5.2- and
11.0-fold, respectively, after introduction of the FMP strains; table S10). Changes in other metabolites such as xanthosine (Fig. 6C), a purine metabolite, suggest that the metabolic consequences of
FMP strain introduction extend beyond the processing of carbohydrates.
Collectively, our transcriptional and metabolite analyses indicated that introducing FMP
strains that constitute a small fraction of a defined model human gut microbiota signals the microbiota to change its metabolic activities, including activities related to carbohydrate metabolism.
With this information in hand, we returned to the human fecal samples to determine the extent to
which observations made in our gnotobiotic mouse model were applicable to humans.
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Microbiome transcriptional responses to FMP strains that are shared by gnotobiotic
mice and humans. Microbial RNA-Seq analysis was performed on human fecal samples obtained
1 week before FMP consumption, 1 and 4 weeks into the consumption period, and 4 weeks after
cessation (both co-twins from family 1; one co-twin from family 3; see table S1). Using an analysis
pipeline comparable to the one used for the mouse data, we first aligned all RNA-Seq reads against
a reference set of 131 human gut microbial genomes plus the FMP strain genomes, binned the
aligned transcripts on the basis of their EC annotations, and used ShotgunFunctionalizeR to identify ECs whose abundances were significantly changed as a function of FMP exposure (BenjaminiHochberg adjusted P < 0.01).
Categorical analysis of the responses of the human fecal community to FMP consumption
revealed that significantly up-regulated ECs were principally distributed among the KEGG categories carbohydrate metabolism, amino acid metabolism, and metabolism of cofactors and vitamins
(see table S13 for a complete list of ECs identified from the various pairwise comparisons of time
points).
Figure 7 highlights the 86 ECs that were significantly changed (P < 0.01) in the same
direction in all humans and in all sampled mice as a function of exposure to the FMP strain consortium. Similar to our findings in mice, the most prominently represented KEGG category among
up-regulated gene functions in all comparisons of human metatranscriptomes was carbohydrate
metabolism (Fig. 7). The three ECs involved in entry points in the KEGG starch and sucrose
metabolism pathway [levanase (EC 3.2.1.65), pectinesterase (EC 3.1.1.11), and cellobiose phosphorylase (EC 2.4.1.20)] were significantly up-regulated within 1 week after FMP consumption
was initiated in the humans surveyed. This transcriptional response was sustained in the case of
levanase and pectinesterase and ceased (fell to below the limits of detection) within 4 weeks after
FMP administration was stopped (Fig. 5A).
ECs involved in succinate and propionate metabolism (EC 2.7.2.1 and EC 6.4.1.3) were
also up-regulated in the human fecal metatranscriptome within 1 week of the initiation of FMP
44

consumption (FMP1 versus Pre1, Fig. 7). As with levanase, pectinesterase, and cellobiose phosphorylase, this response was sustained during and subsided after the period of FMP consumption
(see “FMP4 versus Pre1” and “FMP1 versus Pre1” in Fig. 7 and table S13).
Human fecal transcripts were detected that mapped to the B. animalis subsp. lactis genome
(see the Supplementary Material). The presence of these transcripts was limited to the period of
FMP consumption, supporting the notion that they emanated from the FMP strain rather than from
a related species present within the microbiota (fig. S9). This clear linkage to FMP consumption
was not evident in the case of other members of the consortium, so we could not confidently analyze their patterns of gene expression in vivo. The highest number of mapped reads to the B. animalis subsp. lactis genome was obtained 1 week after FMP administration began: Among the 4000
reads, we were able to detect transcripts from all but 1 of the 10 genes in the BALAC2494_00604BALAC2494_00614 locus that encodes enzymes involved in the catabolism of xylooligosaccharides, leading us to conclude that this locus is highly expressed in the distal human gut, just as it is
in our mouse model.
Discussion
Repeated sampling of seven healthy MZ adult twin pairs over a 4-month period emphasized that
intrapersonal variation in bacterial community structure was less than interpersonal variation, with
co-twins having significantly more similar phylogenetic and taxonomic structure in their fecal
microbiota compared to those from unrelated individuals (9, 25, 26). The results also showed that
(i) consumption of an FMP containing five bacterial strains was not associated with a statistically
significant change in the proportional representation of resident community members within and
between individuals; (ii) the appearance and disappearance of strains comprising the FMP consortium did not exhibit familial patterns in the fecal microbiota; and (iii) B. animalis subsp. lactis CNCM I-2494 was the most prominent assayed member of the consortium represented in the
microbiota during the 7-week period of FMP consumption. Analyses of the fecal gene repertoire
over the course of the 16 weeks of the experiment indicated that (i) variations in the functional fea45

tures of the (fecal) microbiome were less than the variations in bacterial species composition; (ii)
there was no significant difference in the degree of similarity in representation of KEGG orthology
group functions for a given co-twin at each time point compared to the degree of similarity that
existed between co-twins, whereas individual and twin pair microbiomes were significantly more
similar to one another than those from unrelated individuals; and (iii) there were no statistically
significant changes in the representation of these functions when the FMP strain consortium was
being consumed. With these findings in mind, and with each individual as well as each genetically
identical co-twin serving as a control, we concluded that at least at the depth and frequency of
sampling used for this small healthy cohort, the bacterial species and gene content of their fecal
microbiota/microbiome were not an informative biomarker for understanding whether or how this
commercial FMP affected microbial community properties.
Gnotobiotic mice harboring a model 15-member gut microbial community that represented
the three principal bacterial phyla present in the human gut microbiota, and whose 58,399 known
or predicted protein-coding genes encompassed many of the prominent functions present in the
normal adult human fecal microbiome, provided a means for characterizing the impact of the fivemember FMP strain consortium on expressed gut microbial community functions and then applying the results to the human fecal specimens collected for this study. As with the MZ twins, introduction of the five-member strain consortium did not significantly affect the representation of the
15 species that make up the model human microbiota. As with the MZ twins, B. animalis subsp.
lactis exhibited the greatest fitness of the five FMP strains in the gut, as judged by its prominence
and persistence. Unlike the human arm of the study, where all subjects consumed the FMP twice
daily, the design of the mouse study, with its single- versus multiple-treatment regimens, allowed
us to directly compare the persistence of FMP consortium members. Only B. animalis subsp. lactis and L. lactis subsp. cremoris were able to maintain a foothold in the gut ecosystem at detectable
levels for the entire 4-week monitoring period after a single dose. In addition, colonization levels
were not affected by the number of times the FMP strains were administered to mice.
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An advantage of constructing the model human gut microbiome was that its entire predicted gene repertoire was known. This allowed us to define the impact of introducing the FMP
strain consortium on the functions expressed by the overall community as well as by its individual
components. A major theme emanating from our analysis was the effect of introducing the FMP
consortium on carbohydrate metabolism by the community, as well as the effect of the community on a feature of carbohydrate metabolism by B. animalis subsp. lactis. The model 15-member
community responded to the FMP consortium by inducing genes encoding enzymes involved in
catalyzing reactions that represent the three entry points into the KEGG “starch and sucrose metabolic pathway,” as well as enzymes that catalyze fermentation of carbohydrates to propionate. The
mechanism by which the FMP strains elicit this response is unclear at present, but the effect is
rapid (occurring within the first 24 hours after invasion) and was persistent whether the consortium
was introduced in a single set of gavages during a 1-day period or with subsequent repeated gavage
over a several-week period. The persistence of both the carbohydrate pathway response and of B.
animalis subsp. lactis suggests but does not prove that the latter may be instrumental in instigating
and maintaining the former.
Intriguingly, the carbohydrate response showed features of “differentiation.” As noted in
the Results section, the levanase response was driven almost entirely by changes in transcription
in just a single species (B. vulgatus), the pectinesterase response by six community members (B.
caccae, B. ovatus, B. thetaiotaomicron, B. vulgatus, B. WH2, and C. aerofaciens), and the cellobiose phosphorylase response by three components of the defined model human gut microbiota
(B. uniformis, E. rectale, and R. obeum). Of the 50 genes with predicted xylan-degrading capacity in the model microbiome (that is, those encoding enzymes in ECs 3.2.1.37 and 3.2.1.8), only
BACOVA_04387 and BACOVA_04390 (both from B. ovatus) were significantly up-regulated after
FMP strain introduction (this is ignoring xylanase genes encoded by FMP strains like B. animalis
subsp. lactis). This up-regulation in a limited subset of the model community coincides with an
increase in urinary xylose.
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The ability to attribute EC-level changes to individual genes in specific bacterial species
was not possible with our RNA-Seq analysis of the human fecal samples. The differentiation of
carbohydrate responses among bacterial species documented in gnotobiotic mice emphasizes a
challenge and opportunity that can be addressed in these models, namely, to further delineate the
niches, interactions, and adaptive resource switching behaviors of community members by intentional addition, removal or substitution of taxa, and/or their modification through genetic manipulation. Although requiring significantly more animals and loss of the ability to use an animal as its
own control, future studies could be expanded to include sampling of community gene expression
in different segments of the small intestine.
The increased expression of genes encoding enzymes involved in the interconversion of
propionate and succinate is intriguing given the fact that this short-chain fatty acid has been linked
in some reports to effects on gastrointestinal transit time. However, work in this area has yielded
varying results and conclusions, perhaps because of the diversity of models and methodological
approaches used (27–30). Propionate may also link the gut microbiota and human physiology
through its effects on hepatic and adipose tissue metabolism (31). Notably, another group has reported that in the T-bet−/−Rag2−/− mouse model of colitis, consumption of an FMP containing a dairy
matrix plus the same strains used in this study led to increased cecal propionate levels and a reduction in intestinal inflammation (32).
The extent of translatability of data from gnotobiotic mouse models harboring collections
of sequenced representatives of the human gut microbiota to humans themselves needs to be tested
further, not only at the transcriptional level but also at the level of community-host co-metabolism.
Although current models can and should be evolved to embrace more of the diversity present in
our gut communities, even with current limitations, they can serve as part of a preclinical discovery
pipeline designed to identify candidate biomarkers and mediators of the effects of existing or new
probiotic strains on the properties of microbial communities and their hosts. They also represent
an analytical tool for characterizing the effects of specified dietary components on the indigenous
gut community and on probiotic species that are deliberately consumed. The results could yield
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new candidate prebiotics that may affect the representation and metabolic properties of probiotic
species or entrenched members of our gut microbiota and provide the proof-of-mechanism and
proof-of-principle observations needed to justify, direct, and interpret human studies.
Materials and methods
Human studies
Subject recruitment. Seven MZ female twin pairs aged 21 to 32 years with body mass indices
ranging from 20 to 25 kg/m2 were recruited for this study. These twins were long-standing participants in the Missouri Adolescent Female Twin Study (MOAFTS) (26, 33). Procedures for obtaining consent, for providing fecal samples, and for maintaining diaries of FMP consumption, and
stool frequency and consistency were approved by the Washington University Human Studies
Committee.
Other procedures. Methods used for the production and distribution of the FMP to study
participants, analysis of the effects of FMP consumption on stool parameters, qPCR analysis of
fecal levels of FMP strains (table S14), multiplex pyrosequencing of 16S rRNA genes in fecal samples and the FMP, co-occurrence analysis, and shotgun sequencing of human fecal microbiomes
are described in the Materials and Methods section of the Supplementary Material. Sequenced human gut–associated microbial genomes used to analyze the human fecal RNA-Seq data are listed
in table S15.
Studies in gnotobiotic mice
Colonization of germ-free mice. The justification for using mice and the protocols used for treating
them were approved by the Washington University Animal Studies Committee. Animals belonging
to the C57BL/6J inbred strain were maintained in plastic flexible film gnotobiotic isolators and fed
a standard autoclaved chow diet (B&K rat and mouse autoclavable chow #7378000, Zeigler Bros
Inc.) ad libitum. Two groups of 6- to 8-week-old germ-free male animals (n = 5 per group) were
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colonized with a single gavage of 500 μl of supplemented TYG medium (TYGs) (34) containing
15 sequenced human gut-derived bacterial symbionts (6 × 106 CFU per strain; total of 9 × 107 CFU
for the community). The B. thetaiotaomicron component of this community was composed of a
library of 34,544 transposon mutants prepared as described (34). Fourteen and 15 days later, both
groups of mice were gavaged with a mixture of the five FMP strains (each species at 5 × 106 CFU)
in 300 μl of TYGs. One group of mice received a second pair of gavages 7 and 8 days later, and a
third pair of gavages 21 and 22 days after the initial FMP strain introduction.
Other procedures. Methods used for sampling animals, COPRO-Seq, INSeq, microbial
RNA-Seq, and nontargeted metabolomics via GC-MS, are described in the Methods section of
the Supplementary Material, as are methods for sequencing and annotating FMP strain genomes.
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Footnotes
Accession numbers: The complete genome sequence of Bifidobacterium animalis subsp. lactis
(CNCM I-2494) has been deposited at GenBank under accession number CP002915. The Whole
Genome Shotgun projects for Lactobacillus delbrueckii subsp. bulgaricus (CNCM I-1632, CNCM
I-1519), Streptococcus thermophilus CNCM I-1630, and Lactococcus lactis subsp. cremoris CNCM
I-1631 have been deposited at DDBJ/EMBL/GenBank under accession numbers AGFO00000000,
AGHW00000000, AGFN00000000, and AGHX00000000, respectively. The version of each
of these genomes described in this paper is the first version (CP002915.1, AGFO01000000,
AGHW01000000, AGFN01000000, and AGHX01000000, respectively). COPRO-Seq and RNASeq data are deposited in GEO (accession numbers GSE31943 and GSE31670, respectively),
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Figure legends
Figure 1. Experimental design for human and mouse studies. (A) Human study. Seven healthy
lean MZ female twin pairs were sampled before, during, and after FMP consumption. (B) Gnotobiotic mouse study. Two groups of five germ-free mice were colonized by oral gavage at 6-8 weeks
of age with a 15-member microbial consortium constituting a model human gut microbiota (day
of gavage denoted by black arrows). Two weeks later, the five species FMP strain consortium was
administered by oral gavage to each group of mice twice over two days (denoted by green arrows).
Mice in the single treatment group underwent no further manipulations, whereas animals in the
multiple treatment group received additional two-day gavages one and three weeks following the
first gavage. Samples were collected at the indicated time points for profiling bacterial community
membership (shotgun and 16S rRNA gene sequencing for human fecal samples, COPRO-Seq for
mouse fecal and cecal samples), gene expression profiling (microbial RNA-Seq) and metabolite
analysis (urines, GC/MS). The species comprising the model 15-member human community and
the 5-member FMP consortium are listed in the gray and green boxes, respectively.
Figure 2. Metagenomic studies of human fecal microbiomes sampled over time. (A) 16S
rRNA-based time course study of intra- and interpersonal variations in fecal bacterial community
structure during the course of the 4-month study. Unweighted UniFrac measurements of community distances, from pairwise comparisons of all samples obtained from a given individual, from
co-twins, and from unrelated individuals are plotted as mean values ±SEM. (B) Colored boxes
represent the proportion of bacterial phylotypes that were consistently present within an individual
over time (gray), between co-twins over time (orange), and in all 126 fecal samples (red). The
white box represents the average number of species-level phylotypes found in a given sample.
All measures of spread provided in parentheses represent ±SEM. (C) KEGG Orthology groups
(KOs) consistently present within the fecal microbiome of an individual over time (gray), between
co-twins over time (orange), and in all 48 microbiomes analyzed from the 4 sets of MZ twins during the 4 month study (red). The white box indicates the average number of unique KOs (±SEM)
identified in a particular sample. All measures of spread provided in parentheses represent ±SEM.
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(D) Hellinger distance measurements of fecal microbiomes based on their KO content. Tests of
statistical significance are based on 1000 permutations of a Hellinger distance matrix. Mean values (±SEM) are shown for the three types of comparisons (self-self; co-twin-co-twin; unrelatedunrelated individual).
Figure 3. Correspondence analysis of B. animalis subsp. lactis CAZyme gene expression.
RNA-Seq data for all B. animalis subsp. lactis genes encoding known or predicted CAZymes were
subjected to unconstrained correspondence analysis using the ‘vegan’ package in R. Correspondence analysis (CA) allows for the generation of biplots in which samples and genes can be plotted
in the same ordinate space to reveal associations/anti-associations between the two. Circles represent individual CAZymes (genes). The genes ordinating furthest from the origin in the direction
of one of the sample clusters (treatment groups) are labeled according to their locus number and
are colored based on CAZyme family assignment (see Table to the right of the Figure for details;
the abbreviation NA refers to no designation). Red triangles represent samples and are labeled according to the following nomenclature: LX, logarithmic phase cells in MRS with X being the technical replicate number (e.g. L1 refers to the first technical replicate harvested in log phase); SX,
stationary phase cells in MRS with accompanying replicate number; MX, feces from designated
gnotobiotic animals obtained 4 weeks after the initial invasion with the FMP strain consortium;
PX, samples obtained after fermentation in the FMP dairy matrix. Each cluster of samples from a
particular treatment is associated with a functionally related set of expressed CAZymes.
Figure 4. ‘Top-down’ analysis of the effects of the FMP strain consortium on the model
15-member community’s metatranscriptome. RNA-Seq reads were mapped to the sequenced
genomes of the 15 community members. Transcript counts were normalized [reads per kb of gene
length per million reads (RPKM), see Supplementary Material] and binned using the hierarchical
levels of functional annotation employed by KEGG. For each KEGG category (A) or pathway (B)
shown, boxplots depict the proportion of normalized read counts assignable to that annotation out
of all reads which could be assigned annotations for that hierarchical level. Data shown correspond
to the ‘multiple’ treatment group of mice (the group for which the most time points were collected),
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however, data for all mice are provided in Table S8. (C) Illustration of how a model community’s
functional response (e.g., the increased expression of levanase-encoding genes) can be dissected to
identify the subset of genes/species driving the response. Boxes denote top quartile, median, and
bottom quartile. Whisker length represents 1.5x inter-quartile range (IQR), except where there are
no outliers; in these situations, whiskers span the range from minimum to maximum values. Box
color denotes the day fecal samples were obtained (day 14 is the pre-treatment timepoint immediately preceding gavage of the FMP strain consortium). When an asterisk is centered over a box,
it indicates that there was a statistically significant change following administration of the FMP
consortium relative to the pre-treatment timepoint (p<0.05 by paired, two-tailed Student’s t test).
The positioning of asterisks above versus below a box emphasizes the direction of change (above,
upregulation; below, downregulation).
Figure 5. Mouse and human communities share transcriptional responses to the FMP strain
consortium involving ECs related to carbohydrate metabolism. (A) Box plots of the proportion
of all RPKM-normalized reads in mouse and human fecal metatranscriptomes represented by three
ECs involved in plant biomass degradation. Individual samples are shown as black dots (n=2-10).
Boxes are also colored by fold-change, as determined by comparing mean values at a given time
point to the value at the pre-treatment time point [for gnotobiotic mice pre-treatment refers to day
14; in the case of humans, pre-treatment refers to the fecal sample collected 1 week prior to initiation of FMP consumption (sample ‘Pre1’ in Fig. 1A)]. Statistical significance was determined
using the ShotgunFunctionalizeR package in R and an adjusted p-value cutoff of <0.01. Pre-treatment time points, and subsequent time points where expression levels were not significantly different from the pre-treatment mean are colored white. (B) Components of KEGG ‘starch and sucrose
metabolism’, ‘pentose and glucuronate interconversions’ and ‘pentose phosphate’ pathways whose
expression in the 15-member model community changed compared to pre-treatment values when
the 5-member FMP strain consortium was introduced. Gray indicates that the fold-change was statistically significant (adjusted p-value <0.01). Ovals highlight the three enzymes shown in panel A.
Dashed arrows indicate that multiple enzymatic reactions lead from these ECs and their indicated
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substrates to the products shown. These intermediate reactions have been omitted for clarity or
because the omitted ECs did not manifest significant changes in their expression.
Figure 6. Select urinary metabolites whose levels are altered after the introduction of the
FMP strain consortium into mice harboring a defined model human gut microbiota. The
statistical significance in pairwise comparisons shown in panels A-C was evaluated using a twotailed Student’s t test on the log-transformed spectral abundance of the metabolite in each sample.
Values for the statistical significance of differences between time points as evaluated by one-way
ANOVA, followed by FDR-correction and a post-hoc Tukey HSD test are also provided in Table
S12. Horizontal bars represent group means, vertical bars represent ± SEM. n/s; not significant.
Figure 7. Shared transcriptional responses to FMP strain exposure in mice and humans. The
heatmap shows ECs that exhibit a statistically significant change in their expression (ShotgunFunctionalizeR, adjusted p < 0.01) and manifest a consistent direction of change in their expression in all four comparisons shown. Comparisons include those where the pre-treatment timepoint
was compared with a timepoint shortly after FMP strains were introduced (mouse: ‘d15 vs d14’,
human: ‘FMP1 vs Pre1’) and those where the pre-treatment period was compared to a timepoint
several weeks after strain introduction (mouse: ‘d42multi vs d14’, human: ‘FMP4 vs Pre1’).
‘d42multi’ indicates the multiple-treatment group at day 42 of the mouse experiment. The colored
boxes correspond to the KEGG categories that contain the ECs shown to the right of the heatmap.
The scale refers to fold-difference in the mean of relative abundance of each EC between treatment
and pre-treatment groups based on the mean number of normalized reads (RPKM) of transcripts
assigned to a given EC. The 18 ECs shown at the bottom of the Figure are not associated with the
five prominent KEGG categories listed. Their assigned categories are provided in Table S13.
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EC 5.3.1.8
EC 6.4.1.1
EC 1.2.7.3
EC 2.7.2.3
EC 2.7.9.1
EC 4.1.1.49
EC 4.1.2.13
EC 5.3.1.1
EC 5.3.1.6
EC 1.1.1.158
EC 5.1.3.14
EC 3.2.1.EC 3.5.1.10
EC 2.7.2.1
EC 1.2.1.12
EC 2.7.6.1
EC 3.2.1.20
EC 6.3.2.6
EC 2.3.1.79
EC 2.5.1.55
EC 3.4.24.EC 5.2.1.8
EC 2.4.2.1
EC 2.7.4.3
EC 3.5.4.16
EC 4.2.1.75
EC 2.1.2.3
EC 5.3.1.EC 1.1.1.18
EC 2.7.10.1
EC 1.1.1.69
EC 1.1.1.58
EC 1.2.7.EC 1.6.5.EC 3.6.3.17
EC 3.6.5.3
EC 3.4.11.18
EC 3.4.21.92
EC 6.3.5.2
EC 2.7.7.7
EC 2.3.1.179
EC 2.7.3.9
EC 2.4.2.19
EC 3.2.1.101
EC 4.2.99.18
EC 3.1.26.EC 6.1.1.3

Amino Acid Metabolism

Glycerate kinase
Aspartate-semialdehyde dehydrogenase
Diaminopimelate dehydrogenase
Phosphoribosyl-AMP cyclohydrolase
Phosphoribosyl-ATP diphosphatase
Tryptophan synthase
Dihydrodipicolinate synthase
Aspartate--ammonia ligase
Oxo-acid-lyase
Histidinol-phosphate transaminase
Pentosyltransferase
Carbamoyl-phosphate synthase (glutamine-hydrolyzing)
Threonine synthase
Adenylosuccinate synthase
Valine--tRNA ligase
Aspartate transaminase
Ketol-acid reductoisomerase
2-dehydro-3-deoxy-phosphogluconate aldolase
4-hydroxy-2-oxoglutarate aldolase
Propionyl-CoA carboxylase
Asparagine synthase (glutamine-hydrolyzing)
Argininosuccinate synthase
Transketolase
Geranyltranstransferase
Ribonucleoside-diphosphate reductase
Ribulokinase
Galactokinase
Pectinesterase
Levanase
Endo-1,4-beta-xylanase
Glucosamine-6-phosphate deaminase
Myo-inosose-2 dehydratase
GDP-mannose 4,6-dehydratase
Pectate lyase
Methylglyoxal synthase
L-rhamnose isomerase
4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase
L-arabinose isomerase
Xylose isomerase
Mannose-6-phosphate isomerase
Pyruvate carboxylase
2-oxoglutarate synthase
Phosphoglycerate kinase
Pyruvate, phosphate dikinase
Phosphoenolpyruvate carboxykinase (ATP)
Fructose-bisphosphate aldolase
Triose-phosphate isomerase
Ribose-5-phosphate isomerase
UDP-N-acetylmuramate dehydrogenase
UDP-N-acetylglucosamine 2-epimerase
Glycosidase
Formyltetrahydrofolate deformylase
Acetate kinase
Glyceraldehyde-3-phosphate dehydrogenase (phosphorylating)
Ribose-phosphate diphosphokinase
Alpha-glucosidase
Phosphoribosylaminoimidazolesuccinocarboxamide synthase
Maltose O-acetyltransferase
3-deoxy-8-phosphooctulonate synthase
Metalloendopeptidase
Peptidylprolyl isomerase
Purine-nucleoside phosphorylase
Adenylate kinase
GTP cyclohydrolase I
Uroporphyrinogen-III synthase
Phosphoribosylaminoimidazolecarboxamide formyltransferase
Intramolecular oxidoreductase
Inositol 2-dehydrogenase]
Receptor protein-tyrosine kinase]
Gluconate 5-dehydrogenase]
Tagaturonate reductase
Oxidoreductase
Oxidoreductase
Monosaccharide-transporting ATPase
Protein-synthesizing GTPase
Methionyl aminopeptidase
Endopeptidase Clp
GMP synthase (glutamine-hydrolyzing)
DNA-directed DNA polymerase
Beta-ketoacyl-acyl-carrier-protein synthase II
Phosphoenolpyruvate--protein phosphotransferase
Nicotinate-nucleotide diphosphorylase (carboxylating)
Mannan endo-1,6-alpha-mannosidase
DNA-(apurinic or apyrimidinic site) lyase
Endoribonuclease
Threonine--tRNA ligase

Carbohydrate Metabolism

Biosynthesis of Secondary Metabolites
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Nucleotide Metabolism

Metabolism of Cofactors and Vitamins

Supplementary material
Supplementary materials and methods
Microbial genome sequencing. The following bacterial strains are incorporated into the commercially available FMP: Bifidobacterium animalis subsp. lactis (strain CNCM I-2494), Lactobacillus
delbrueckii subsp. bulgaricus (strains CNCM I-1632, CNCM I-1519), Lactococcus lactis subsp.
cremoris (strain CNCM I-1631), and Streptococcus thermophilus (strain CNCM I-1630). We performed shotgun 454 FLX pyrosequencing of both L. delbrueckii subsp. bulgaricus strains (CNCM
I-1632, CNCM I-1519), plus the L. lactis subsp. cremoris strain (33-, 32- and 51-fold coverage, respectively). Using the Newbler assembler (v1.1, 454 Life Sciences) and already sequenced
strains of these species, we obtained draft genome assemblies with N50 contig sizes of 69,466 and
55,626 and 55,851 bp, respectively. The total sizes of the assembled L. delbrueckii genomes were
1,767,897 bp (CNCM I-1632) and 1,795,730 bp (CNCM I-1519), while the L. lactis assembly had
an aggregate genome size of 2,511,332 bp. A finished genome sequence of the B. animalis subsp.
lactis genome and a deep draft assembly of the S. thermophilis genome were previously generated
by Integrated Genomics (see Table S3 for a summary of genome metrics).
Annotation and comparative genomic analysis. The predicted proteins of all the sequenced
bacterial species used in this study were annotated using BLASTP searches (E-value <10-5) against
version 54 (v54) of the Kyoto Encyclopedia of Genes and Genomes (KEGG) database (S1-3) and
the Carbohydrate Active Enzyme (CAZy) database (S4). BLAST results were parsed into a lookup
table for each genome, and each fecal microbiome, using a Perl script (lookup_KEGG_for_genes_
BLAST.pl) that assigned to each gene the KEGG Orthology (KO) identifier associated with its top
BLAST hit (E-value <10-5). In cases where the query protein’s top match to the reference database
was ambiguous (i.e., when there were multiple top matches with equally good scores), the gene
was annotated with the KOs of all the top-matching database entries.
These lookup tables were then used to calculate the ‘coverage ratio’ of each KEGG metabolic pathway for each bacterial genome in this study using the Perl script kegg_key.pl. For each
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edge (enzymatic reaction) of each KEGG metabolic pathway, this script checks for the presence
of a gene whose assigned KO corresponds with that reaction in (i) a given microbial genome, (ii)
defined collections of microbial genomes, or (iii) larger, incompletely sequenced microbiomes.
KEGG pathway coverage ratios for several combinations of genomes, as well as several published
gut microbiomes, were calculated and used to perform average linkage hierarchical clustering in
Cluster 3.0 (S5) using an un-centered correlation similarity metric. A heatmap visualization of this
clustered data was generated using the Java Treeview application (jtreeview.sourceforge.net).
Culturing of B. animalis subsp. lactis. A frozen stock of B. animalis subsp. lactis (strain
CNCM I-2494) was streaked out on MRS-agar plates (BD/Difco) and transferred to a Coy chamber for overnight growth at 37oC under an atmosphere of 5% H2, 20% CO2 and 75% N2. Single
colonies were picked and inoculated into 10 ml of pre-reduced MRS broth (BD/Difco) that had
been stored for 24 h in an anaerobic chamber. The medium was not supplemented with cysteine.
Each culture was passaged four times to stationary phase, and growth curves were recorded to discern growth kinetics under these conditions. 100 ml of an overnight culture was used to inoculate
10 ml of fresh anaerobic MRS in 27 ml Balch tubes with rubber stoppers and aluminum crimp
tops. The initial headspace of the tubes was composed of 5% H2, 20% CO2, and 75% N2 at ambient
pressure. Tubes were incubated at 37oC, and 4 ml aliquots were collected at mid-log phase (9 h
post-inoculation, OD600=0.2) and during late stationary phase (27 h post-inoculation, OD600=2.6).
Each aliquot from each culture (n=2) was immediately combined with 8 ml of RNAprotect Bacteria Reagent (Qiagen), incubated for 5 min at room temperature, then centrifuged (3,220 x g; 15
min at 25oC). The pellets were snap-frozen in liquid nitrogen and stored at -80oC, and total cellular
RNA was subsequently isolated as described previously (S6).
Human studies
Production and distribution of the FMP to study participants. The FMP used for this study was
produced in Danone’s pilot plant located in Fort Worth, TX. Batches were shipped directly to
subjects by an independent delivery service so that the names of study participants would remain
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unknown to all but those in the MOAFTS study group. Each subject received 4 shipments of FMP,
spaced at 2-week intervals. Each shipment was composed of sufficient numbers of cups (pots) so
that study participants could consume one 4 oz serving twice a day (each serving consisted of a
single pot). Each co-twin chose her flavors (strawberry, vanilla, and/or peach). The same flavor
selection was shipped each time. Each subject was allowed to vary the sequence of selected flavors
according to her wishes.
Analysis of the effects of FMP consumption on stool parameters. Stool consistency, difficulty of passage, and frequency were assessed using a daily stool diary in which participants
recorded the time of day for each bowel movement. Participants rated the stool consistency using
the seven point Bristol Stool Form Scale (S7) and the difficulty of passage using a five-point scale
(no difficulty to extreme difficulty).
Quantitative PCR (qPCR) analysis of fecal levels of FMP strains. qPCR was used to define the levels of selected FMP strains in fecal samples obtained from MZ co-twins and gnotobiotic
mice (S8-12). The PCR primer sets targeting each strain’s 16S rRNA gene or CRISPR locus are
described in Table S14, as are the amplification conditions. Samples were analyzed on an Applied
Biosystems 7900HT instrument using SYBR Green chemistry. Standard curves were constructed
using genomic DNA prepared from a known number of bacterial cells harvested from monocultures grown to stationary phase (cells were DAPI stained and counted by microscopy); Ct values
for each reaction could, therefore, be expressed in terms of cell equivalents (CE).
To calculate the concentration of a given bacterial strain in each fecal sample, three serial
dilutions of extracted fecal DNA (10 ng, 1 ng, 0.1 ng) were assayed in at least two independent
qPCR reactions. Ct values falling within the linear range of the assay were referenced to the standard curves, while those outside the linear range were excluded from the analysis. For human
samples, data were log-transformed and normalized to fecal mass (log10 CE/g feces). For mouse
samples, data were log-transformed and normalized to mass of template DNA (log10 CE/mg DNA).
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Multiplex pyrosequencing of 16S rRNA genes in fecal samples and the FMP. A total of
126 fecal samples (9 samples per individual) were collected over the course of 4 months according
to the schedule shown in Fig. 1. All fecal samples were frozen at -20oC within 30 min after they
were produced. The samples were maintained at this temperature for the period of time required
to ship them to a biospecimen repository (less than 24 h). As soon as samples were received, they
were de-identified and stored at -80°C. DNA was extracted from frozen, pulverized fecal samples
by bead beating followed by phenol-chloroform extraction, as described previously (S13). Methods for generating and performing multiplex pyrosequencing of amplicons from variable region 2
(V2) of bacterial 16S rRNA genes are described in (S13). Bacterial V2 16S rRNA gene sequencing
data were pre-processed to remove sequences with low quality scores, sequences with ambiguous
characters, and sequences outside the length bounds (200-300 nt). All subsequent data processing
and analyses were done using QIIME software (S14). Pyrosequencing ‘noise’ was removed with
an algorithm implemented in QIIME. 16S rRNA reads were binned according to their samplespecific, error-correcting barcode incorporated into the reverse primer. Similar sequences were
binned into phylotypes using CD-HIT with minimum pairwise identity of 97% (S15).
Aliquots of freshly produced as well as 30 day-old FMP from 6 batches of each flavor were
sent directly from the pilot production plant to one of our labs using the same shipping protocol
that was used to deliver the FMP to study participants. DNA was extracted and amplicons from
the V2 region of bacterial 16S rRNA were generated and sequenced using the protocols described
above. 49,959 high quality reads were obtained from a total of 33 FMP samples (1,332±187 reads/
sample (mean ± S.D)): 43,729 reads of these were classified using the GreenGenes database (http://
greengenes.lbl.gov/cgi-bin/nph-index.cgi) and belonged to the genera Streptococccus, Lactococcus, Lactobacillus or Bifidobacterium.
Co-occurrence analysis. To determine whether there were statistically significant
associations between the presence of B. animalis subsp. lactis and the occurrence of resident gut
bacterial species-level phylotypes in human fecal samples, a co-occurrence analysis was performed
using software tools present in QIIME under the script otu_category_significance.py. We used this
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script to employ an ANOVA test to search our fecal 16S rRNA datasets for phylotypes whose
relative abundances were higher in samples in which B. animalis subsp. lactis was present versus
samples in which this strain was absent, as determined using qPCR. To avoid biases that might
be introduced by differences in sample sequencing depth, we randomly selected an even number
of sequences/sample (1,644 sequences) prior to performing the analysis. The raw p-values were
corrected for multiple tests using the false discovery rate (fdr) correction (S16). We also performed
the analysis at the genus and family levels by binning all operational taxonomic units (OTUs)
that mapped to the same family or genus based on classification with the RDP classifier, using the
summarize_taxa.py script in QIIME.
Shotgun sequencing of fecal microbiomes. Forty-eight fecal samples from four twin pairs
were selected for multiplex shotgun pyrosequencing of total community DNA (454 FLX chemistry). For each individual, two fecal samples were analyzed before initiation of FMP consumption,
two samples during the period when FMP was being consumed, and two samples after consumption had ceased.
Each fecal community DNA sample was randomly fragmented to an average length of 500
bp by nebulization, and then labeled with a distinct multiplex identifier (MID; Roche) using the
manufacturer’s protocol. Equivalent amounts of 12 MID-labeled samples from each family were
pooled prior to each pyrosequencing run. Shotgun reads were subsequently filtered using publicly
available software (S17) to remove (i) all reads less than 60 nt, (ii) LR70 reads with at least one
degenerate base (N) or reads with two continuous and/or three total degenerate bases, (iii) all duplicates, defined as sequences whose initial 20 nt were identical and shared an overall identity of
>97% throughout the length of the shortest read, and (iv) all sequences with significant similarity
to human reference genomes (i.e., having a BLASTN match with E-value <10-5, bitscore >50, and
percent identity >75%) to ensure continued de-identification of samples.
Reads obtained from shotgun sequencing of the twins’ fecal microbiomes were used to
query v54 of the KEGG GENES database using BLASTX (E-value <10-5, bitscore >50, and
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%identity >50). A comparable annotation was performed for published fecal microbiomes that
had been generated from 124 deeply sampled unrelated adult Europeans (S18), and from a pair of
obese adult MOAFTS twins (S19).
Microbial RNA-Seq analysis of human fecal metatranscriptomes. Methods used to prepare fecal RNA, generate RNA-Seq data, and perform computational analyses of these datasets
are described in detail below and in one of our previously published studies (S6, Fig. S4B). The
only difference in the analysis pipeline used for human versus mouse RNA-Seq datasets was the
choice of reference genomes. To map RNA-Seq reads from human fecal samples to genes, we used
a collection of 131 bacterial genomes encompassing much of the diversity documented in human
gut communities, plus the genomes of the five FMP strains; these genomes are listed in Table S15.
Studies in gnotobiotic mice
Using INSeq to assay the determinants of fitness in a saccharolytic member of the 15-species
model human microbiota. INsertion Sequencing (INSeq) is a method based on a mutagenic transposon modified so that discrete fragments of adjacent chromosomal DNA can be captured when
the transposon is excised from bacterial genomes by the restriction enzyme MmeI (S20). Sequencing fragments excised from a mixed population of tens of thousands of transposon mutants provides information about the location of each transposon in the genome. The number of occurrences
of the transposon insertion site sequence mirrors the relative abundance of that mutant in the mixed
population. By identifying mutants that significantly decrease in relative abundance after passage
through a selective condition, INSeq allows a genome-wide map of in vivo fitness determinants to
be created.
To determine whether introduction of the FMP strain consortium results in differences in
the in vivo fitness requirements of a human gut symbiont present in the 15-member community,
B. thetaiotaomicron strain VPI-5482 was mutagenized with the INSeq transposon (S20). A library
of 34,544 randomly inserted transposon mutant strains covering 3,435 of the organism’s 4,779
genes was introduced, by gavage, together with the other 14 non-mutagenized members of the
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community into germ-free mice. Fecal samples were subsequently collected from each mouse (n
= 10) before (d7, d14), immediately after (d16), and 7 d after (d21) initial introduction of the FMP
strains. INSeq libraries were prepared as described (S20) and sequenced using an Illumina GA IIx
instrument (~1,000,000 36 nt reads/sample; Table S6). Resulting sequences were mapped to the
B. thetaiotaomicron reference genome and quantified as described (S20). We found that insertions
in 626 genes showed a significantly decreased relative abundance in the day 14 fecal microbiota
(multiple hypothesis testing-corrected q<0.001), reflecting a fitness requirement for these genes in
the colonization process (Table S6). Analysis of fecal samples collected just prior to, one day after,
and 7 days after introduction of the FMP consortium established that exposure to the FMP strains
did not impose significant new fitness pressures on specific genes present in this saccharolytic
bacterial species.
Animal sampling. Fecal samples were obtained from each animal at the time points indicated in Fig. 1. Each fecal sample was collected directly as it emerged from the anus into a 1.7 ml
screw cap Eppendorf tube, which was immediately deposited in a stainless steel dewer containing
liquid N2 (the dewer was introduced into the gnotobiotic isolator on the day of collection after it
had been sterilized in the isolator’s entry port with chlorine dioxide spray (Clidox-S; PRL Pharmacal)). Various subsets of samples were subjected to COPRO-Seq, INSeq and microbial RNA-Seq
analyses. Blood samples were collected into lithium heparin tubes (Becton Dickinson), placed immediately on ice, and then centrifuged (2,700 x g; 3 min at 4°C). The resulting plasma supernatant
was stored at -80oC until assay. Urine was collected directly into Eppendorf tubes and immediately
frozen in liquid N2. Upon sacrifice, ceca were dissected and cecal contents were frozen immediately at -80oC.
Isolation of DNA from cecal contents and feces. Microbial community DNA was prepared in a two-step process consisting of a crude extraction step followed by additional purification and RNAse treatment.
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Crude extraction. The sample (typically 25-100 mg of frozen feces or 50-125 mg of frozen
cecal contents) was combined with 250 ml of 0.1 mm zirconium beads (BioSpec Products), 500 ml
Buffer A (200 mM NaCl, 200 mM Tris, 20 mM EDTA), 210 ml SDS (20% v/v, filter-sterilized), and
500 ml phenol:chloroform:isoamyl alcohol (25:24:1, pH 7.9; Ambion), and the mixture was briefly
chilled on ice. Samples were then disrupted using a Mini-BeadBeater-8 (BioSpec) set to 'homogenize' (bead-beating for 2 min at room temperature, followed by placement on ice for 1-2 min, followed by bead-beating for an additional 2 min). The aqueous phase (~600 ml) was collected after
centrifugation (6,800 x g; 3 min at 4oC) and combined with an equal volume of phenol:chloroform
in 2 ml ‘light’ phase-lock gel tubes (5Prime) per the manufacturer’s protocol. After spinning, the
aqueous phase was combined with 1 volume of chilled 100% isopropanol (-20oC) and 1/10 volume
sodium acetate (3 M, pH 5.5). Following incubation at -20oC for 1 h, the precipitate was pelleted
(20,800 x g; 20 min at 4oC), washed in 100% EtOH, dried, and resuspended in 5 ml TE (pH 7.0)
per milligram of original sample material.
RNAse treatment and further purification. Aliquots of crude DNA were transferred to a
96-well plate. Buffer PM (Qiagen) was mixed with RNase A (Qiagen) to a final concentration of
1.3 mg/ml. Three volumes of this mixture were added to each well and the reactions were allowed
to incubate at room temperature for 2 min. Following RNase digestion, samples were applied to a
QIAquick 96 PCR purification plate (Qiagen) and processed according to the manufacturer’s instructions using a QIAvac 96 vacuum manifold. DNA was eluted in 100 ml of Buffer EB (Qiagen).
DNA quality and purity were verified using a NanoDrop spectrophotometer (model ND-1000).
Preparing DNA libraries for Illumina sequencing and COPRO-Seq analysis in a 96-well
format. DNA libraries were prepared for sequencing using a modified version of Illumina’s sample
preparation protocol for generating libraries from genomic DNA. The six steps of this modified
preparation are as follows:
(i) Fragmentation. Two micrograms of each purified DNA sample was suspended in 100 ml
Buffer EB and fragmented by sonication in 1.7 ml Eppendorfs using the BioruptorXL multi-sam75

ple sonicator (Diagenode) set on ‘high’. Samples were sonicated over the course of 20 min using
successive cycles of 30 sec ‘on’ followed by 30 sec ‘off ‘. Sonicated samples were subsequently
cleaned up using the MinElute 96 UF PCR Purification Kit (Qiagen) per the manufacturer's instructions. Each sonicated DNA sample in each well of the 96-well plate was eluted with 22 ml
Buffer EB.
(ii) ‘Add-only’ enzymatic modification. Ten microliters of each eluate from step (i) was
transferred to a 96-well plate where it was subjected to enzymatic blunting. Each 20 ml reaction
contained: 10 ml DNA, 2 ml T4 DNA ligase buffer [10X; New England Biolabs (NEB), catalogue
number B0202S], 1 ml dNTPs (1 mM; NEB, N1201AA), 0.5 ml Klenow DNA polymerase (5 U/
ml; NEB, M0210S), T4 PNK (10 U/ml; NEB, M0201S), and 6 ml molecular grade water. Blunting
reactions were incubated (25oC, 30 min) then heat-inactivated (75oC, 20 min). Residual dNTPs
were dephosphorylated by adding 1 ml of shrimp alkaline phosphatase (1 U/ml; Promega, M820A)
to each reaction. Reactions were incubated (37oC, 30 min) and heat-inactivated (75oC, 30 min).
Adenine tailing reactions were set up in 30 ml reaction volumes that contained 21 ml of the inactivated phosphatase reaction, 6.4 ml T4 DNA ligase buffer (diluted to 1X; NEB, B0202S), 0.6 ml
dATP (5 mM), and 2 ml Klenow 3'->5' exo- (5 U/ml; NEB, M0212L). Reactions were incubated (37
C, 30 min) and heat-inactivated (75oC, 20 min).
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(iii) Ligation. Customized Illumina adapters containing maximally distant 4 bp barcodes
described elsewhere (S6) were ligated to the polyA-tailed DNA in 50 ml reactions as follows.
Thirty microliters of the inactivated A-tailing reaction described in the preceding paragraph was
added to 5 ml T4 DNA ligase buffer (10X), 5 ml adapter mix (1 mM final concentration per adapter),
and 9 ml water at 4oC. One microliter of T4 DNA ligase (2,000,000 U/ml; NEB M0202M) was subsequently added and reactions were incubated (16oC, 1 h), followed by heat-inactivation (65oC, 10
min). Ligation reactions were cleaned up using the MinElute 96 UF PCR Purification Kit (Qiagen)
according to the manufacturer’s recommended protocol. DNA was eluted in 22 ml Buffer EB.
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(iv) Gel purification. 10 ml of each elution was separated by gel electrophoresis on 2%
agarose. DNA migrating at 200 bp was excised and gel slices were purified using a QIAquick 96
PCR Purification Kit (Qiagen).
(v) PCR amplification. Each library was PCR amplified for 19 cycles using Illumina’s
standard amplification primers with modifications to impart barcode-specificity (S6) and Illumina’s recommended amplification conditions/reagents. Products were purified using a QIAquick 96
PCR Purification Kit (Qiagen). An aliquot of this purification was also subjected to 2% agarose gel
electrophoresis to confirm the absence of any significant adapter-dimer contamination.
(vi) Library pooling and sequencing. The concentration of each purified library was quantified using the Qubit dsDNA HS Assay Kit (Invitrogen). Barcoded libraries were subsequently
pooled (typically in groups of 16) at equivalent final concentrations. Sequencing was performed
using the standard Illumina GA IIx sequencing protocol, with libraries loaded on the flow cell at
a concentration of 2.0-2.5 pM).
A custom software pipeline was written in Perl for performing COPRO-Seq data processing in a computer cluster environment running Sun Grid Engine. These data processing steps are
schematized in Fig. S4A. Briefly, raw Illumina GA IIx reads from a sequencing pool were first deplexed by barcode and trimmed to 34 bp (30 bp genome sequence + 4 bp barcode). Trimmed reads
were aligned to the genomes of the 20 microbial strains used in this study using Illumina’s ELAND
aligner. Perfect, unique alignments to the reference genomes were retained, while those mapping
less than perfectly or having multiple possible alignments to the reference genomes were filtered
out, ensuring that only high-quality, unambiguous reads were used. Hits to each genome were
then tallied, after which the summed counts for each genome were normalized by that genome’s
‘informative genome size’ (term defined in Results) to adjust for both genome size and uniqueness
relative to all other genomes in the experiment. The Perl scripts supporting the COPRO-Seq analytic pipeline can be downloaded from: http://gordonlab.wustl.edu/projects/2011-McNulty_etal.
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Characterizing gene expression with microbial RNA-Seq. Following extraction of total
nucleic acid with phenol-chloroform, and precipitation with isopropanol, fecal samples were subjected to DNAse digestion (S6). Total RNA was then: (i) passed through a MEGAClear column
(Ambion) to deplete RNAs <200 nt (removing most 5S rRNA and tRNA species; (S6)); (ii) subjected to another round of DNAse digestion; (iii) passed through another MEGAClear column;
and (iv) subjected to a hybridization-based pulldown of 16S and 23S rRNA using custom-designed
biotinylated oligonucleotides that contain short rDNA sequences conserved across a set of 37
human gut-derived sequenced microbial genomes (S6). The depletion protocol, which has been
adapted to 96-well format, is described elsewhere (S6). PCR (30 cycles) targeting a short (<100
bp) region from the genome of an abundant community member (typically Bacteroides WH2) was
used to verify the absence of detectable gDNA in each RNA preparation.
Doubled stranded cDNA (dscDNA) was synthesized using random hexanucleotide primers. At the conclusion of the reaction, Illumina adapters containing sample-specific 4 nt barcodes
were ligated to the dscDNA. Multiplex sequencing was performed using the Illumina GA IIx
instrument. We typically sequenced two barcoded in vitro samples/lane of the 8-lane flow cell; in
vivo samples were not multiplexed (i.e. 1 sample was analyzed per sequencing lane). This allowed
us to identify mRNA present at levels representing ≥0.001% of all reads.
The pipeline for processing microbial RNA-Seq data is presented in Fig. S4B. The 8-20
million 36 nt cDNA reads from each sequencing lane were separated by barcode, and mapped
against the relevant set of genome sequences using the SSAHA2 algorithm (S21) to determine the
raw unique-match ‘counts’ (reads) for each gene present in the relevant microbial genome or microbiome. Reads that mapped non-uniquely were added to each gene in proportion to each gene’s
fraction of unique-match counts (e.g., a non-unique read that maps equally well to gene A with
18 unique reads and gene B with 2 unique reads would be scored as 0.9 of a count to gene A, and
0.1 of a count to gene B; the influence of ties is negligible for RNA-Seq given the small numbers
of distinct genomes, but would become more important with more complex communities). Raw
counts were then normalized to reads/kb gene length/million mapped reads (RPKM) using one or
more gene position file(s) in conjunction with custom Perl scripts.
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Data normalization was carried out at two different levels in this study. For our ‘top-down’
analysis, data were normalized at the level of the entire community metatranscriptome (i.e., raw
counts from all species were normalized simultaneously using a single gene position file that included the positions of all genes in the model community metatranscriptome). Data normalized
in top-down fashion allowed us to determine, after binning gene expression values by function,
how the collective operations of the model community were changing as the result of experimental
perturbations. In our ‘bottom-up’ analysis, data were normalized at the level of individual species
(i.e., raw counts from each individual species were normalized separately from one another, in
each case using a species-specific gene position file describing the positions of only that species’
genes). Data normalized in bottom-up fashion allowed us to interrogate what statistically significant gene expression changes were occurring within a given species of interest.
Bottom-up normalized transcript data were analyzed by Cyber-T (S22) to identify mRNAs
that exhibited significant differences in their levels of expression between samples. For each comparison, transcripts were then binned into a list where the magnitude of the difference in their
expression was greater than or equal to 4-fold. Binned transcripts were subsequently annotated
using the kegg_counting.pl Perl script described above. Each resulting annotated dataset was used
to determine the representation of KEGG pathways and categories within these lists.
Further functional comparisons were carried out using ShotgunFunctionalizeR, an R package designed to analyze differences between metagenomic datasets using a Poisson statistical
model (S23). The RPKM-normalized counts for each gene in the model microbiome were then
binned by EC number using each gene’s previously assigned annotation. Summed reads in each
EC bin were rounded to the nearest integer, and the data were imported into ShotgunFunctionalizeR, which was used to identify ECs that were differentially expressed.
Identification of predictive KEGG categories, pathways and ECs using a Random Forests classifier. To identify KEGG categories, ECs, or pathways that were significantly differentiated across treatment states, we used the Random Forests classifier (S24) described in (S25). Mouse
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samples were divided into 10 pre-treatment samples (experimental day 14) and 20 post-treatment
samples (experimental days 15 and 42). To estimate the generalization error of the classifier we
used leave-one-out cross-validation, in which each sample’s group was predicted by a classifier
trained on the other 29 samples. Training was done using default settings for the randomForest
package in R (S24). Each feature’s predictiveness was estimated by calculating the mean increase
in estimated generalization error when the values of that feature were permuted at random. Features whose removal caused an average error increase of at least 0.1% were labeled as ‘predictive’;
those with an increase of at least 1% were labeled as ‘highly predictive’.
Non-targeted metabolomics via gas chromatography/mass spectrometry (GC/MS).
Urines were first assayed for creatinine content as measured by a modified Jaffe method using the
three microliter “random-urine” routine and CR-S 3000 reagent on the UniCel DxC 600 Synchron
Clinical System (Beckman Instruments, Brea, CA). A urine volume equivalent to 0.2 micromoles
of creatinine was then aliquoted and spiked with perdeuterated myristic acid (D27-C14:0) as an
internal standard for retention-time locking (RTL IS). Following treatment with 7.5 volumes of
methanol, the mixture was centrifuged and the supernatant was decanted and dried.
Derivatization of all dried supernatants for GC/MS followed a method adapted with modifications from that of (S26). Reagents were from Sigma-Aldrich (St. Louis, MO), unless otherwise
noted. Briefly, certain reactive carbonyls were first methoximated at 50ºC with a saturated solution
of methoxyamine hydrochloride in dry pyridine, followed by replacement of exchangeable protons
with trimethylsilyl (TMS) groups using N-methyl-N-(trimethylsilyl) trifluoroacetamide with a 1%
v/v catalytic admixture of trimethylchlorosilane (Thermo-Fisher Scientific, Rockford, IL) at 50ºC.
GC/MS methods generally followed those of Fiehn (S27) and Kind (S28), and used a 6890N
GC connected to a 5975 Inert single-quadrupole MS (Agilent, Santa Clara, CA). A large-volume,
ProSep inlet enabled programmed-temperature vaporization and diversion of heavy contaminants
away from the GC and MS, as described below, greatly reducing maintenance time (Apex Technologies, Inc., Independence, KY). The two wall-coated, open-tubular GC columns connected in
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series were both from J&W/Agilent (part 122-5512), DB5-MS, 15 m in length, 0.25 mm in diameter, with a 0.25 µm luminal film. Prior to each run, initial inlet pressures were empirically adjusted
such that the resulting retention time (RT) of the TMS-D27-C14:0 standard was set at ~16.727
min. Under these conditions, derivatized metabolites eluted from the column and reached the electron-ionization (EI) source in the MS at known times (e.g., bis-TMS-lactic acid at ~6.85 min, and
TMS-cholesterol at ~27.38 min). A mid-column, microfluidic splitter (Agilent) provided a means
for hot back-flushing of the upstream GC column at the end of each run while the oven was held at
325ºC for a terminal “bake-out” (another antifouling and anti-carryover measure analogous to that
described in (S29)). During this terminal “bake-out,” the inlet was also held at 325ºC, and it was
purged with a large flow of the carrier gas, helium. Positive ions generated with conventional EI at
70 eV were scanned broadly from 600 to 50 m/z in the detector throughout the run.
Raw data from Agilent’s ChemStation software environment were imported into the freeware, Automatic Mass Spectral Deconvolution and Identification Software (AMDIS) (developed
by Drs. Steve Stein, W. Gary Mallard, and their coworkers at National Institute of Standards and
Technology (S30-32); http://chemdata.nist.gov/mass-spc/amdis/). Deconvoluted spectra were
identified, to the extent possible, using several commercial and public spectral libraries. Our primary source was the Fiehn GC/MS Metabolomics RTL Library (a gift from Agilent Technologies,
Santa Clara, CA, part number G1676-90000). Additional spectra for comparison were gleaned
from the Golm Metabolome Library (courtesy of Dr. Joachim Kopka and coworkers at the Max
Planck Institute of Molecular Plant Physiology, Golm, Germany (S33); http://csbdb.mpimp-golm.
mpg.de/csbdb/gmd/gmd.html), the commercial NIST/EPA/NIH Mass Spectral Library and our
own purpose-built spectral library. Where indicated, peak alignment was performed with SpectConnect freeware (courtesy of Dr. Gregory Stephanopoulos, Massachusetts Institute of Technology (S34); http://www.spectconnect.mit.edu). Chemometrics were performed with Mass Profiler
Professional (a recent descendant of GeneSpring MS, purchased from Agilent), along with our
own custom macros, written in Visual Basic for use in the Excel software environment.

81

The statistical significance of differences in the log2 spectral abundances of each metabolite
in samples obtained at different time points was tested using two approaches. A first-pass, highlypermissive set of pairwise comparisons was calculated between each combination of samples (d0
versus d14, d0 versus d42, d14 versus d42) using a simple two-tailed Student’s t-test. The resulting p-values, which were not corrected for multiple hypothesis testing, are listed in Table S12.
Given the high ratio of hypotheses tested to samples per group (198 metabolites; 5-8 samples per
group), we also guarded against false discovery by performing a more stringent set of calculations
that produced a shorter list of metabolites with significant differences in abundance. This latter
procedure consisted of first taking metabolite data from all three time points and subjecting them
to a one-way ANOVA. The resulting p-values were then adjusted using Benjamini-Hochberg correction, generating q-values. The log2 spectral abundances of all metabolites whose q-values were
below 0.05 were then subjected to Tukey’s HDS (Honestly Significantly Different) post-hoc test
to determine which time points were significantly different from one another. All Tukey’s HDS
p-values that were calculated are provided in Table S12.
Supplementary results
Human studies
Analysis of the effects of FMP consumption on stool consistency, difficulty of passage,
and frequency. To determine whether there were differences in stool consistency and difficulty
of passage of stools between pre-treatment, treatment, and post-treatment study periods, we first
constructed a dataset in which the unit of analysis was ‘bowel movement’. Using ordinal logistic
regression, we analyzed separate models predicting stool consistency and difficulty of stool passage using ‘treatment period’ as the reference group. We adjusted for clustering of observations
using a Huber-White robust variance estimator (STATA 2004). When data from the entire study
period were included in the analyses, no significant differences were observed between study
periods for either stool consistency or difficulty passing stool. Next, we conducted an alternate
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analysis in which data from the first two weeks of the treatment and of the post-treatment phases
were omitted. We found that women had lower stool consistency scores during the last two weeks
of the post-treatment phase compared to the last two weeks of the treatment phase: i.e., stools were
softer during the treatment period (OR=0.69; p=0.04). The difference in stool consistency between
the pre-treatment phase and the last two weeks of the treatment phase was not significant; however, there was a significant difference between the pre-treatment versus treatment compared to the
post-treatment versus treatment odds ratios (p=0.005).
Analyses for stool frequency were conducted similarly to those above with the exception
that the unit of analysis was the ‘person-day’ (i.e., one observation per person per day) and the
dependent variable was number of bowel movements per day. We did not find stool frequency to
be associated with study period regardless of which study days were included in the analysis.
One participant had a diarrheal illness on three of the FMP treatment days, with a dramatic
increase in stool frequency and decrease in stool firmness on these days. She reported taking four
2 mg tablets of loperamide [4-(p-chlorophenyl)-4-hydroxy-N, N-dimethyl- a, a-diphenyl-1-piperidinebutyramide monohydrochloride] to relieve her symptoms during this period. Therefore, data
from these bowel movements were excluded from the analyses.
Co-occurrence analysis. As noted above, to identify species-level phylotypes that
consistently increase or decrease in abundance when B. animalis subsp. lactis is present in human
fecal samples, we performed a co-occurrence analysis using QIIME (see Supp. Methods). This
analysis indicated that no OTUs present in the pre-treatment microbiota exhibited a statistically
significant change in their proportional representation in feces during the period of FMP consumption
or during the post-treatment period in any individual after correction for multiple tests. The OTU
that most nearly achieved significance was closely related to Lactococcus lactis (raw p=0.00067;
ANOVA: p>0.05 after FDR correction). A follow-up co-occurrence analysis for all genera also
identified the genus Lactococcus as being significantly more abundant when B. animalis subsp.
lactis was present (the latter determined by qPCR). It is reasonable that L. lactis would co-occur
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with B. animalis subsp. lactis given the presence of both strains in the FMP. A co-occurrence
analysis performed at the family level of taxonomy failed to identify any significant differences.
Our ability to identify L. lactis in our co-occurrence analysis was encouraging, but raised
the question of why an OTU representing B. animalis subsp. lactis did not achieve significance,
given that nearly every sample collected during the period of FMP consumption was positive for
this strain by qPCR. Of the 58 samples deemed positive for B. animalis subsp. lactis by qPCR,
only 7 yielded an OTU in our 16S rRNA dataset with a 100% identity match to B. animalis subsp.
lactis. This OTU was not detected in any of the samples deemed negative by qPCR. Therefore, we
concluded that the discrepancy between B. animalis subsp. lactis being called ‘present’ by qPCR
and by 16S rRNA sequencing was due to inadequate depth of sequencing. Extrapolating, there
could be other rare species whose changes in abundance were not detected. To explore this latter
possibility, the fecal microbiota of two healthy MZ twin pairs, similar in age and body mass index,
but with marked differences in their degree of geographical proximity (Table S1), were subjected to
deeper sequencing (n=36 samples, yielding an additional 411,177 16S rRNA sequences, resulting
in 14,241±2,144 (mean±SD) reads/sample from these individuals). No significant changes at any
level of bacterial taxonomy were observed in this small sample dataset.
Studies in gnotobiotic mice
Measurement of adiposity. The body weights and epididymal fat pad weights of mice from both
treatment groups were measured at the time of sacrifice. We observed no significant differences
between the single and multiple treatment groups in either measurement (p=0.6865, p=0.3516,
respectively; two-tailed Student’s t-test). Furthermore, all measurements of adiposity and weight
were in line with those of mice from other studies that had involved animals from the same inbred
strain, who were similarly aged, the same gender, on the same diet, and who harbored comparable
defined model human gut microbiota (without FMP strains).
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In vitro studies
RNA-Seq profiling of B. animalis subsp. lactis during growth in vitro. Sequencing of transcripts
expressed by B. animalis subsp. lactis during mid-log phase growth in MRS medium (1.5-2.9 million reads per technical replicate; n=2 independent cultures) detected products from 1,618 of the
organism’s 1,660 predicted genes, while profiling during late stationary phase indicated that 1,609
of its genes were expressed. The transition from logarithmic to stationary phase was accompanied
by significant up- or down-regulation of 98 and 194 genes, respectively, including those involved
in various aspects of carbohydrate, amino acid and nucleotide metabolism (see Table S7A).
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Supplementary figure legends
Figure S1. Levels of B. animalis subsp. lactis (CNCM I-2494) in human fecal samples collected prior to, during, and after consumption of a FMP. (A) qPCR assays; each dot represents
a sample from a given individual. The green bar denotes the period of FMP consumption. (B)
Comparison of qPCR results to the number of shotgun reads mapped to the genomes of three B.
animalis subsp. lactis strains. qPCR results are plotted on the X-axis, while the proportional representation of reads that mapped to the B. animalis subsp. lactis genomes is presented on the Y-axis.
Figure S2. KEGG pathway coverage ratios suggest that the model human gut microbiome
encodes many of the functions present in more complex human fecal communities. Genes in
(i) the genomes of the five-member FMP strain consortium, (ii) the 15-member model human gut
microbiota, (iii) a highly simplified two-member human gut microbiota composed of B. thetaiotaomicron and a prominent gut Firmicute (Eubacterium rectale) (S35), (iv) a reference set of 127
sequenced human gut microbial isolates, (v) the deeply sampled fecal microbiomes of 124 unrelated adult Europeans from a recent METAHIT study (S18), (vi) the fecal microbiomes of the 7
twin pairs characterized in the present study, and (vii) the deeply sequenced fecal microbiomes of
an obese adult MZ twin pair (S19) were annotated using v54 of the KEGG GENES database. The
presence/absence of each KO in each KEGG pathway was determined for every set of genes and
the pathway coverage ratio (i.e., % of a pathway’s components called ‘present’; BLASTP E-value
<10-5) was calculated and depicted as the heatmap shown using Cluster 3.0/Treeview.
Figure S3. CAZyme profiles of the 20 bacterial strains introduced into gnotobiotic mice. The
indicated genomes were annotated for all glycoside hydrolases (GH), glycosyltransferases (GT),
carbohydrate binding modules (CBM), and polysaccharide lyases (PL) using the CAZy classification scheme. The Bacteroides possess a larger and more diverse arsenal of CAZymes relative
to the Firmicutes/Actinobacteria, though most CAZyme families encoded in the genomes of the
FMP strains were also present in defined community members. The small number of FMP strainspecific CAZyme families (CBM5, CBM10, CBM23, CBM33, GH85, and GT39) are highlighted
in red. The scale refers to the number of genes in a given CAZy family in a given genome.
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Figure S4. Summary of analysis pipelines utilized in this study. (A) COPRO-Seq. (B) RNASeq.
Figure S5. COPRO-Seq-based time series analysis of the abundance of members of the model human microbiota and of the FMP strain consortium in the feces of gnotobiotic mice. Relative abundance, expressed as the log10 of percent representation of all detected community members was calculated over time (d0, time of colonization with the model 15-member community;
d14, time of first gavage with the FMP consortium for the single and multiple treatment groups;
d21 and d35, times of subsequent gavage with the FMP consortium for the multiple treatment
group). For each treatment, animals were gavaged twice over a 24 h period. Mean values ± SEM
are plotted (n=5 animals/treatment group; 1 fecal sample/animal/time point; limit of detection =
0.003%). (A) COPRO-Seq data for 13 members of the 15 member community (F. prausnitzii and
C. spiroforme were at levels below the limit of detection throughout the study and are not shown).
(B) Data obtained from the two members of the FMP consortium that persisted at levels above the
limit of detection following their introduction into mice. (C) Data from panel A representing the
response of C aerofaciens to introduction of the FMP strain consortium (see text for details).
Figure S6. Top-down analysis of the model community’s transcriptional response to the FMP
strain consortium reveals upregulation of genes involved in interconversion of propionate
and succinate. RPKM-normalized RNA-Seq data were binned at the level of EC, and comparisons were made between early responses (d14 versus d15, representing time points just before
and 1 day after gavage with the strain consortium) and late responses (d14 versus d42). Boxes and
lines are colored according to the key shown above the pathway map and in the legend to panel B
of Fig. 5.
Figure S7. A species’ contribution to the metatranscriptome is not necessarily proportional to
its abundance in the 15-member community. Microbial RNA-Seq data from d14 of the mouse
study were parsed by species to determine the total number of reads that each community member
contributed to the total sequenced transcript pool (‘metatranscriptome’) (both raw and normalized
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reads as defined in Fig. S4B). Data were further broken down into reads that could be mapped to
genes with known functions (as defined by KEGG) and those with unknown functions (lacking
any KO in v54 of the KEGG GENES database). Mean values ± SD are plotted for each of the four
types of data presented. Note, for example, the large number of raw reads attributed to R. obeum
despite its low proportional abundance in the community. Conversely, Bacteroides WH2 contributes a far smaller proportion of total raw RNA-Seq reads to the pool than its relative abundance in
the community might have suggested.
Figure S8. Bottom-up analysis of genes whose expression changes significantly following introduction of the FMP strain consortium. (A) Volcano plots of the >48,000 expressed genes
detected in at least one fecal RNA sample. Colored points represent genes whose difference in
expression following introduction of the FMP strain consortium was (i) ≥4-fold (increase or decrease) relative to the d14 pre-treatment time point and (ii) statistically significant (p<0.05; twotailed Student’s t-test). Dots are colored according to each gene’s species of origin (color key
shown to the right of the panel). Black dots represent genes whose change in expression is less than
4-fold at the time points indicated and/or not statistically significant. See Table S10 for a complete
list of all the genes shown as colored dots. (B) Breakdown by species of differentially expressed
genes. (C) Breakdown by KEGG category of differentially expressed genes, showing that late responses are more numerous than immediate ones, and that there is a noticeable bias towards genes
involved in carbohydrate and glycan metabolism, particularly in the late response to introduction
of the FMP strain consortium.
Figure S9. The number of RNA-Seq reads obtained from human fecal samples that map to
genomes in the FMP strain consortium peaks shortly after FMP consumption begins. RNASeq reads derived from selected human samples were mapped back to the five genomes in the
FMP consortium to determine which species’ transcripts could be detected over time. B. animalis
transcripts were detected only during periods of FMP consumption. Reads attributed to L. lactis,
S. thermophilus, and L. delbrueckii at time points before consumption began may reflect ‘spurious’ mapping to related endogenous strains in the gut community. Facet labels located at the top
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of each bar chart correspond to the sample labels shown in Fig. 1A of the main text. Numbers are
presented below each bar chart correspond to the code number assigned to each de-identified cotwin (see Table S1).
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Figure S1.
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Supplementary table legends
Table S1. Characteristics of adult female monozygotic (MZ) twins enrolled in study.
Table S2. Summary of human fecal metagenomic datasets. (A) Multiplex pyrosequencing of
fecal bacterial 16S rRNA V2 amplicons. (B) Multiplex shotgun pyrosequencing of total fecal community DNA.
Table S3. Features of the microbial genomes in the 5-member FMP strain consortium and
the 15-member model human gut microbiota.
Table S4. Carbohydrate active enzyme (CAZy) annotation data. (A) CAZy summaries by genome. (B) CAZy annotations for the 20 bacterial species in this study.
Table S5. COPRO-Seq analysis of bacterial species abundance in mouse fecal samples. (A)
Proportional representation of the 20 bacterial species in this study in mouse fecal samples as
measured by COPRO-Seq. (B) Statistical significance and fold-change of differences in pairwise
comparisons of abundance calculated from data in panel A. The group mean for each day/treatment/species combination at time points after the introduction of the FMP strain consortium was
compared to the mean for the same treatment/species at d14 (the last time point collected prior to
introduction of the FMP strains) using Welch’s t-test. Values have not been corrected for multiple
hypothesis testing. p-values <0.05 are highlighted in pink. Fold-changes greater than 2 or less than
-2 are highlighted in pink and green, respectively.
Table S6. INSeq analysis. (A) INSeq analysis sequencing statistics. Scale factor corresponds
to counts per million normalization; underrepresented samples were re-sequenced and combined
with original data so that all samples were represented by ~1 million reads. (B) Genes required by
B. thetaiotaomicron for survival in the intestines of mice harboring the 15-member model human
gut microbiota. The table describes the relative abundance of transposon insertions in each gene
(rows) in the input community (average of two independent technical replicates) and in the output
communities (fecal samples collected from 10 mice two weeks after introduction of the synthetic
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model community, immediately prior to introduction of the FMP strain consortium). A z-test was
used to identify genes whose log-transformed output to input ratios were significantly different
from the overall distribution (a uniform value of 1 was added to all counts, and genes with no
insertions were removed to allow ratios to be calculated). Resultant p-values were corrected for
multiple hypothesis testing by q-test (S36). Genes assigned a q-value <0.001 are highlighted in red.
Data filtering, normalization, mapping, and statistical analysis were conducted in Perl and Matlab.
Table S7. Differentially expressed B. animalis subsp. lactis (CNCM I-2494) genes. (A) Log
versus stationary growth in MRS medium. (B) In vivo (mouse) versus in vitro (logarithmic phase
in MRS) growth.
Table S8. Top-down function-level analysis of the impact of the FMP strain consortium on
the model human gut microbiota’s metatranscriptome. (A) Proportional representation of assignable normalized RNA-Seq counts binned by KEGG category in fecal samples collected over
time from singly- and multiply-treated animals. (B) Proportional representation of assignable normalized RNA-Seq counts binned by KEGG pathway in fecal samples collected over time from
singly- and multiply-treated animals.
Table S9. Model human gut microbiota membrane transport genes demonstrating ≥4-fold
increases or decreases in their expression following introduction of the FMP strain consortium.
Table S10. Bottom-up (gene-level) analysis of the impact of the FMP strain consortium on the
model community’s metatranscriptome. (A) Breakdown by microbial species of significantly
up/down-regulated genes. (B) Breakdown by KEGG category of significantly up/down-regulated
genes. (C) Model community microbiome genes demonstrating significant increases/decreases in
their expression following introduction of the FMP strain consortium.
Table S11. Results of Random Forests supervised classification analysis.
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Table S12. Urine metabolites whose levels change significantly in transitions between colonization states. The ‘Reverse match score’ column contains the AMDIS, dot-product, reverse-match
scores (S32) which in this case evaluate not only mass-spectral concordance, but also the goodness
of fit of chromatographic retention-time index made by comparison to (i) commercial and public
target-compound libraries of small metabolites (S28, 33), and (ii) our own in-house reference library. Metabolites with match scores less than an arbitrary threshold of 65% were excluded from
these results. (A) Day 0 (germ-free) versus day 14 (colonized with 15-member model community). (B) Day 14 (colonized with 15-member model community) versus day 42 (colonized with
15-member model community plus five-member FMP consortium).
Table S13. ShotgunFunctionalizeR analysis of EC-level changes in the metatranscriptome as
a function of FMP strain introduction into mice and humans. The table shows fold-change in
mean proportional representation of each EC between groups for each comparison. Values for nonsignificant EC changes in a comparison (adjusted p≥0.01, ShotgunFunctionalizeR) are reported as
“NS”. Note that ECs can have multiple KEGG pathway and category assignments.
Table S14. Primers and amplification conditions used for quantitative PCR assays of FMP
consortium strains in fecal DNA. (A) Primers used to assay human fecal samples. (B) Primers
used to assay mouse fecal samples. (C) Amplification conditions.
Table S15. List of 136 microbial genomes used to analyze human fecal RNA-Seq data.
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Abstract
The human gut microbiota is an important metabolic organ. However, little is known about how its
individual species interact, establish dominant positions, and respond to changes in environmental
factors such as diet. In the current study, gnotobiotic mice colonized with a simplified model microbiota composed of 12 sequenced human gut bacterial species were fed oscillating diets of disparate
composition. Rapid, reproducible and reversible changes in community structure were observed.
Time series microbial RNA-Seq analyses revealed staggered functional responses to diet shifts
throughout the community that were heavily focused on carbohydrate and amino acid metabolism.
High-resolution shotgun metaproteomics analysis confirmed many of these responses at a protein
level. One member, Bacteroides cellulosilyticus WH2, proved exceptionally fit regardless of diet.
Its genome has the largest collection of carbohydrate active enzymes of any Bacteroides species
reported to date. Whole genome transcriptional profiling indicated that B. cellulosilyticus WH2 is
an adaptive forager that tailors its versatile carbohydrate utilization strategy to the dietary polysaccharides available, with a strong emphasis on highly branched plant cell wall xylans that are
abundant in dietary staples like cereal grains. Two highly expressed, diet-specific polysaccharide
utilization loci (PULs) in B. cellulosilyticus WH2 were identified, one with characteristics similar
to xylan utilization systems. Introduction of a B. cellulosilyticus WH2 library of 26,750 isogenic
transposon mutants into gnotobiotic mice along with other model community members confirmed
that these loci represent some of its most critical diet-specific fitness determinants. The specific
carbohydrates that trigger overexpression of these two loci and many of the organism’s 111 other
predicted PULs were identified by RNA-Seq analysis during in vitro growth on 31 distinct carbohydrate substrates, allowing us to better interpret the in vivo RNA-Seq and proteomics data. These
results offer insight into how gut microbes adapt to dietary perturbations, both at a community
level and from the perspective of a well-adapted symbiont with exceptional saccharolytic capabilities, and illustrate the value of studying defined models of the human gut microbiota.
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Introduction
A growing body of evidence indicates that the tens of trillions of microbial cells that inhabit
our gastrointestinal tracts (microbiota) extend our biological capabilities in important ways [1,2].
Microbial enzymes process many compounds that would otherwise pass through our intestines
unaltered [3], and cases of particular nutrient substrates favoring the growth of particular taxa are
being reported [4,5]. Changes in diet are therefore expected to lead to changes in the composition
and function of the microbiota [6]. However, our understanding of diet-microbiota interactions at
a mechanistic level is still in its infancy.
The absence of a complete catalog of the microbial strains and associated genome sequences that comprise a given microbiota complicates efforts to describe how particular dietary substrates influence individual taxa, how taxa cooperate/compete to utilize nutrients, and how these
many interactions in aggregate lead to emergent host phenotypes. Gnotobiotic mice colonized with
defined consortia of sequenced human gut microbes, on the other hand, provide an in vivo model of
the microbiota in which the identity of all taxa and genes comprising the system are known [7]. In
these systems, expressed mRNAs and proteins can be attributed to their genome, gene and species
of origin, and findings of interest can be pursued in follow-up in vitro or in vivo experiments. These
models afford an opportunity to tightly control experimental variables to a degree not possible in
human studies and have proven useful in studying microbial invasion [8], inter-phylum microbemicrobe interactions [9], and the metabolic roles of key ecological guilds [10]. Studies aiming to
better understand community-level assembly, resilience, and adaptation are also likely to benefit
from a focus on such fully defined systems.
Culture-independent surveys of the healthy adult gut microbiota consistently conclude that
it is composed primarily of Bacteroidetes and Firmicutes species [11-13]. The dominance of these
two bacterial phyla suggests that their representatives in the human gut are exquisitely adapted to
its dynamic conditions, which include a constantly evolving nutrient environment. Members of the
genus Bacteroides are known to be adept at utilizing both plant- and host-derived polysaccharides
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[14-16]. Comparisons of available Bacteroides genomes with those from other gut species indicate that the former are enriched in genes involved in the acquisition and metabolism of various
glycans, including glycoside hydrolases and polysaccharide lyases, as well as linked environmental sensors that control their expression (e.g., hybrid two-component systems, extracytoplasmic
function (ECF) sigma factors and anti-sigma factors). Many of these genes are organized into
polysaccharide utilization loci (PULs) that are distributed throughout the genome [17]. Recent
studies have focused on better understanding the evolution, specificity and regulation of PULs in
the genomes of species like Bacteroides thetaiotaomicron and Bacteroides ovatus [18,19]. Little
is known, however, about the metabolic strategies adopted by multiple competing species in more
complex communities, how dietary changes lead to shifts in the Bacteroides fraction of communities [20] through changes in individual species, or how dietary context influences the repertoires
of genes the most dominant species rely on to remain competitive with other microbes, including
those genes that are components of PULs.
Here, we adopt a multi-faceted approach to the study of model communities in gnotobiotic
mice fed changing diets in order to better understand: (i) the process by which communities reconfigure themselves structurally in response to changes in host diet; (ii) how aggregate community
function, as judged by the metatranscriptome and the metaproteome, is impacted when host diet is
altered; (iii) how the metabolic strategies of individual microbes change, if at all, when the nutrient milieu is dramatically altered, with an emphasis on one prominent but understudied member of
the human gut Bacteroides; and (iv) whether a microbe’s metabolic versatility/flexibility correlates
with competitive advantage in a microbiota comprising numerous related and unrelated species.
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Results and discussion
Sequencing the Bacteroides cellulosilyticus WH2 genome
Though at least 8 complete and 68 draft genomes of Bacteroides spp. are currently available [21],
there are numerous examples of distinct clades within this genus where little genomic information
exists. To further explore the genome space of one such clade, we obtained a human fecal isolate
whose four 16S rRNA gene sequences indicate a close relationship to Bacteroides cellulosilyticus (Figs. S1A, B). The genome of this isolate, which we have designated B. cellulosilyticus
WH2, was sequenced deeply, yielding a high quality draft assembly (23 contigs with an N50 value
of 798,728 bp; total length of all contigs in the assembly, 7.1 Mb; Table S1). Annotation of its
5,244 predicted protein-coding genes using the carbohydrate active enzyme (CAZy) database [22]
revealed an extraordinary complement of 503 CAZymes comprising 373 glycoside hydrolases
(GHs), 23 polysaccharide lyases (PLs), 28 carbohydrate esterases (CEs), and 84 glycosyltransferases (GTs) (see Table S2 for all annotated genes in the B. cellulosilyticus WH2 genome predicted
to have relevance to carbohydrate metabolism). One distinguishing feature of gut Bacteroides
genomes is the substantial number of CAZymes they encode relative to those of other intestinal
bacteria [23]. The B. cellulosilyticus WH2 CAZome is enriched in a number of GH families even
when compared with prominent representatives of the gut Bacteroidetes (Fig. S2A). When we
expanded this comparison to include all 86 Bacteroidetes in the CAZy database, we found that the
B. cellulosilyticus WH2 genome had the greatest number of genes for 19 different GH families, as
well as genes from two GH families that had not previously been observed within a Bacteroidetes
genome (Fig. S2B). Altogether, B. cellulosilyticus WH2 has more GH genes at its disposal than
any other Bacteroidetes species analyzed to date.
In Bacteroides spp., CAZymes are often located within PULs [24]. At a minimum, a typical
PUL harbors a pair of genes with significant homology to the susC and susD genes of the starch
utilization system (Sus) in B. thetaiotaomicron [24]. Other genes encoding enzymes capable of
liberating oligo- and monosaccharides from a larger polysaccharide are also frequently present.
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The susC- and susD-like genes of these loci encode the proteins that comprise the main outer
membrane binding and transport apparatus and thus represent key elements of these systems. A
search of the B. cellulosilyticus WH2 genome for genes with strong homology to the susC- and
susD-like genes in B. thetaiotaomicron VPI-5482 (see Methods) revealed an unprecedented number of susC/D pairs (a total of 118). Studies of other prominent Bacteroides spp. have found that
the evolutionary expansion of these genes has played an important role in endowing the Bacteroides with the ability to degrade a wide range of host- and plant-derived polysaccharides [18,25].
Deep sampling of the gut microbiota of adult humans indicates that B. cellulosilyticus strains are
common in humans, colonizing approximately 77% of 124 adult Europeans characterized in one
study [11] and 62% of 139 individuals living in the USA examined in another survey [12]. We
hypothesized that the apparent success of B. cellulosilyticus in the gut is derived in part from its
substantial arsenal of genes involved in carbohydrate utilization.
Measuring changes in the structural configuration of a 12-member model microbiota in
response to a dietary perturbation
To test the fitness of B. cellulosilyticus WH2 in relation to other prominent gut symbionts, and the
importance of diet on its fitness, we carried out an experiment in gnotobiotic mice (experiment 1,
“E1”, Fig. S3). Two groups of 10-12 week-old male germ-free C57BL/6J animals were moved to
individual cages within gnotobiotic isolators (n=7 animals/group). At day zero, each animal was
colonized by oral gavage with a synthetic community comprising 12 prominent, sequenced human gut bacterial species (Fig. 1A) whose taxonomic and functional attributes (as judged by their
annotated gene content) are representative of a more complex human microbiota (Tables S3, S4).
For two weeks, each treatment group was fed a standard low-fat, high-plant polysaccharide (LF/
HPP) mouse chow, or a ‘Western’-like diet where calories are largely derived from fat, starch, and
simple sugars [high-fat/high-sugar (HF/HS)] [9]. Over the course of six weeks, diets were changed
twice at two-week intervals, such that each group began and ended on the same diet, with an intervening two-week period during which the other diet was administered (Fig. S3).
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Using fecal DNA as a proxy for microbial biomass, the plant polysaccharide-rich LF/HPP
diet supported 2- to 3-fold more total bacterial growth (primary productivity) despite its lower
caloric density (3.7 kcal/g versus 4.5 kcal/g for the HF/HS diet; Fig. S4A). The HF/HS diet contains carbohydrates that are easily metabolized and absorbed in the proximal intestine (sucrose,
corn starch and maltodextrin), with cellulose being the one exception (4% of the diet by weight
versus 46.3% for the other carbohydrate sources). Thus, in mice fed the HF/HS diet, diet-derived
simple sugars are likely to be rare in the distal gut where the vast majority of gut microbes reside.
This may provide an advantage to those bacteria capable of utilizing other carbon sources (e.g.,
proteins/oligopeptides, host glycans). In mice fed the LF/HPP diet, on the other hand, plant polysaccharides that are indigestible by the host should provide a plentiful source of carbon for saccharolytic members of the community.
To evaluate the impact of each starting diet and the diet switch on the structural configuration of the model human microbiota, we subjected DNA isolated from fecal samples collected
throughout the course of the experiment and from cecal DNA at sacrifice to shotgun sequencing
(COmmunity PROfiling by Sequencing; COPRO-Seq) [8]. The resulting relative abundances of
each species in each sample (defined by the number of sequencing reads that could be unambiguously assigned to community members after adjusting for genome uniqueness) were subjected to
ordination by principal coordinates analysis (PCoA) (Fig. S5A). As expected, diet was found to be
the predominant explanatory variable for observed variance (see separation along principal coordinate 1, ‘PC1’, which accounts for 52% of variance). Overall community structure achieved quasiequilibrium before the midpoint of the first diet phase, as evidenced by the lack of any significant
movement along PC1 after day five. Reconfiguration of overall community structure following a
transition to the second diet phase also took place over the course of ~5 days. Notably, communities showed a near-perfect inversion in their positions along PC1 after the first diet switch, with
animals transitioning from LF/HPP to HF/HS diets adopting a structure like that of the communities that were initially assembled while animals were consuming a starting HF/HS diet, and vice
versa. The second diet switch from phase two to three resulted in a similar movement along PC1
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in the opposite direction, indicating a reversion of each community to its originally assembled
configuration. These results, in addition to demonstrating the significant impact of these two diets
on the structure of this 12-member model human gut microbiota, also suggest that communities of
this size are capable of demonstrating resilience in the face of substantial diet perturbations.
The assembly process and observed diet-induced reconfigurations also proved to be highly
reproducible as evidenced by COPRO-Seq results from a replication of E1 (experiment 2, “E2”).
In this follow-up experiment, fecal samples were collected more frequently than in E1, providing a
dataset with improved temporal resolution. Ordination of E2 COPRO-Seq data by PCoA (Fig. 1B)
showed that the model microbiota in each E2 treatment group assemble in a manner similar to their
counterparts in E1, that structural reconfigurations in response to diet occur with the same timing
as in E1, and that the quasi-equilibrium community configurations achieved during each diet phase
are highly similar between experiments for each treatment group. As in E1, cecal data for each E2
treatment group overlap with their corresponding fecal samples, and DNA yields from E2 fecal
samples vary substantially as a function of host diet (Fig. S4B).
COPRO-Seq provides precise measurements of the proportional abundance of each species present in a defined microbiota. Data collected in both E1 and E2 (Table S5) revealed significant differences between microbiota members in terms of the maximum abundance levels they
achieved, the rates at which their abundance levels were impacted by diet shifts, and the degree
to which each species demonstrated a preference for one diet over another (Fig. S4C). Changes
in each species’ abundance over time replicated well across animals in each treatment group, suggesting the assembly process and diet-induced reconfigurations occur in an orderly and rules-based
fashion, with minimal stochasticity. A species’ relative abundance immediately after colonization
(i.e., 24 hours after gavage / day 1) was, in general, a poor predictor of its abundance at the end
of the first diet phase (i.e. day 13) (E1 R2=0.23; E2 R2=0.27), suggesting early dominance of the
founder population was not strongly tied to relative success in the assembly process.
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In communities that assembled in mice initially fed a HF/HS diet, four Bacteroides spp.
(B. caccae, B. cellulosyliticus WH2, B. thetaiotaomicron, and B. vulgatus) each achieved relative
abundances of ≥10% by the end of the first diet phase (day 13 post-gavage), with B. caccae attaining the highest levels (37.1±4.9% and 34.2±5.5%; group mean ± SD in E1 and E2, respectively).
In animals fed the plant polysaccharide-rich LF/HPP chow during the first diet phase, B. cellulosilyticus WH2 was dominant, achieving levels of 37.1±2.0% (E1) and 41.6±3.9% (E2) by day 13. B.
thetaiotaomicron and B. vulgatus also attained relative abundances of >10%.
Changes in diet often resulted in rapid, dramatic changes in a species’ proportional representation. Because the dynamic range of abundance values observed when comparing multiple
species was substantial [lowest, D. longicatena (<0.003%); highest B. caccae (55.0%)], comparing diet responses on a common scale using raw abundance values was challenging. To represent
these changes in a way that scaled absolute increases/decreases in community proportion to the
abundance range of each strain, we also normalized community representation at each time-point
to the maximum level each microbe achieved across all time-points within each mouse. Plotting
the resulting measure of abundance (percentage of maximum achieved, ‘PoMA’) over time demonstrates which microbes are strongly responsive to diet (experience significant swings in PoMA
value following a diet switch) and which are relatively diet-insensitive (experience only modest or
no significant change in PoMA value following a diet switch). Heatmap visualization of E1 PoMA
values (Fig. S5B) indicated that those microbes with a preference for a particular diet in one animal treatment group also tended to demonstrate the same diet preference in the other. Likewise,
diet insensitivity was also consistent across treatment groups; diet-insensitive microbes were insensitive regardless of the order in which diets were introduced.
Of the diet-sensitive components of the model microbiota, those showing the most striking
responses were B. caccae and B. ovatus, which strongly preferred the ‘Western’-like HF/HS diet
and the polysaccharide-rich LF/HPP diet, respectively (Figs. 1C, S4C). Of the diet-insensitive
components of the microbiota, B. thetaiotaomicron showed the most stability in its representation
(Figs. 1C, S4C), consistent with its reputation as a versatile forager. Paradoxically, B. cellulosi116

lyticus WH2 was found to be both diet-sensitive and highly fit on its less-preferred diet. Although
this strain clearly achieved higher levels of community representation in animals fed the LF/HPP
diet, it maintained strong levels of representation in animals fed HF/HS as well (Figs. 1C, S4C).
When taking into account the abundance data for all 12 community members, proportional
representation at the end of the first diet phase (i.e., day 13) was a good predictor of representation
at the end of the third diet phase (i.e., day 42) (E1 R2=0.77; E2 R2=0.84), suggesting that the intervening dietary perturbation had little effect on the ultimate outcomes for most species within the
community. However, one very low-abundance strain (Dorea longicatena) achieved significantly
different maximum percentages across the two treatment groups in each experiment, suggesting
that steady-state levels of this strain may have been impacted by diet history. In communities that
assembled in mice fed LF/HPP chow, D. longicatena was found to persist throughout the experiment at low levels on both diet regimens. In communities that assembled in mice fed the HF/HS
diet, D. longicatena dropped below the limit of detection before the end of the first diet phase, was
undetectable by the end of the second diet phase, and remained undetectable throughout the rest of
the time course. This interesting example raises the possibility that for some species, irreversible
hysteresis effects may play a significant role in determining the likelihood that they will remain
members of a microbiota over long periods of time. For most strains, however, these data suggest
that diet-driven increases or decreases in a species’ abundance are likely to be reversible over short
time spans.
The cecal community metatranscriptome sampled at the time of sacrifice
These diet-induced reconfigurations in community structure led us to examine the degree to which
members of the community were modifying their metabolic strategies. To establish an initial baseline static view of expression data for each microbe on each diet, we developed a custom GeneChip
whose probe sets were designed to target 46,851 of the 48,023 known or predicted protein-coding
genes within our model human gut microbiome (see Methods). Total RNA was collected from the
cecal contents of each animal in E1 at the time of sacrifice and hybridized to this GeneChip. The to117

tal number of genes whose expression was detectable on each diet was remarkably similar (14,929
and 14,594 detected in the LF/HPPèHF/HSèLF/HPP and HF/HSèLF/HPPèHF/HS treatment
groups, respectively). A total of 11,373 genes were expressed on both diets (Fig. S6A) while 2,003
(4.3%) were differentially expressed to a statistically significant degree, including 161 (6%) of
the 2,640 genes in the model human gut microbiome encoding proteins with CAZy-recognized
domains. Fig. S6B illustrates the fraction of the community CAZome and several species-level
CAZomes expressed on each diet (see Table S6 for a comprehensive list of all genes, organized
by species and fold-change in expression, whose cecal expression was detectable on each diet and
all genes whose expression was significantly different when comparing data from each treatment
group).
Of the community members demonstrating obvious diet preferences (as judged by relative abundance data), Bacteroides caccae and Bacteroides cellulosilyticus WH2 served as a particularly interesting pair of organisms whose CAZy-level responses to diet change are different
in several respects. Our ability to evaluate shifts in B. caccae’s metabolic strategy in the gut was
limited by the very low abundance of this species in animals fed LF/HPP chow (i.e., at these low
levels of abundance, our mRNA and subsequent protein assays were often not sensitive enough to
exhaustively sample B. caccae’s metatranscriptome and metaproteome). Our observations regarding this species’ carbohydrate utilization capabilities and preferences are summarized in Supplementary Results. In contrast, the abundance of Bacteroides cellulosilyticus WH2, which favored
the LF/HPP diet, remained high enough on both diets to allow for a comprehensive analysis of its
expressed genes and proteins. This advantage, along with the exceptional carbohydrate utilization
machinery encoded within the genome of this organism, encouraged us to focus on further dissecting the responses of B. cellulosilyticus WH2 to diet changes.
Detailed inspection of the expressed B. cellulosilyticus WH2 CAZome (503 CAZymes in
total) provided an initial view of this microbe’s sophisticated carbohydrate utilization strategy. A
comparison of the top decile of expressed CAZymes on each diet disclosed many shared elements
between the two lists, spanning many different CAZy families, with just over half of the 50 most
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expressed enzymes on the plant polysaccharide-rich LF/HPP chow also occurring in the list of
most highly expressed enzymes on the sucrose-, corn starch- and maltodextrin-rich HF/HS diet
(Fig. 2A). 25 of the 50 most expressed CAZymes on the LF/HPP diet were significantly upregulated compared to the HF/HS diet; of these, seven were members of the GH43 family (Fig. 2B).
The GH43 family consists of enzymes with activities required for the breakdown of plant-derived
polysaccharides such as hemicellulose and pectin. Inspection of the enzyme commission (EC) annotations for the most upregulated GH43 genes shows that they encode xylan 1-4-b-xylosidases
(EC 3.2.1.37), arabinan endo-1,5-a-L-arabinosidase (EC 3.2.1.99), and a-L-arabinofuranosidases
(EC 3.2.1.55). The GH10 family, which is currently comprised exclusively of endo-xylanases (EC
3.2.1.8, EC 3.2.1.32), was also well represented among this set of 25 genes, with four of the seven
putative GH10 genes in the B. cellulosilyticus WH2 genome making the list. Strikingly, of the 45
predicted genes with putative GH43 domains in the B. cellulosilyticus WH2 genome, none were
upregulated on the ‘Western’-style HF/HS chow.
The most highly expressed B. cellulosilyticus WH2 CAZyme on the plant polysacchariderich chow (which was also highly-expressed on the HF/HS chow) was BWH2_1228, a putative
a-galactosidase from the GH36 family. These enzymes, which are not expressed by humans in the
stomach or intestine, cleave terminal galactose residues from the non-reducing ends of raffinose
family oligosaccharides (RFOs, including raffinose, stachyose, and verbascose), galacto(gluco)
mannans, galactolipids, and glycoproteins. RFOs, which are well represented in cereal grains consumed by humans, are expected to be abundant in the LF/HPP diet given its ingredients (e.g.,
soybean meal), but potential substrates in the HF/HS diet are less obvious, possibly implicating
a host glycolipid or glycoprotein target. Surface glycans in the intestinal epithelium of rodents
are decorated with terminal fucose residues [26] as well as terminal sialic acid residues and sulfate [27]. Hydrolysis of the α-2 linkage connecting terminal fucose residues to the galactose-rich
extended core is thought to be catalyzed in large part by GH95 and GH29 enzymes [28]. The B.
cellulosilyticus WH2 genome is replete with putative GH95 and GH29 genes (total of 12 and 9,
respectively), but only a few (BWH2_1350/2142/3154/3818) were expressed in vivo on at least
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one diet, and their expression was low relative to many other CAZymes (see Table S6). Cleavage
of terminal sialic acids present in host mucins by bacteria is usually carried out by members of
the GH33 family. B. cellulosilyticus WH2 has two GH33 genes that are expressed on either one
diet (BWH2_3822, HF/HS) or both diets (BWH2_4650), but neither is highly expressed relative
to other B. cellulosilyticus WH2 CAZymes. Therefore, utilization of host glycans by B. cellulosilyticus WH2, if it occurs, likely requires partnerships with other members of the community that
express GH29/95/33 enzymes (see Table S6 for a list of members that express these enzymes in a
diet-independent and/or diet-specific fashion).
Among the 50 most highly expressed B. cellulosilyticus WH2 CAZymes, 12 were significantly upregulated on the HF/HS diet compared to the LF/HPP diet, with members of family GH13
being most prevalent. While the enzymatic activities and substrate specificities of GH13 family
members are varied, most relate to the hydrolysis of substrates comprising chains of glucose subunits, including amylose (one of the two components of starch) and maltodextrin, both prominent
ingredients in the HF/HS diet.
GeneChip-based profiling of the E1 cecal communities provided a snapshot of the metatranscriptome on the final day of the final diet phase in each treatment group. The analysis of B.
cellulosilyticus WH2 CAZyme expression suggested that this strain achieves a ‘generalist’ lifestyle
not by relying on substrates that are present at all times (e.g., host mucins), but rather by modifying
its resource utilization strategy to effectively compete with other microbes for diet-derived polysaccharides not metabolized by the host.
Community-wide analysis of diet-induced changes in microbial gene expression
To develop a more complete understanding of the dynamic changes that occur in gene expression
over time and throughout the community following diet perturbations, we performed microbial
RNA-Seq analyses using feces obtained at select time-points from mice in the LF/HPPèHF/
HSèLF/HPP treatment group of E2 (Fig. S3).
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We began with a ‘top-down’ analysis in which every RNA-Seq read count from every gene
in the model microbiome was binned based on the functional annotation of the gene from which it
was derived, regardless of its species of origin. In this case, the functional annotation used as the
binning variable was the predicted enzyme commission (EC) number for a gene’s encoded protein
product. Expecting that some changes might occur rapidly, while others might require days or
weeks, we searched for significant differences between the terminal time-points of the first two
diet phases (i.e., points at which the model human gut microbiota had been allowed 13 days to
acclimate to each diet). The 157 significant changes we identified were subjected to hierarchical
clustering by EC number to determine which functional responses occurred with similar kinetics.
The results revealed that unlike the rapid diet-induced structural reconfigurations in community
composition, community-level changes in gene expression occurred with highly variable timing
that differed from function to function. These changes were dominated by EC numbers associated
with enzymatic reactions relevant to carbohydrate and amino acid metabolism (see Table S7 for
a summary of all significant changes observed, including aggregate expression values for each
functional bin (EC number) at each time-point). Significant responses could be divided into one
of three groups: ‘rapid’ responses denoting EC numbers whose representation in the transcriptome
increased/decreased dramatically within 1-2 days of a diet switch; ‘gradual’ responses where the
representation of EC numbers changed notably, but slowly, between the two diet transition points;
and ‘delayed’ responses where no significant change occurred immediately but did occur by the
end of a diet phase (Fig. 3, Table S7). EC numbers associated with reactions important in carbohydrate metabolism and transport were distributed across all three response types for each of the two
diets. Nearly all genes encoding proteins with EC numbers related to amino acid metabolism that
were significantly upregulated on HF/HS chow binned into the ‘rapid’ or ‘gradual’ groups, suggesting this diet put immediate pressure on the community to increase its repertoire of expressed
amino acid biosynthesis and degradation genes. Genes with assigned EC numbers involved in
amino acid metabolism that were significantly upregulated on the other, polysaccharide-rich, LF/
HPP diet were spread more evenly across the three groups (Fig. 3).
121

Careful inspection of our top-down analysis results and a complementary ‘bottom-up’ analysis in which normalization was performed at the level of individual species, rather than the community, allowed us to identify other important responses that would have gone undetected were it
not for the fact that we were dealing with a defined community where all genes in its component
members’ genomes (microbiome) were known. For example, an assessment of the representation of EC 3.2.1.8 (endo-1,4-β-xylanase) within the metatranscriptome before and after the first
diet switch (LF/HPPèHF/HS) initially suggested that this activity was reduced to a statistically
non-significant degree as a result of the diet switch (day 13 versus day 27, p=0.25; Fig. S7A). Aggregation by species of all sequencing read counts assignable to mRNAs encoding proteins with
this EC number revealed that over 99% of the contributions to this functional bin originated from
B. cellulosilyticus WH2 (Fig. S7B), implying that the community-level response and the response
of this Bacteroides species were virtually one and the same. A tally of all sequencing reads assignable to B. cellulosilyticus WH2 at each time-point disclosed that although this strain maintains
high proportional representation in the community throughout each diet oscillation period (range:
10.3-42.5% and 11.6-43.3% for E1 and E2, respectively), its contribution to the community metatranscriptome is substantially decreased during the HF/HS diet phase (Fig. S7C). This dramatic
reduction in the extent to which B. cellulosilyticus WH2 contributes to the community metatranscriptome in HF/HS-fed mice ‘masks’ the highly significant upregulation of EC 3.2.1.8 (endo-1,4β-xylanase) that occurs within the B. cellulosilyticus WH2 transcriptome following the first diet
shift (Fig. S7D). A further breakdown of endo-1,4-β-xylanase upregulation in B. cellulosilyticus
WH2 when mice are switched to the HF/HS diet reveals that most of this response is driven by two
genes, BWH2_4068 and BWH2_4072 (Fig. S7E). Our realization that one of the most significant
diet-induced gene expression changes in the second most abundant strain in the model community
was undetectable when inspecting functional responses at the community level provides a strong
argument for expanding the use of model microbiota comprised exclusively of sequenced species,
whose individual contributions to community activity can be evaluated in a rigorous way that is
not possible with consortia of unknown or poorly defined gene composition.
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High-resolution profiling of the cecal metaproteome sampled at the time of sacrifice
In principle, protein measurements can provide a more direct readout of expressed community
functions than an RNA-level analysis, and thus a deeper understanding of community members’
interactions with one another and with their habitat [29,30]. For these reasons and others, much
work has been dedicated to applying shotgun proteomics techniques to microbial ecosystems in
various environments [31,32]. Though these efforts have provided illustrations of significant methodological advances, they have been limited by the complexity of the metaproteomes studied and
by the difficulties this complexity creates when attempting to assign peptide identities uniquely
to proteins of specific taxa. Recognizing that a metaproteomics analysis of our model community
would not be subject to such uncertainty given its fully-defined microbiome and thus fully-defined
theoretical proteome, we subjected cecal samples from two mice from each diet treatment group
in E1 (n=4 total) to high-performance liquid chromatography-tandem mass spectrometry (LC-MS/
MS; see Methods). We had three goals: (i) to evaluate how our ability to assign peptide-spectrum
matches (PSMs) to particular proteins within a theoretical metaproteome is affected by the presence of close homologs within the same species and within other, closely-related species; (ii) to
test the limits of our ability to characterize protein expression across different species given the
substantial dynamic range we documented in microbial species abundance; and (iii) to collect
semi-quantitative peptide/protein data that might validate and enrich our understanding of functional responses identified at the mRNA level, particularly with respect to the niche (profession) of
CAZyme-rich B. cellulosilyticus WH2.
Given the evolutionary relatedness of the strains involved, we expected that some fraction
of observed PSMs from each sample would be of ambiguous origin due to non-unique peptides
shared between species’ proteomes. To assess which species might be most affected by this phenomenon when characterizing the metaproteome on different diets, we catalogued each strain’s
theoretical peptidome using an in silico tryptic digest. This simulated digest took into account both
the potential for missed trypic cleavages and the peptide mass range that could be detected using
our methods. The results (Fig. S8A, Table S8) demonstrated that for a community of modest com123

plexity, the proportion of peptides within each strain’s theoretical peptidome that are ‘unique’ (i.e.,
assignable to a single protein within the theoretical community metaproteome) varies substantially
from species to species, even among those that are closely related. We found the lone representative of the Actinobacteria in the community, C. aerofaciens, to have the highest proportion of
unique peptides (94.2%), while B. caccae had the lowest (63.0%). Interestingly, there was not a
strong correlation between the fraction of a species’ peptides that were unique and the total number
of unique peptides that species contributed to the theoretical peptidome. For example, C. aerofaciens (2,367 predicted protein-coding genes) contributed only 81,894 (1.5%) unique peptides,
the lowest of any community member, despite having a proteome composed of mostly unique
peptides. B. cellulosilyticus WH2, on the other hand (5,244 predicted protein-coding genes), contributed 241,473 (4.5%) unique peptides, the highest of any community member, despite a high
fraction of non-unique peptides (18.4%) within its theoretical peptidome. The evolutionary relatedness of the Bacteroides components of the model gut microbiota appeared to negatively affect
our ability to assign their peptides to specific proteins; their six theoretical peptidomes had the six
lowest uniqueness levels. However, their greater number of proteins and peptides relative to the
Firmicutes and Actinobacteria within the community more than compensated for this deficiency;
over 60% of unique peptides within the unique theoretical metaproteome were contributed by the
Bacteroides.
We also found that the proportion of PSMs uniquely assignable to a single protein within
the metaproteome varied significantly by function, suggesting that some classes of proteins can
be traced back to specific microbes more readily than others. For example, when considering all
theoretical peptides that could be derived from the proteome of a particular bacterial species, those
from proteins with roles in categories with high expected levels of functional conservation (e.g.,
translation and nucleotide metabolism) were on average deemed unique more often than those
from proteins with roles in functions we might expect to be less conserved (e.g., glycan biosynthesis and metabolism) (See Table S8 for a summary of how peptide uniqueness varied across different KEGG categories and pathways, and across different species in the experiment). However,
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even in KEGG categories and pathways with high expected levels of functional conservation, the
vast majority of peptides were found to be unique when a particular species was not closely related
to other members of the model community.
Next, we determined the average number of proteins that could be experimentally identified in our samples for each microbial species within each treatment group in E1. The results (Fig.
S8B, Table S9) illustrate two important conclusions. First, although equal concentrations of total
protein were evaluated for each sample, slightly less than twice as many total microbial proteins
were identified in samples from the LF/HPP-fed mice as those from mice fed the HF/HS diet
(4,659 versus 2,777, respectively). While there are a number of possible explanations, this finding
and the higher number of mouse proteins detected in samples from this treatment group is consistent with our fecal DNA analysis that had indicated that the HF/HS diet supports lower levels of
gut microbial biomass compared to the LF/HPP diet (Figs. S4A, B). Second, a breakdown of all
microbial proteins detected by species of origin (Fig. S8B) revealed that the degree to which we
could inspect protein expression for a given species was dictated to a large degree by its relative
abundance and the diet to which it was exposed.
Next, our ability to detect a substantial number of B. cellulosilyticus WH2’s expressed
transcripts and proteins in samples from mice on either diet allowed us to determine the degree to
which RNA and protein data for an abundant, active member of the community might correlate,
and whether or not the type of genes considered might influence the degree of correlation between
these two datasets. We first performed a spectral count-based correlation analysis on the dietinduced, log-transformed, average fold-differences in expression for all B. cellulosilyticus WH2
genes that were detectable at both the RNA and protein level for both diets. The results revealed
a moderate degree of linear correlation between RNA and protein observations (Fig. S8C, black
plot; r=0.53). However, subsequent division of these genes into functionally related subsets, which
were each subjected to their own correlation analysis, revealed striking differences in the degree
to which RNA level and protein-level expression changes agreed with one another. For example,
diet-induced changes in mRNA expression for genes involved in translation showed virtually no
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correlation with changes measured at the protein level (Fig. S8C, red plot; r=0.03). Correlations
for other categories of B. cellulosilyticus WH2 genes, such as those involved in energy metabolism (Fig. S8C, green plot; r=0.36) and amino acid metabolism (Fig. S8C, orange plot; r=0.48)
were also poorer than the correlation for all genes collectively. In contrast, the correlation for the
110 genes with predicted involvement in carbohydrate metabolism was quite strong (Fig. S8C,
blue plot; r=0.69), and was in fact the best correlation identified for any functional category of
genes considered. The significant range of correlations observed in different categories of genes
suggests that the degree to which RNA-based analyses provide an accurate picture of microbial
adaptation to environmental perturbation may be strongly impacted by the functional nature of
the genes involved. Additionally, these data further emphasize the need for enhanced dynamic
range metaproteome measurements and better bioinformatic methods to assign/bin unique and
non-unique peptides so that deeper and more thorough surveys of the microbial protein landscape
may be performed and evaluated alongside more robust transcriptional datasets. Below we focus
on two highly expressed, strongly diet-specific loci relevant to in vivo carbohydrate utilization by
B. cellulosilyticus WH2.
Identifying two diet-inducible, xylanase-containing PULs whose genetic disruption results in
diet-specific loss of fitness
Several of the most highly expressed and diet-sensitive B. cellulosilyticus WH2 genes in this study
fell within two putative PULs. One PUL (BWH2_4044-55) contains 12 ORFs that include a dual
susC/D cassette, three putative xylanases assigned to CAZy families GH8 and GH10, a putative
multifunctional acetyl xylan esterase/a-L-fucosidase, and a putative hybrid two-component system regulator (Fig. 4A). Gene expression within this PUL was markedly higher in mice consuming
the plant polysaccharide-rich LF/HPP diet at both the mRNA and protein level. mRNA analysis
disclosed that BWH2_4047 was the most highly expressed B. cellulosilyticus WH2 susD homolog
on this diet. Likewise, BWH2_4046/4, the two susC-like genes within this PUL, were the 2nd and
4th most highly expressed B. cellulosilyticus WH2 susC-like genes in LF/HPP-fed animals, and
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exhibited reductions in expression levels of 99.5% and 93% in animals consuming the HF/HS diet.
The same LF/HPP diet bias was observed for other genes within this PUL (Figs. 2A, 4B) but not
for neighboring genes. The same trends were obvious and amplified when we quantified protein
expression (Fig. 4C). In mice fed LF/HPP chow, only three B. cellulosilyticus WH2 SusC-like proteins had higher protein levels than BWH2_4044/6, and only two SusD-like proteins had higher
levels than BWH2_4045/7. Strikingly, we were unable to detect a single peptide from 9 of the 12
proteins in this PUL in samples obtained from mice fed the HF/HS diet, emphasizing the strong
diet specificity of this locus.
A second PUL in the B. cellulosilyticus WH2 genome composed of a susC/D-like pair
(BWH2_4074/5), a putative hybrid two-component system regulator (BWH2_4076), and a xylanase (GH10) with dual carbohydrate binding module domains (CBM22) (BWH2_4072) (Fig.
4A) demonstrated a strong but opposite diet bias, in this case exhibiting significantly higher expression in animals consuming the HF/HS ‘Western’-like diet. mRNA-level analysis showed that
this xylanase was the second most highly-expressed B. cellulosilyticus WH2 CAZyme in animals
consuming this diet (Fig. 2A). As with the previously described PUL, shotgun metaproteomics
validated the transcriptional analysis (Figs. 4B, C); except the gene encoding the PUL’s presumed
transcriptional regulator (BWH2_4076), the diet specificity was substantial with protein-level fold
changes ranging from 10.0-33.3 across the locus (Table S10).
Recent work by Dodd and colleagues has done much to advance our understanding of
the regulation and metabolic role of xylan utilization system gene clusters in xylanolytic members of the Bacteroidetes, particularly within the genus Prevotella [33]. The ‘core’ gene cluster of
the prototypical xylan utilization system they described consists of two tandem repeats of susC/
susD homologs (xusA/B/C/D), a downstream hypothetical gene (xusE) and a GH10 endoxylanase
(xyn10C). The 12-gene PUL identified in our study (BWH2_4044-55) appears to contain the only
instance of this core gene cluster within the B. cellulosilyticus WH2 genome, suggesting that this
PUL, induced during consumption of a plant polysaccharide-rich diet, is likely to be the primary
xylan utilization system within this organism. A recent study characterizing the carbohydrate utili127

zation capabilities of B. ovatus ATCC 8483 also identified two PULs involved in xylan utilization
whose gene configurations differ from the paradigm described by Dodd [18]. The smaller of the
two xylanase-containing PULs described above appears to be evolutionarily related to a subset of
the genes found within BACOVA_04385-94, highlighting the fact that Bacteroidetes have likely
evolved multiple strategies for the utilization of this important hemicellulose.
Having established that expression of BWH2_4044-55 and BWH2_4072-6 is strongly dictated by diet, we next sought to determine if these PULs are required by B. cellulosilyticus WH2
for fitness in vivo. A follow-up study was performed in which mice were fed either a LF/HPP or
HF/HS diet after being colonized with a model human gut microbiota similar to the one utilized
in E1 and E2 (see Methods). In this community, the wild-type B. cellulosilyticus WH2 strain used
in our previous experiments was replaced with a transposon mutant library consisting of 26,750
distinct transposon insertion mutants in over 78% of all predicted ORFs (average 5.3 distinct insertion mutants / ORF). The library was constructed using methods similar to those reported by
Goodman et al. (see Methods) so that the relative proportion of each insertion mutant in both the
input (orally gavaged) and output (fecal) populations could be determined using insertion sequencing (INSeq) [34]. The results of this analysis revealed clear, diet-specific losses of fitness when
components of these loci were disrupted (Fig. 4D). Additionally, as observed in E1 and E2, expression of each PUL was strongly biased by diet, with genes BWH2_4072-5 demonstrating upregulation on the HF/HS diet and BWH2_4044-55 on the LF/HPP diet. The extent to which a gene’s
disruption impacted the fitness of B. cellulosilyticus WH2 on one diet or the other correlated well
with whether or not that gene was highly expressed on a given diet. For example, four of the five
most highly expressed genes in the BWH2_4044-55 locus were the four genes shown to be most
crucial for fitness on the LF/HPP diet. Of these four genes, three were homologs of either the susC
or susD gene in B. thetaiotaomicron (the fourth was the putative endo-1,4-b-xylanase thought to
constitute the last element of the xylan utilization system core). Though the fitness cost of disrupting genes within BWH2_4044-55 varied from gene to gene, disruption of any one component of
the BWH2_4072-6 PUL had serious consequences for B. cellulosilyticus WH2 in animals fed the
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HF/HS diet. This could suggest that while disruption of some components of the BWH2_4044-55
locus can be rescued by similar or redundant functions elsewhere in the genome, the same is not
true for BWH2_4072-5. Notably, disruption of the BWH2_4076 gene (which is predicted to encode a hybrid two-component regulatory system) had negative consequences on either diet tested,
suggesting that the regulation of this locus is crucial even when the PUL is not actively expressed.
While many genes outside of these two PULs were also found to be important for the in vivo fitness
of B. cellulosilyticus WH2, those within these PULs were among the most essential to diet-specific
fitness, suggesting these loci are central to the metabolic lifestyle of B. cellulosilyticus WH2 in the
gut.
Characterizing the carbohydrate utilization capabilities of B. cellulosilyticus WH2 and B.
caccae
The results described in the preceding section indicate that B. cellulosilyticus WH2 prioritizes xylan as a nutrient source in the gut and that it tightly regulates the expression of its xylan utilization
machinery. Moreover, the extraordinary number of putative CAZymes and PULs within the B.
cellulosilyticus WH2 genome suggests that it is capable of growing on carbohydrates with diverse
structures and varying degrees of polymerization. To characterize its carbohydrate utilization capabilities, we defined its growth in minimal medium supplemented with one of 46 different carbohydrates [18]. Three independent growths, each consisting of two technical replications, yielded a
total of six growth curves for each substrate. Of the 46 substrates tested, B. cellulosilyticus WH2
grew on 39 (Table S11); they encompassed numerous pectins (6 of 6), hemicelluloses/β-glucans
(8 of 8), starches/fructans/α-glucans (6 of 6) and simple sugars (14 of 15), as well as host-derived
glycans (4 of 7) and one cellooligosaccharide (cellobiose). The seven substrates that did not support growth included three esoteric carbohydrates (carrageenan, porphyran, and alginic acid), the
simple sugar N-acetylneuraminic acid, two host glyans (keratan sulfate and mucin O-glycans)
and fungal cell wall-derived α-mannan. B. cellulosilyticus WH2 clearly grew more robustly on
some carbohydrates compared to others. Excluding simple sugars, fastest growth was achieved
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on dextran (0.099±0.048), laminarin (0.095±0.014 OD600 units/h), pectic galactan (0.088±0.018),
pullulan (0.088±0.026), and amylopectin (0.085±0.003). Although one study has reported that
the type strain of B. cellulosilyticus degrades cellulose [35], the B. cellulosilyticus WH2 strain of
B. cellulosilyticus failed to demonstrate any growth on minimal medium plus cellulose (specifically, Solka-Floc 200 FCC, International Fiber Corp.) after five days. Maximum cell density was
achieved with amylopectin (1.17±0.02 OD600 units), dextran (1.12±0.20), cellobiose (1.09±0.08),
laminarin (1.08±0.08), and xyloglucan (0.99±0.04). Total B. cellulosilyticus WH2 growth (i.e.,
maximum cell density achieved) on host-derived glycans was typically very poor, with only two
substrates achieving total growth above 0.2 OD600 units (chondroitin sulfate, 0.50±0.04; glycogen, 0.99±0.02). The disparity between total growth on plant polysaccharides versus host-derived
glycans, including O-glycans which are prevalent in host mucin, indicates a preference for dietderived saccharides, consistent with our in vivo mRNA and protein expression data.
We determined how the growth rate of B. cellulosilyticus WH2 on these substrates compared to the growth rates for other prominent gut Bacteroides spp.. After subjecting B. caccae
to the same phenotypic characterization as B. cellulosilyticus WH2, we combined our measurements for these two strains with previously published measurements for B. thetaiotaomicron and
B. ovatus [18]. The results underscored the competitive growth advantage B. cellulosilyticus WH2
likely enjoys when foraging for polysaccharides in the intestinal lumen. For example, of the eight
hemicelluloses and β-glucans tested in our carbohydrate panel, B. cellulosilyticus WH2 grew fastest on six while B. ovatus grew fastest on two (Table S11). B. caccae and B. thetaiotaomicron, on
the other hand, failed to grow on any of these substrates. Across all the carbohydrates for which
data are available for all four species, B. cellulosilyticus WH2 grew fastest on the greatest number
of polysaccharides (11 of 26) and tied with B. caccae for the greatest number of monosaccharides
(6 of 15). B. thetaioatomicron and B. caccae did, however, outperform the other two Bacteroides
tested with respect to utilization of host glycans in vitro, demonstrating superior growth rates on
four of five substrates tested (Table S11).
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B. cellulosilyticus WH2’s rapid growth to high densities on xylan, arabinoxylan, and xyloglucan, as well as xylose, arabinose, and galactose, is noteworthy given our prediction that two of
its most tightly-regulated, highly-expressed PULs appear to be involved in the utilization of xylan,
arabinoxylan, or some closely-related polysaccharide. To identify specific mono- and/or polysaccharides capable of triggering the activation of these two PULs, as well as the 111 other putative
PULs within the B. cellulosilyticus WH2 genome, we used RNA-Seq to characterize its transcriptional profile at mid-log phase in minimal medium (Table S12) plus one of 16 simple sugars or
one of 15 complex sugars (Table S13) (see Methods; n= 2-3 cultures/substrate; 5.2-14.0 million
raw Illumina HiSeq reads generated for each of the 90 transcriptomes). After mapping each read
to the B. cellulosilyticus WH2 reference gene set, counts were normalized using DESeq to allow
for direct comparisons across samples and conditions. Hierarchical clustering of the normalized
dataset resulted in a well-ordered dendrogram in which samples clustered almost perfectly by
the carbohydrate on which B. cellulosilyticus WH2 was grown (Fig. 5A). The consistency of this
clustering illustrates how (i) technical replicates within each condition exhibit strong correlation
with one another, suggesting any differences between cultures in a treatment group (e.g., small differences in density or growth phase) had at best minor effects on aggregate gene expression, and
(ii) growth on different carbohydrates results in distinct, substrate-specific gene expression signals
capable of driving highly discriminatory differences between treatment groups. The application of
rigorous bootstrapping to our hierarchical clustering results also revealed several cases of higherlevel clusters in which strong confidence was achieved. These dendrogram nodes (illustrated as
white circles), indicate sets of growth conditions that yield gene expression patterns more like
each other than like the patterns observed for other substrates. Two notable examples were xylan/
arabinoxylan (which are structurally related and share the same xylan backbone) and L-fucose/Lrhamnose (which are known to be metabolized via parallel pathways in E. coli).
Importantly, these findings suggested that when combined with in vivo expression data from
the model community, it is possible to identify the particular carbohydrates to which B. cellulosilyticus WH2 is exposed and accessing within its gut environment. To explore this concept further,
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we compared expression of each gene in each condition to its expression on our control treatment,
minimal medium plus glucose (MM-G). The results revealed a dynamic PUL activation network
in which some PULs were activated by a single substrate, some by multiple substrates, and some
that were transcriptionally silent across all conditions tested. Of the 118 putative susC/D pairs in
B. cellulosilyticus WH2 that we have used as markers of PULs, 30 were dramatically activated
on one or more of the substrates tested; in these cases, both the susC- and susD-like genes in the
cassette were upregulated an average of >100-fold relative to MM-G across all technical replicates
(Fig. 5B). At least one susC/D activation signature was identified for every one of the 17 oligosaccharides and polysaccharides and for six of the 13 monosaccharides tested (Table S14). The lack
of carbohydrate-specific PUL activation events for some monosaccharides (fructose, galactose,
glucuronic acid, sucrose, and xylose) was expected, given that these loci are primarily dedicated to
polysaccharide acquisition. Further inspection of gene expression outside of PULs disclosed that
B. cellulosilyticus WH2 prioritizes use of its non-PUL-associated carbohydrate machinery, such
as putative phosphotransferase system (PTS) components and monosaccharide permeases, when
grown on these monosaccharides (Table S14).
Several carbohydrates activated the expression of multiple PULs. Growth on water-soluble xylan and wheat arabinoxylan produced significant upregulation of five susC/D-like pairs
(BWH2_0865/0866, 0867/0868, 4044/4045, 4046/4047, and 4074/4075). No other substrate tested activated as many loci within the genome, again hinting at the importance of xylan and arabinoxylan to this strain’s metabolic strategy in vivo. Cecal expression data from E1 showed that 15
of these activated PULs were expressed in vivo on one or both of the diets tested (see circles to
the right of heatmap in Fig. 5B). In mice fed the polysaccharide-rich LF/HPP chow, B. cellulosilyticus WH2 upregulates three susC/D pairs (BWH2_2717/8, 4044/5, 4046/7) whose expression
is activated in vitro by arabinan and xylan/arabinoxylan. The three most significantly upregulated
susC/D pairs (BWH2_1736/7, 2514/5, 4074/5) in mice fed the HF/HS diet rich in sugar, corn
starch and maltodextrin are activated in vitro by amylopectin, ribose, and xylan/arabinoxylan,
respectively. All three PULs identified as being upregulated at the RNA level in LF/HPP-fed mice
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were also found to be upregulated at the protein level (Fig. 5B). Two of the three PULs induced
at the mRNA level in HF/HS-fed mice were shown to be upregulated at the protein level as well,
along with four other PULs whose upregulation was only evident in our LC-MS/MS data. The
presence of a dextran (starch)-activated PUL among the latter four loci is noteworthy, given the
significant amount of starch present in the HF/HS diet. Such examples of loci whose induction is
expected but evident only in one data type or the other reinforce the notion that protein data both
complement and supplement mRNA data when profiling microbes of interest.
Two of the five susC/D pairs activated by xylan/arabinoxylan form the four-gene cassette
in the previously discussed PUL comprising BWH2_4044-55 that is activated in mice fed the plant
polysaccharide-rich chow (see Fig. 4A). Another one of these five is the susC/D pair found in
the PUL comprising BWH2_4072-6 that is activated in mice fed the HF/HS ‘Western’-like chow
(see Fig. 4A). Thus, we have identified a pair of putative PULs in close proximity to one another
on the B. cellulosilyticus WH2 genome that encode CAZymes with similar predicted functions,
are subject to near-identical levels of specific activation by the same two polysaccharides (i.e.,
xylan, arabinoxylan) in vitro, but are discordantly regulated in vivo in a diet-specific manner. The
highly expressed nature of these PULs in the diet environment where they are active, their shared
emphasis on xylan/arabinoxylan utilization, and their tight regulation indicate that they are likely
to be important for the in vivo success of this organism in the two nutrient environments tested.
However, the reasons for their discordant regulation are unclear. One possibility is that in addition
to being activated by xylan/arabinoxylan and related polysaccharides, these loci are also subject
to repression by other substrates present in the lumen of the gut, and this repression is sufficient
to block activation. Alternatively, the specific activators of each PUL may be molecular moieties
shared by both xylan and arabinoxylan that do not co-occur in the lumenal environment when mice
are fed the diets tested in this study.
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Prospectus
Elucidating generalizable ‘rules’ for how microbiota operate under different environmental conditions is a substantial challenge. As our appreciation for the importance of the gut microbiota in
human health and well-being grows, so too does our need to develop such rules using tractable experimental models of the gut ecosystem that allow us to move back and forth between in vivo and
ex vivo analyses, using one to inform the other. Here, we have demonstrated the extent to which
high-resolution DNA-, mRNA- and protein-level analyses can be applied (and integrated) to study
a model community of sequenced human gut microbes colonizing gnotobiotic mice. Our efforts
have focused on characterizing community-level and species-level adaptation to dietary change
over time and ‘leverage’ results obtained from in vitro expression profiling of individual community member responses to a panel of purified carbohydrates to deduce glycan exposures and consumption strategies in vivo. This experimental paradigm could be applied to any number of questions related to microbe-microbe, environment-microbe and host-microbe interactions, including
for example the metabolic fate of particular nutrients of interest (metabolic flux experiments),
microbial succession, and biotransformations of xenobiotics. Studying representative model communities in gnotobiotic mice also allows us to evaluate the technical limitations of current molecular approaches for characterizing native gut communities. For example, the structure of a defined
community can be evaluated over time at low cost using short read shotgun DNA sequencing data
mapped to all microbial genomes within the community (COPRO-Seq). This allows for a much
greater depth of sequencing coverage (i.e., more sensitivity) and much less ambiguity in the assignment of reads to particular taxa than traditional 16S rRNA gene-based sequencing allows.
Short read cDNA sequences transcribed from total community RNA can also often be assigned to
the exact microbial gene from which they were derived, and the same is also often true for peptides derived from particular microbial proteins. However, substantial dynamic range in species/
transcript/protein abundance within any microbiota, defined or otherwise, imposes limits on our
ability to characterize the least abundant elements of these systems.
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The effort to obtain a more complete understanding of the operations and behaviors of minor components of the microbiota is an area deserving of significant attention, given known examples of low-abundance taxa that play key roles within their larger communities and in host physiology [5,36]. Developing such an understanding requires methods and assays that are collectively
capable of assessing the structure and function of a microbiota at multiple levels of resolution.
The need for high sensitivity and specificity in these approaches will become increasingly relevant
as we transition towards experiments involving defined communities of even greater complexity,
including bacterial culture collections prepared from the fecal microbiota of humans [37]. We anticipate that the study of culture collections transplanted to gnotobiotic mice will be instrumental
in determining the degree to which physiologic or pathologic host phenotypes can be ascribed to
the microbiota as well as specific constituent taxa.
One of the greatest advantages of studying defined model microbiota is the ability they
afford to interrogate the biology of key bacterial species of interest in a focused manner. The
synthetic model human gut microbiota we studied included Bacteroides cellulosilyticus WH2, a
species that warrants further study as a model gut symbiont given its exceptional carbohydrate
utilization capabilities, its apparent fitness advantage over many other previously characterized gut
symbionts, and its genetic tractability. This genetic tractability should facilitate future experiments
in which transposon mutant libraries are screened in vivo as one component of a larger model community in order to identify this strain’s most important fitness determinants under a wide variety of
dietary conditions. Identifying the genetic elements that allow B. cellulosilyticus to persist at the
relatively high levels observed, regardless of diet, should provide microbiologists and synthetic
biologists with new ‘standard biological parts’ that will aid them in developing the next generation
of prebiotics, probiotics, and synbiotics.
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Figure legends
Figure 1. COPRO-Seq analysis of the structure of a 12-member model human microbiota as
a function of diet and time. (A) The 12 bacterial species comprising the model microbiota in this
study. (B) Principal coordinates analysis (PCoA) was applied to relative abundance data generated
by COPRO-Seq from two experiments (E1, E2), each spanning six weeks. Following colonization
(day 0), mice were switched between two different diets at two-week intervals as described in Fig.
S3. COPRO-Seq data from E1 and E2 were ordinated in the same multi-dimensional space. For
clarity, only data from E2 are shown here (for the E1 PCoA plot, see Fig. S5A). Red/blue, feces;
magenta/cyan, cecal contents. (C) Proportional abundance data from E1 illustrating the impact of
diet on fecal levels of a diet-sensitive strain with higher representation on HF/HS chow (B. caccae), a diet-sensitive strain with higher representation on LF/HPP chow (B. ovatus), a diet-insensitive strain with no obvious diet preference (B. thetaiotaomicron), and a diet-sensitive strain with a
preference for the LF/HPP diet that also achieves a high level of community representation on the
HF/HS diet (B. cellulosilyticus WH2). Mean values ± SEM are shown. Plots illustrating changes
in abundance over time for all species in both experiments are provided in Fig. S4C.
Figure 2. B. cellulosilyticus WH2 CAZyme expression in mice fed different diets.
(A) Overview of the 50 most highly expressed B. cellulosilyticus WH2 CAZymes (i.e., glycoside
hydrolases (GH), glycosyltransferases (GT), polysaccharide lyases (PL) and carbohydrate esterases (CE)) for samples from each diet treatment group. List position denotes the rank order of gene
expression for each treatment group, with higher expression levels situated at the top of each list.
Genes common to both lists are identified by a connecting line, with the slope of the line indicating
the degree to which a CAZyme’s prioritized expression is increased/decreased from one diet to the
other. CAZy families in bold, colored letters highlight those list entries found to be significantly
upregulated relative to the alternative diet (i.e., a CAZyme with a bold green family designation
was upregulated on the LF/HPP diet; a bold orange family name implies a gene was upregulated
significantly on HF/HS diet). Statistically significant fold-changes between diets are denoted in
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the “F.C.” column (non-significant fold-changes are omitted for clarity). (B) Breakdown by CAZy
family of the top 10% most expressed CAZymes on each diet whose expression was also found to
be significantly higher on one diet than the other. Note that for each diet, the family with the greatest number of upregulated genes was also exclusively upregulated on that diet (LF/HPP, GH43;
HF/HS, GH13). In total, 25 genes representative of 27 families and 12 genes representative of 13
families are shown for the LF/HPP and HF/HS diets, respectively.
Figure 3. Top-down analysis of fecal microbiome gene expression in mice receiving oscillating diets. The fecal metatranscriptomes of four animals in the LF/HPPèHF/HSèLF/HPP
treatment group of E2 were analyzed using microbial RNA-Seq at seven time-points to evaluate
the temporal progression of changes in expressed community functions triggered by a change in
diet. After aligning reads to genes in the defined model human gut microbiome, raw counts were
collapsed by the functional annotation (EC number) of the gene from which the corresponding
reads originated. Total counts for each EC number in each sample were normalized, and any EC
numbers demonstrating a statistically significant difference in their representation in the metatranscriptome between the final days of the first two diet phases were identified using a model based
on the negative binomial distribution [38]. Normalized expression values for 157 significant EC
numbers (out of 1,021 total tested) were log-transformed, mean-centered, and subjected to hierarchical clustering, followed by heatmap visualization. ‘Rapid’ responses are those where expression increased/decreased dramatically within 1-2 days of a diet switch; ‘gradual’ responses are
those where expression changed notably, but slowly, between the two diet transition points; and
‘delayed’ responses denote changes that did not achieve statistical significance until the end of a
diet phase. EC numbers specifying enzymatic reactions relevant to carbohydrate metabolism and/
or transport are denoted by purple markers, while those with relevance to amino acid metabolism
are indicated using orange markers. A full breakdown of all significant responses over time and the
outputs of the statistical tests performed are provided in Table S7.
Figure 4. Two xylanase-containing B. cellulosilyticus WH2 PULs demonstrating strong dietspecific expression patterns in vivo. (A) The PUL spanning genes BWH2_4044-55 includes a
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four-gene cassette comprising two consecutive susC/D pairs, multiple genes encoding glycoside
hydrolases (GHs) and carbohydrate esterases (CEs), and a gene encoding a putative hybrid twocomponent system (HTCS) presumed to play a role in the regulation of this locus. GH10 enzymes
are endo-xylanases (most often endo-b-1,4-xylanases), while some GH5 and GH8 enzymes are
also known to have endo- or exo-xylanase activity. CE6 enzymes are acetyl xylan esterases, as
are some members of the CE1 family. A second PUL spanning genes BWH2_4072-6 contains a
susC/D cassette, an endo-xylanase with dual GH10 modules as well as dual carbohydrate (xylan)
binding modules (CBM22), a hypothetical protein of unknown function, and a putative HTCS.
(B) Heat map visualization of GeneChip expression data for BWH2_4044-55 and BWH2_4072-6
showing marked upregulation of these putative PULs when mice are fed either a plant polysaccharide-rich LF/HPP diet or a diet high in fat and simple sugar (HF/HS), respectively. Data are from
cecal contents harvested from mice at the endpoint of experiment E1. (C) Mass spectrometry-based
quantitation of the abundance of all cecal proteins from the BWH2_4044-55 and BWH2_4072-6
PULs that were detectable in the same material used for GeneChip quantitation in panel B. Bars
represent results (mean ± SEM) from two technical runs per sample. For each MS run, the spectral
counts for each protein were normalized against the total number B. cellulosilyticus WH2 spectra
acquired. (D) Comparison of in vivo PUL gene expression as measured by RNA-Seq (top) and the
degree to which disruption of each gene within each PUL by a transposon impacts the fitness of B.
cellulosilyticus WH2 on each diet, as measured by insertion sequencing (INSeq, bottom). For the
lower plots, fitness measurements are calculated by dividing a mutant’s representation (normalized
sequencing counts) within the fecal output community by the mutant’s representation within an input population that was introduced into germ-free animals by oral gavage along with other model
community members. For cases in which no instances of a particular mutant could be measured
in the fecal output community (resulting in a fitness calculation denominator of zero), the data are
plotted as “<0.01” and are drawn without error bars.
Figure 5. In vitro microbial RNA-Seq profiling of B. cellulosilyticus WH2 during growth on
different carbohydrates. (A) Hierarchical clustering of the gene expression profiles of 90 cul138

tures grown in minimal medium supplemented with one of 31 simple or complex sugars (n=2-3
replicates per condition). Circles at dendrogram branch points identify clusters with strong bootstrapping support (>95%; 10,000 repetitions). Solid circles denote clusters comprising only replicates from a single treatment group/carbohydrate, while open circles denote higher-level clusters comprising samples from multiple treatment groups. Colored rectangles indicate the type of
carbohydrate on which the samples within each cluster were grown. (B) Unclustered heat map
representation of fold-changes in gene expression relative to growth on minimal medium plus
glucose (MM-Glc) for 60 of the 236 paired susC- and susD-like genes identified within the B.
cellulosilyticus WH2 genome (for a full list of all paired and unpaired susC and susD homologs,
see Table S2). Data shown are limited to those genes whose expression on at least one of the 31
carbohydrates tested demonstrated a >100-fold increase relative to growth on MM-Glc for at least
one of the replicates within the treatment group. Yellow boxes denote areas of the map where both
genes in a susC/D pair were upregulated >100-fold for at least two of the replicates in a treatment
group and where the average upregulation for each gene in the pair was >100-fold across all replicates of the treatment group. Two sets of columns to the right of the heatmap indicate PULs that
were detectably expressed at the mRNA level (left set of columns) and/or protein level (right set of
columns) in experiment 1 (E1). Red and black circles indicate that both genes in a susC/D pair were
consistently expressed on a particular diet, as determined by GeneChip analysis of cecal RNA (≥5
of 7 animals assayed) or LC-MS/MS analysis of cecal protein (2 of 2 animals assayed). In both
cases, a red circle denotes significantly higher expression on one diet compared to the other.
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Supplementary material
Supplementary materials and methods
B. cellulosilyticus WH2 genome sequencing. A strain of B. cellulosilyticus designated ‘WH2’
(see Figs. S1A, B) was isolated from a human fecal sample during an iteration of the Microbial
Diversity Summer Course overseen by A. Salyers (Univ. of Illinois, Urbana-Champaign) at the
Marine Biological Laboratory (Woods Hole, MA). The genome of this isolate was sequenced using a combination of long-read and short-read technologies, yielding 51,819 plasmid and fosmid
end reads (library insert sizes: 3.9, 4.9, 6.0, 8.0, and 40 kb; ABI 3730 platform), 333,883 unpaired
454 reads (FLX+ and XL+ chemistry), and 10 million unpaired Illumina reads (HiSeq; 42 nt read
length). A hybrid assembly was constructed using MIRA v3.4.0 (method: de novo; type: genome;
quality grade: accurate) with default settings [39,40]. Gene calling was performed using the YACOP metatool [41]. Additionally, the four ribosomal RNA (rRNA) operons within the B. cellulosilyticus WH2 genome were sequenced individually to ensure high sequence accuracy in these
difficult to assemble regions. Further details for the B. cellulosilyticus WH2 assembly are provided
in Table S1.
Bacterial strains. Details regarding the 12 bacterial strains used in this study are provided
in Table S3. Cells were grown in supplemented TYG (TYGS; [34]) at 37°C under anaerobic conditions in a Coy anaerobic chamber (atmosphere; 75% N2, 20% H2, 5% CO2). After reaching stationary phase, cells were pelleted by centrifugation and resuspended in TYGS medium supplemented
with 20% glycerol. Individual aliquots containing 400-800 µL of each cell suspension were stored
at -80°C in 1.8 mL borosilicate glass vials with aluminum crimp tops. The identity of each species was verified prior to its use in experiments by extracting DNA from a frozen aliquot of cells,
amplifying the 16S rRNA gene by PCR using primers 8F/27F (AGAGTTTGATCCTGGCTCAG;
[42]) and 1391R (GACGGGCGGTGWGTRCA; [43]), sequencing the entire amplicon with an
ABI 3730 capillary sequencer (Retrogen, Inc.), and comparing the assembled 16S rRNA gene
sequence to the known reference sequence.
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Preparation of strains for oral gavage. Details regarding the construction of each inoculum are provided in Table S4. The inocula used to gavage germ-free mice in each experiment were
prepared either directly from frozen stocks (experiment #1, E1) or from a combination of frozen
stocks and overnight cultures (experiment #2, E2). The recoverable cell density for each batch of
frozen stocks used in inoculum preparation was determined prior to pooling, while the same values for overnight cultures were calculated after pooling. An aliquot of cells from each overnight
culture or set of frozen stocks was used to prepare a ten-fold dilution series in phosphate-buffered
saline (PBS), and each dilution series was plated on brain-heart-infusion (BHI; BD Difco) agar
supplemented with 10% (v/v) defibrinated horse blood (Colorado Serum Co.). Plates were grown
for up to 3 d at 37°C under anaerobic conditions in a Coy chamber, colonies were counted, and the
number of colony-forming units per milliliter (CFUs/mL) was calculated. The volume of each cell
suspension included in the final inoculum was normalized by its known or estimated viable cell
concentration in an effort to ensure that no species received an early advantage during establishment of the model human gut microbiota in the germ-free animals. Total CFUs per gavage were
estimated at 8.0x107 and 4.2x108 for experiments E1 and E2, respectively.
Mice. Experiments were performed using protocols approved by the animal studies committee of the Washington University School of Medicine (animal studies protocol #20110232). For
each experiment, two groups of 10-12 week-old male germ-free C57BL/6J mice were maintained
in flexible film gnotobiotic isolators under a strict 12 h light cycle, during which time they received
sterilized food and water ad libitum. Animals were fasted for 4 h prior to gavage with 500 µL of
a cell suspension inoculum containing the 12 sequenced, human-gut derived bacterial symbionts.
After gavage, animals were maintained in separate cages throughout the course of the experiment.
Fresh fecal pellets were periodically collected directly into screw-cap sample tubes that were immediately frozen in liquid nitrogen. At the time of sacrifice, the contents of each animal’s cecum
were divided into thirds and snap-frozen in liquid nitrogen for later use in DNA, RNA, and total
protein isolations.
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Diets. Animals were subjected to dietary oscillations comprising three consecutive phases
of two weeks each (see Fig. S3). Prior to inoculation, germ-free mice were maintained on a standard autoclaved chow diet low in fat and rich in plant polysaccharides (‘LF/HPP’, B&K rat and
mouse autoclavable chow #73780000, Zeigler Bros, Inc). Three days prior to inoculation, one
group of germ-free animals was switched to a ‘Western’-like chow high in fat and simple sugars
(‘HF/HS’; Harlan Teklad TD96132), while the other continued to receive LF/HPP chow. After
gavage, each group of animals was maintained on its respective diet for two weeks, after which
each treatment group was switched to the alternative diet. Two weeks later, the diets were switched
back to their original starting diet and were retained on this diet up through the time of sacrifice.
The ingredients in plant polysaccharide-rich LF/HPP chow include: wheat, soybean meal, wheat
middlings, corn, fish meal, lignin sulfoate, soy oil, dicalcium phosphate, limestone, sodium chloride, calcium propionate, L-lysine, choline chloride, zinc sulfate, vitamin E, and other vitamin and
mineral premixes. The ingredients in the ‘Western’-like HF/HS diet include (% by weight): casein
(23.60%), sucrose (18.262%), corn starch (16.0%), maltodextrin (12.0%), shortening (10.0%),
beef tallow (10.0%), mineral mix [TD 94046] (4.13%), cellulose (4.0%), vitamin mix [Teklad
40060] (1.18%), calcium phosphate [dibasic] (0.472%), DL-methionine (0.354%), and ethoxyquin
(0.002%).
DNA and RNA extraction. DNA and RNA were extracted from fecal pellets and cecal
contents as previously described [8].
COmmunity PROfiling by Sequencing (COPRO-Seq). COPRO-Seq measurements of the
proportional representation of all species present in each fecal/cecal sample analyzed were performed as previously described [8] using short-read (36 nt) data collected from an Illumina GAIIx
sequencer. After deplexing of each barcoded pool, reads were trimmed to 25 bp prior to alignment
to the reference genomes. An abundance threshold cutoff of 0.003% was set, based on the proportion of reads from each experiment that were found to spuriously align to distractor reference
genomes of bacterial species not included in this study. Normalized counts for each bacterial species in each sample were used to calculate a simple intra-sample percentage (“% of community”).
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In order to make changes in abundance over time more easily comparable between species with
significantly different relative abundances, these percentages were also normalized by the maximum abundance (%) observed for a given species across all time-points from a given animal. This
transformation resulted in a value representing the ratio of a given percentage to the maximum
percentage achieved (“% of % max”) that was used to evaluate which species were most/least
responsive to dietary interventions.
Ordination of COPRO-Seq data using QIIME. COPRO-Seq proportional abundance data
were subjected to ordination using scripts found in QIIME v1.5.0-dev [44]. Data from both E1
and E2 were combined to generate a single tab-delimited table conforming to QIIME’s early (prev1.4.0-dev) OTU table format. This pseudo-OTU table was subsequently converted into a biomformatted table object that was used as the input for beta_diversity.py to calculate the pairwise
distances between all samples using a Hellinger metric. Principle coordinates analysis (PCoA)
calculations were performed using principal_coordinates.py. These coordinates and sample metadata were passed to make_3d_plots.py to generate PCoA plots. Plots shown are visualized using
v2.21 of the KiNG software package [45].
Metatranscriptomics (GeneChip). A custom Affymetrix GeneChip (‘SynComm1’) with
perfect match/mismatch (PM/MM) probe sets targeting 97.6% of the predicted protein-coding
genes within the genomes of the 12 bacterial species in this study (plus three additional species
not included in the model human gut microbiota) was designed and manufactured in collaboration
with the Affymetrix chip design team. Control probes targeting intergenic regions from each genome were also tiled onto the array to allow detection of any contaminating gDNA. Hybridizations
were carried out with 0.9-5.1 µg cDNA using the manufacturer’s recommended protocols. Details
regarding the design of this GeneChip are deposited under Gene Expression Omnibus (GEO) accession GPL9803.
Custom mask files were generated for each species on the GeneChip for the purposes of
performing data normalization one species at a time. Normalization of raw intensity values was
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carried out in Affymetrix Microarray Suite (MAS) v5.0. MAS output was exported to Excel where
advanced filtering was used to identify those probe sets called present in at least 5 of 7 cecal
RNA samples in at least one diet tested. Data from probe sets that did not meet these criteria (i.e.,
genes that were not expressed on either condition) were not included in subsequent analyses. Normalized, filtered data were evaluated using the Cyber-T web server [46] to identify differentially
expressed genes. Genes were generally considered significantly differentially expressed in cases
meeting the following three criteria: p < 0.01, PPDE(<p) ≥ 0.99, and |fold-change| ≥2.
Metatranscriptomics (microbial RNA-Seq). Methods for extracting total microbial RNA
from mouse feces and cecal contents, depleting small RNAs (e.g., tRNA) and ribosomal RNA (5S,
16S, and 23S rRNA), and for converting depleted RNA to double-stranded cDNA were described
previously [10]. Illumina libraries were prepared [8] from 26 fecal samples obtained from the
second diet oscillation experiment (4 animals, 6-7 time-points surveyed per animal), using 500 ng
of input double-stranded cDNA/sample/library. RNA-Seq reads were aligned to the reference genomes using the SSAHA2 aligner [47]. Normalization of the resulting raw counts was performed
using the DESeq package in R [38]. Raw counts derived from the community metatranscriptome
were normalized either at the community level (i.e., counts from all genes were included in the
same table during normalization) for purposes of looking at community-level representation of
functions (ECs) of interest, or at the species level (i.e., counts from each species were independently normalized) for purposes of looking at gene expression changes within individual species. Data
adjustment (logarithmic transformation) and hierarchical clustering were performed using Cluster
3.0 [48] and GENE-E. Heatmap visualizations of expression data were prepared using JavaTreeview [49] and Microsoft Excel. The B. cellulosilyticus WH2 in vitro gene expression dendrogram
presented was prepared using GENE-E. Bootstrap probabilities at each edge of the dendrogram
were calculated using the ‘pvclust’ package in R (10,000 replications). Clusters with bootstrap pvalues >0.95 were considered strongly supported and statistically significant.
Metaproteomics (sample preparation). Cecal contents were collected from four mice and
solubilized in 1 mL SDS lysis buffer (4% w/v SDS, 100mM Tris·HCl (pH 8.0), 10mM dithioth149

reitol (DTT)), lysed mechanically by sonication, incubated at 95°C for 5 min, and centrifuged at
21,000 x g. Crude protein extracts were precipitated using 100% trichloroacetic acid (TCA), pelleted by centrifugation, and washed with ice-cold acetone to remove lipids and excess SDS. Protein precipitates were resolubilized in 500 µL of 8M urea and 100mM Tris·HCl (pH 8.0), reduced
by incubation in DTT (final concentration of 10mM) for 1 h at room temperature, and sonicated
in an ice water bath (Branson (model SSE-1) sonicator; 20% amp; 2 min total (cycles of 5 sec on,
10 sec off)). An aliquot of each protein extract was quantified using a bicinchoninic acid (BCA)based protein assay kit (Pierce). Protein samples (1 mg) were subsequently diluted with 100mM
Tris·HCl and 10mM CaCl2 (pH 8.0) to a final urea concentration below 4M. Proteolytic digestions
were initiated with sequencing grade trypsin (1/100, w/w; Promega) and incubated overnight at
room temperature. A second aliquot of trypsin was added (1/100) after the reactions were diluted
with 100mM Tris·HCl (pH 8.0) to a final urea concentration below 2M. After incubation for 4 h
at room temperature, samples were reduced by incubation in 10 mM DTT for 1 h at room temperature. Finally, the peptides were acidified (protonated) in 200mM NaCl and 0.1% formic acid,
filtered, and concentrated with a 10 kDa molecular weight cutoff spin column (Sartorius).
Metaproteomics (LC-MS/MS data collection). The peptide mixture from each mouse was
analyzed in technical duplicate via two-dimensional liquid chromatography (LC)-MS/MS on a
hybrid LTQ Orbitrap Velos mass spectrometer (Thermo Fisher Scientific). Peptides (~100 µL per
sample) were separated using a split phase 2D (strong-cation exchange (SCX) and C18 reverse
phase (RP))-LC column over a 12-step gradient for each run. All MS analyses were performed in
positive ion mode. Mass spectral data were acquired using Xcalibur (v2.0.7) in data-dependent
acquisition mode for each chromatographic separation (22 h run). One precursor MS scan was
acquired in the Orbitrap at 30K resolution followed by ten data-dependent MS/MS scans (m/z 4001700) at 35% normalized collision energy with dynamic exclusion enabled at a repeat count of 1.
MS/MS spectra were searched with SEQUEST (v.27; [50]) using the following settings: enzyme
type = trypsin; precursor ion mass tolerance = 3.0 Da; fragment mass tolerance = 0.5 Da; fully
tryptic peptides and those resulting from up to 4 missed cleavages only. All datasets were filtered
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with DTASelect (v1.9; [51]) using the following parameters: Xcorrs of 1.8, 2.5, and 3.5 for singly,
doubly, and triply charged precursor ions; DeltCN ≥ 0.08; ≥ 2 fully tryptic peptides per protein.
A custom-built FASTA target-decoy database [52,53] was generated and searched with
SEQUEST at a peptide-level false positive rate (FPR) estimated at ≤ 0.5%. The database contained
theoretical proteomes predicted from the genomes of the 12 bacterial species characterized in this
study (see Tables S3, S8), some diet components (e.g., rice and yeast) and common contaminants
(e.g., keratins). Three additional theoretical bacterial proteomes predicted from the genomes of
Eubacterium rectale, Faecalibacterium prausnitzii M21/2 and Ruminococcus torques were included as distractors (negative controls) that were not expected to be present in any of the samples
analyzed. An in silico tryptically digested protein sequence database was also used to generate a
theoretical peptidome of unique peptides within a mass range of 600-4,890 Da and ≤ 1 miscleavages.
Metaproteomics (analysis of proteomic datasets). Spectral counts for each protein were
normalized by either the total number of spectra collected for all species in a sample (normalization by community, ‘NBC’), or by the total number of spectra collected for all proteins from a
given species (normalization by species, ‘NBS’). p values for each protein were calculated using
the Mann–Whitney U test. To correct for multiple comparisons, q values were calculated using an
optimized false discovery rate (FDR) approach with the ‘qvalue’ package in BioConductor. Regardless of the normalization strategy employed, p and q values were only calculated for proteins
with at least 3 valid runs, where a valid run was one with more than 5 spectral counts. In NBC data,
p and q values were calculated for all proteins within the model metaproteome. In NBS data, p and
q values were calculated for each species-specific set of proteins. Differences in spectral counts
between treatment groups (diets) were calculated using group medians. A protein was designated
as ‘UP’-regulated if both its p and q values were less than 0.05 and the spectral count difference
between treatment groups was greater than 5. The same criteria were applied in the opposite direction for proteins labeled as ‘DOWN’. For proteins labeled ‘NULL’, there was insufficient evidence
to report any significant difference between the two treatment groups. Finally, a protein was con151

sidered detected, or ‘present’, in a sample if at least four (raw) spectral counts were assigned to
that protein when aggregating the results from the two runs (technical replications) performed on
the sample.
Phenotypic screen of the growth of Bacteroides spp. on various carbohydrates. The ability of Bacteroides cellulosilyticus WH2 and Bacteroides caccae (ATCC 43185) to grow on a panel
of 47 simple and complex carbohydrates was evaluated using a phenotypic array whose composition has been previously described [18]. Growth measurements were collected in duplicate (2
wells per substrate) over the course of three days at 37°C under anaerobic conditions. A total of
three independent experiments were performed for each species tested (i.e., n=6 growth profiles/
per substrate/species). Total growth (Atot) was calculated from each growth curve as the difference between the maximum and minimum optical densities (OD600) observed (i.e., Amax - Amin).
Growth rates were calculated as total growth divided by time (Atot / (tmax-tmin)), where tmax and tmin
correspond to the time-points at which Amax and Amin, respectively, were collected. Consolidated
statistics from all six replicates for each of the 47 conditions tested for each species are provided
in Table S11.
Profiling of B. cellulosilyticus WH2 gene expression during growth in defined minimal
medium containing various carbohydrates (microbial RNA-Seq). To characterize the impact of
select mono- and polysaccharides on the in vitro gene expression of B. cellulosilyticus WH2, cells
were cultured in minimal medium (‘MM’) supplemented with one of 31 distinct carbohydrates
(for the formulation of MM and a list of the carbohydrates used as growth substrates, see Tables
S12, S13). After recovery from a frozen stock on BHI blood agar, a single colony was picked and
inoculated into 5 mL of MM containing 5 mg/mL glucose. Anaerobic conditions were generated
within each individual culture tube using a previously described method [54] with the following
modifications: (i) the cotton plug was lit and extinguished before being pushed below the lip of
the culture tube; and, (ii) 200 µL of saturated sodium bicarbonate was combined with 200 µL 35%
(w/v) pyrogallate solution on top of the cotton plug before a bare rubber stopper was used to seal
the tube. Cultures were grown overnight at 37°C. Twenty microliters of this ‘starter’ culture was
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subsequently inoculated into a series of ‘acclimatization’ cultures, each containing 5 mL of MM
plus one of the 31 carbohydrates to be tested (5 mg/mL final concentration), and anaerobic culturing was carried out as above. This second round of culturing served two purposes: (i) it ensured
cells were acclimated to growth on their new carbohydrate substrate prior to the inoculation of
the final cultures that were harvested for RNA; and (ii) it provided an opportunity to obtain OD600
measurements indicating, for each carbohydrate, the range of optical densities corresponding to
B. cellulosilyticus WH2’s logarithmic phase of growth. Finally, 50 µL of each ‘acclimatization’
culture was inoculated into triplicate 10 mL volumes of medium of the same composition, and
the 93 ‘harvest’ cultures were grown anaerobically at 37°C. At mid-log phase, 5 mL of cells were
immediately preserved in Qiagen RNAprotect Bacteria Reagent according to the manufacturer’s
instructions. Cells were then pelleted, RNAprotect reagent was poured off, and the bacteria were
stored at -80°C.
After thawing, while still cold, each bacterial cell pellet was combined with 500 µL Buffer B
(200mM NaCl, 20mM EDTA), 210 µL of 20% SDS, and 500 µL of acid phenol:chloroform:isoamyl
alcohol (125:24:1, pH 4.5). The pellet was resuspended by manual manipulation with a pipette tip
and transferred to a 2 mL screwcap tube containing acid-washed glass beads (Sigma, 212-300 µm
diameter). Tubes were iced, bead-beaten for 2 min at room temperature (BioSpec Mini-Beadbeater-8; set to ‘homogenize’), placed on ice, and bead-beaten for an additional 2 min, after which time
the RNA extraction protocol proceeded as for fecal/cecal samples.
Identification of diet-specific fitness determinants within the B. cellulosilyticus WH2
genome using INsertion Sequencing (INSeq). Whole genome transposon mutagenesis of B. cellulosilyticus WH2 was performed using protocols originally developed for B. thetaiotaomicron
[Goodman 2009, 2011], with some modification. Initial attempts to transform B. cellulosilyticus
WH2 with the pSAM_Bt construct reported by Goodman et al. yielded very low numbers of antibiotic resistant clones, which we attributed to poor recognition of one or more promoters in the
mutagenesis plasmid. Replacement of the promoter driving expression of the transposon’s erythromycin resistance gene (ermG) with the promoter for the gene encoding EF-Tu in B. cellulosi153

lyticus WH2 (BWH2_3183) dramatically improved the number of resistant clones recovered after
transformation. The resulting library consisted of 26,750 distinct transposon insertion mutants in
78.8% of all predicted ORFs (mean = 5.3 distinct insertion mutants / ORF).
At 11-weeks-of-age, male germ-free C57BL/6J mice (individually caged) were fed either
a diet low in fat and rich in plant polysaccharides (LF/HPP) or high in fat and simple sugars (HF/
HS). After a week on their experimental diet, the animals received a single gavage containing the
B. cellulosilyticus WH2 transposon library and 14 other species of bacteria (i.e., the model community consisted of the 12 species listed in Fig. 1A, plus B. thetaiotaomicron 7330, Eubacterium
rectale ATCC 33656, and Clostridium symbiosum ATCC 14940). After 16 d, fecal pellets were
collected, and total fecal community DNA was extracted.
Five hundred nanograms of each fecal DNA extraction was diluted in 15 µL of TE buffer
and digested with MmeI (4 U, New England Biolabs) in a 20 µL reaction supplemented with 10
pmoles of 12 bp DNA containing an MmeI restriction site (to improve the efficiency of restriction
enzyme digestion) [Goodman, 2009]. The reaction was incubated for 1 h at 37oC and then terminated (80oC for 20 min). MmeI-digested DNA was subsequently purified using 125 µL of AMPure
beads (after washing the beads once with 100 µL of sizing solution (1.2 M NaCl and 8.4% PEG
8000)). The digested DNA was added to the beads and the solution incubated at room temperature
for 5 min. Beads were pelleted with a Magnetic Particle Collector (MPC), washed twice (each time
using a mixture composed of 20 µL TE (pH 7.0) and 100 µL sizing solution, with bead recovery
via MPC after each wash), followed by two ethanol washes (180µL 70% ethanol/wash) and airdrying for 10 min. Samples were resuspended in 18 µL TE (pH 7.0) and the DNA was removed
after pelleting beads with the MPC. Ligation of adapters was performed in a 20 µL reaction that
contained 16 µL of purified DNA, 1 µL of T4 Ligase (2000 U/µL; NEB), 2 µL 10X ligase buffer and10 pmoles of barcoded adapter (incubation for 1 h at 16oC). Ligations were subsequently
diluted with TE (pH 7.0) buffer to a final volume of 50 µL, mixed with 60 µL of AMPure beads,
and incubated at room temperature for 5 min. Beads with bound DNA were pelleted using the
MPC and washed twice with 70% ethanol as above. After allowing the ethanol to evaporate for 10
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min, 35 µL of nuclease-free water was added and the mixture was incubated at room temperature
for 2 min before collecting the beads with the MPC. Enrichment PCR was performed in a final
volume of 50 µL using 32µL of the cleaned up sample DNA, 10 µL 10X Pfx amplification buffer
(Invitrogen), 2 µL 10mM dNTPs, 0.5 µL 50mM MgSO4, 2 µL of 5µM amplification primers (Forward primer: 5’CAAGCAGAAGACGGCATACG3’, Reverse primer: 5’AATGATACGGCGACCACCGAACACTCTTTCCCTACACGA3’), and 1.5 µL Pfx polymerase (2.5 U/µL; Invitrogen)
22 cycles of denaturation at 94oC for 15 sec, annealing at 65oC for 1 min and extension at 68oC for
30 sec. The 134 bp PCR product from each reaction was purified [4% metaphore gel; MiniElute
Gel extraction kit (Qiagen)] in a final volume of 20 µL, and was quantified (Qubit, dsDNA HS Assay Kit; Invitrogen). Reaction products were then combined in equimolar amounts into a pool that
was subsequently adjusted to 10nM and sequenced (Illumina Hi-Seq2000 instrument).
Supplementary results
Evaluating the carbohydrate utilization capabilities and preferences of B. caccae, a HF/HS
diet-adapted species. Comparing CAZyme expression between three diet-insensitive Bacteroides
spp. (B. thetaiotaomicron, B. vulgatus, and B. cellulosilyticus WH2) and HF/HS-favoring B. caccae revealed that these two groups have dissimilar profiles. While diet-insensitive strains express
many CAZymes on both diets, and roughly equal percentages of their encoded CAZymes in a
diet-specific manner, B. caccae’s CAZyme utilization is heavily skewed (Fig. S6B). While 19% of
B. caccae CAZymes were expressed in mice regardless of the diet consumed, an additional 28%
of this species’ predicted CAZymes were expressed in animals consuming the HF/HS diet. In contrast, B. caccae expressed only 1% of its predicted CAZymes in a LF/HPP diet-specific manner.
Phenotypic characterization of B. caccae on the same carbohydrate growth array we used
to characterize B. cellulosilyticus WH2’s substrate utilization capabilities revealed significant deficiencies in B. caccae’s ability to utilize many simple and complex sugars (Table S11). Of particular note were its complete lack of any starch utilization system (as evidenced by its inability
to grow on amylopectin derived from both potato and maize, as well as dextran and pullulan) and
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its inability to utilize any type of hemicellulose or β-glucan tested. These deficiencies strongly
contrast the strong growth we observed for B. cellulosilyticus WH2 when it was grown on several
such compounds. A complete comparison of the growth capabilities of B. cellulosilyticus WH2 and
B. caccae reveals the striking fact that with the exception of one monosaccharide (N-acetylneuraminic acid), B. cellulosilyticus WH2 growth outperforms that of B. caccae on every carbohydrate
tested.
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Supplementary figure legends
Figure S1. Phylogenetic relatedness of B. cellulosilyticus WH2 to other Bacteroides species.
(A) Near full-length 16S rRNA gene sequences from the B. cellulosilyticus WH2 isolate, its three
closest relatives (B. xylanisolvens, B. intestinalis, and B. cellulosilyticus), and Parabacteroides
distasonis (the latter was included as an outgroup) were aligned against the SILVA SEED using the
SINA aligner [55]. The 5’ and 3’ ends of the resulting multiple sequence alignment were trimmed
to remove ragged edges, and the final alignment was used to construct an approximately-maximum-likelihood phylogenetic tree using FastTree v2.1.4 [56]. Sequences in the trimmed alignment
used to generate the tree shown correspond to bases 22-1498 of the Escherichia coli 16S rRNA
gene [57]. Parenthetical identifiers indicate the locus tag (for B. cellulosilyticus WH2, whose genome contains four copies of the 16S rRNA gene) or accession number (for all other strains) of
each sequence included in the phylogenetic analysis. (B) Identity matrix summarizing the pairwise
similarities (as % nucleotide sequence identity) for all 16S rRNA gene sequences used to construct
the tree shown in panel A.
Figure S2. Representation of all putative glycoside hydrolase (GH) families identified in the
B. cellulosilyticus WH2 genome compared to their representation in other sequenced Bacteroidetes species. Enumeration of the GH repertoire of Bacteroides cellulosilyticus WH2 relative
to (A) the six other Bacteroidetes species included in the model community described in Fig. 1A,
and (B) the 86 Bacteroidetes currently annotated in the CAZy database. GH numbers in red signify
CAZy families whose representation is greater in B. cellulosilyticus WH2 than any of the other
Bacteroidetes to which it is being compared. An asterisk following a GH family number indicates
genes encoding proteins from that family were found exclusively in the B. cellulosilyticus WH2
genome. In (B), GH family numbers are ordered from left to right and from top to bottom by their
average representation within the 87 Bacteroidetes genomes included in the analysis.
Figure S3. Design and sampling schedule for experiments E1 and E2.
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Figure S4. COPRO-Seq analysis of the proportional representation of component taxa in
the 12-member model human gut microbiota as a function of time after colonization of gnotobiotic mice and the diet they were consuming. (A) Average DNA yields from fecal and cecal
samples collected from each treatment group in experiment E1. (B) DNA yields from samples collected in experiment E2. (C) COPRO-Seq quantitation of the 12 bacterial species comprising the
synthetic community used to colonize germ-free mice in experiments E1 and E2. Vertical dashed
lines at days 14 and 28 denote time-points at which diets were switched. Panels A-C share a common key, provided in the upper right. Circles and triangles denote samples from experiments E1
and E2, respectively. Cecal sample data points (obtained at sacrifice on day 42 of the experiment)
are plotted as for fecal sample data, but with inverted colors (i.e., colored outline, solid black fill).
For all panels (A-C), data shown are mean ± SEM.
Figure S5. Further COPRO-Seq analysis of the relative abundance of components of the
12-member model human microbiota as a function of diet and time. (A) Plot of the ordination
results for experiment 1 (E1) from the principle coordinates analysis (PCoA) described in Fig. 1B.
COPRO-Seq data from E1 and E2 were ordinated in the same multi-dimensional space. For clarity, only data from E1 are shown (for the E2 PCoA plot, see Fig. 1B). Color code: red/blue, feces;
magenta/cyan, cecal contents. (B) Heatmap representation of the relative abundance data from
E1 normalized to each species’ maximum across all time-points within a given animal (“% of %
max”). Each heatmap cell denotes the mean for one treatment group (n=7 animals), and each treatment group is shown as its own heatmap.
Figure S6. GeneChip profiling of the cecal metatranscriptome in mice fed different diets. (A)
Venn diagram illustrating the number of bacterial genes whose expression was scored as ‘present’
(i.e., detectable in ≥ 5 of 7 animals), only in mice that were consuming the plant polysacchariderich LF/HPP diet, only in mice that were consuming a ‘Western’-like HF/HS diet, or in both
groups. (B) Overview of the diet-specificity of CAZyme gene expression in the 12-member model
microbiota and in four prominent community members that maintained a proportional representation in the cecal microbiota that was >5% on each diet.
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Figure S7. Dissecting the model human gut microbiota’s in vivo expression of EC 3.2.1.8 (endo1,4-β-xylanase). (A) Gene expression in E2 fecal samples was evaluated by microbial RNA-Seq.
After data from all 12 species in the model microbiome were binned by EC number annotation and
normalized (i.e., data were ‘community-normalized’ at the level of ECs), no significant difference
in the representation of EC 3.2.1.8 in the metatranscriptome was observed when comparing day
13 (LF/HPP diet) and day 27 (HF/HS diet) data. (B) Transcribed B. cellulosilyticus WH2 genes
account for >99% of community-normalized RNA-Seq counts assignable to EC 3.2.1.8. Thus, B.
cellulosilyticus WH2 virtually dictates the degree to which expressed endo-1,4-β-xylanase genes
are represented within the community metatranscriptome. (C) B. cellulosilyticus WH2 contributes
a greater number of normalized RNA-Seq counts to the community metatranscriptome in HF/
HS-fed mice, despite being relatively more abundant in LF/HPP-fed animals. (D) When B. cellulosilyticus WH2 gene expression data are normalized independently of data from other community members (i.e., when data are ‘species-normalized’), statistically significant increases in the
representation of EC 3.2.1.8 within the B. cellulosilyticus WH2 transcriptome become apparent
in HF/HS-fed mice. (E) Breakdown of the total species-normalized counts in (D) by the B. cellulosilyticus WH2 gene from which they were derived. Mean values ± SEM are shown. Means for
all panels were calculated from data from four animals at each time-point, except day 26 (n=2).
Figure S8. Shotgun metaproteomic analysis of cecal samples from gnotobiotic mice colonized
with the model 12-member human gut microbiota. (A) Each species’ theoretical proteome was
subjected to in silico trypsinization (see Methods). Of the resulting peptides, those specific to a
single protein within our database of all predicted proteins encoded by the genomes of the 12 bacterial community members, the mouse, and 3 bacterial ‘distractors’ (Eubacterium rectale, Faecalibacterium prausnitzii, and R. torques) were classified as ‘unique’, while all others were considered
‘non-unique’. The ‘unique’ fraction of a species’ predicted peptides indicates how many can be
unambiguously traced back to a single protein of origin if detected by LC-MS/MS. (B) Comparison of the average relative cecal abundance of each bacterial community member (dark gray bars)
with the percentage of proteins within its theoretical proteome that were detected by LC-MS/MS
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(red bars), and the percentage of all genes within its genome whose expression was detected using
our custom GeneChip (light gray bars). Data shown are mean values ± SEM. (C) Scatter plots illustrating Pearson’s correlation between log-transformed averages of diet-specific expression folddifferences as determined by GeneChip assay (RNA, x-axis) and LC-MS/MS (protein, y-axis) in
E1. Data points within the black scatter plot represent the 448 B. cellulosilyticus WH2 genes for
which reliable quantitative data could be obtained for animals in both diet treatment groups for
both the GeneChip and LC-MS/MS assays (i.e., any gene for which a signal could not be detected
on at least one diet treatment in at least one assay were excluded). Scatter plots in color represent
the results of correlation analyses performed on subsets of genes within the black plot whose
KEGG annotations fall within particular functional categories, including “Translation” (r=0.03,
59 genes), “Energy metabolism” (r=0.36, 58 genes), “Amino acid metabolism” (r=0.48, 67 genes)
and “Carbohydrate metabolism” (r=0.69, 110 genes). For both (B) and (C), n=2 mice per treatment
group (4 mice total).
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Supplementary figures
Figure S1.
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Figure S2.
A

Parabacteroides distasonis (ATCC 8503)
Bacteroides caccae (ATCC 43185)
Bacteroides vulgatus (ATCC 8482)
Bacteroides uniformis (ATCC 8492)
Bacteroides thetaiotaomicron (VPI-5482)
Bacteroides ovatus (ATCC 8483)
Bacteroides cellulosilyticus (WH2)

50

Number of genes

45
40
35
30
25
20
15
10
5
2
3
5
8*
9
10
13
15
16
18
20
23
24
25
26
27
28
29
30
31
32
33
35
36
38
39*
42
43
50
51
53
55
57
63
65
66
67
73
74
76
77
78
79*
84
88
89
91
92
93
94
95
97
98
99
105
106
108
109
110
115
116
117*
120
121*
123
125
127
130

0

Glycoside

B

hydrolase

(GH) fam

ily

50

Bacteroides cellulosilyticus WH2
Other Bacteroidetes

40

20

10

10

5

50

81

98

8

42

*
79

10

84

59

66

8

38

47

3

3
12

91

53

39

86

11

1

19

12

0

0
11
11

63

67
74

89
99

7

24
87

37

15
44

11

57
11

5

5

35
93

11

77
64

12

9

65
85

76
17

82

32
6

0

10

5

Glycoside hydrolase (GH) family

162

4

1*
12

10

9

0

4

12

10

12

4

55

6

8
12

94

0

26

7

27

36

12

9

6
10

30

10

0

10

13

88

51

33

5

18

78

10

95

43

28

25

5

73

16

31

97

20

29

92

2

23

3

13

0

11

Number of genes per Bacteroidetes genome

30

Figure S3.

x7

-3

0

2w

4w

6w

-3

0

2w

4w

6w

-3

0

2w

4w

6w

-3

0

2w

4w

6w

C57BL/6J

E1
x7
C57BL/6J

x7
C57BL/6J

E2
x8
C57BL/6J

LF/HPP diet
HF/HS diet

Fecal pellet (DNA, COPRO-Seq)
Fecal pellet (RNA, RNA-Seq)
Cecal contents (DNA, COPRO-Seq; RNA, GeneChip; Protein, LC-MS/MS)
Cecal contents (DNA, COPRO-Seq)

163

Gavage with 12-member
community

Figure S4.

28

5

0

0

14

Day

28

C. scindens

10

5

0

0

14

Day

28

D. longicatena

1.0

0.5

0.0

0

14

Day

28

en
t

0

42

14

Day

28

1

Day

P. distasonis

6
4
2
0

0

14

Day

164

28

42

28

42

20
10
0

14

Day

28

42

C. aerofaciens

8
6
4
2
0

14

Day

28

42

R. obeum

10

8

Day

30

0

42

14

B. cellulosilyticus WH2

10

2

28

0

40

0

42

3

14

HF/HS=>LF/HPP=>HF/HS

10

50

C. spiroforme

0

E1
E2

20

0

42

20

10

Abundance (%)

1.5

28

40

0

42

Day

B. vulgatus

4

Abundance (%)

15

5
14

LF/HPP=>HF/HS=>LF/HPP

B. thetaiotaomicron

30

10

0

Diet regiment

E1
E2

42

15

0

42

28

B. ovatus

60

10

Day

20

0

42

Abundance (%)

Abundance (%)

Day

B. uniformis

15

Abundance (%)

14

14

Abundance (%)

Abundance (%)

Abundance (%)

20

0

0

25

40

0

0

42

B. caccae

60

2

Abundance (%)

C

Day

28

4

Abundance (%)

14

Fe
ca
l
Ce
ca
l
Ex
pe
r im

ug DNA / mg sample

ug DNA / mg sample

0.5

0

Fecal DNA yield (E2)

6

1.0

0.0

Abundance (%)

B

Fecal DNA yield (E1)

1.5

Abundance (%)

A

8
6
4
2
0

0

14

Day

28

42

.l
o
B.ngic
a
B.unif ten
vu orm a
B.
ce C. sB. clga is
B.llulo C piroacctus
th si . s fo ae
et lyt cin rm
a i
C iot cus dene
. a ao W s
er m H
of icr 2
P. R. aci on
di ob ens
s e
B. tasoum
ov ni
at s
us
D
.l
C ong
. s ic
p a
C C. iro ten
. a sc fo a
er in rm
of de e
B.
th B. aci ns
et B. ca en
ai v c s
o
P. taoulgacae
di m tu
st ic s
B.
a r
ce
B. B. so on
llu
unova nis
lo R if tu
si . or s
ly o m
tic b is
us eu
Wm
H
2

D

Day

A
/

/

1
2
5
12
13
15
16
19
26
27
29
30
33
41
42

LF/HPP
HF/HS

0
14
Day

Day

PC1 (52%)

Figure S5.

HF/HS
LF/HPP
LF/HPP
HF/HS

E1

28
42

B

1
2
5
12
13
15
16
19
26
27
29
30
33
41
42
0 .3 .4 .5 .6 .7 1
Percentage of maximum
achieved (PoMA)

LF/HPP
HF/HS

Diet sensitive
Diet insensitive

165

Figure S6.

A
LF/HPP-specific
(3,556 genes)

HF/HS-specific
(3,221 genes)

Shared
(11,373 genes)

B
SC12

CAZyme diet specificity

9%

LF/HPP only

17%

Both LF/HPP + HF/HS
HF/HS only

7%

67%

Neither diet

B. cellulosilyticus WH2

B. vulgatus

B. thetaiotaomicron

B. caccae
1%

4%

5%
19%

8%

16%
34%
8%

52%
28%

52%

71%
10%

166

26%
58%
8%

Figure S7.
A

B

Average total expression, EC 3.2.1.8
(all species, community-normalized)
n/s

2000

Total normalized counts

1500
1000
500

1000
500

D

Avg. contribution to total
community-normalized counts
(WH2)

d3
0

d2
9

d2
7

d2
6

Average total expression, EC 3.2.1.8
(WH2, species-normalized)
2000

Total normalized counts

30

d1
6

d1
3

d3
0

d2
9

d2
7

d2
6

d1
6

d1
5

d1
3

C

d1
5

0

0

20

10

0

1500
1000
500

E
1500

d3
0

d2
9

d2
7

d2
6

d1
3

d3
0

d2
9

d2
7

d2
6

d1
6

d1
5

d1
3

0

d1
6

% of normalized counts

1500

d1
5

Total normalized counts

2000

Average total expression, EC 3.2.1.8
(WH2, community-normalized)

Average expression, genes annotated as EC 3.2.1.8
(WH2, species-normalized)
LF/HPP diet

1000

500

167

BW
H
2_
46
80

BW
H
2_
40
72

BW
H
2_
40
68

BW
H
2_
40
50

d1
3
d1
5
d1
6
d2
6
d2
7
d2
9
d3
0

BW
H
2_
40
49

BW
H
2_
30
53

0
BW
H
2_
17
08

Total normalized counts

HF/HS diet

A

Percentage of predicted peptides
.a
e
C rof
. s ac
p i
P. iro ens
di for
st m
a e
R so
B.
C . ob nis
.
ce D sc eu
llu . lo in m
lo ng de
si ic n
ly a s
tic te
u n
B. s W a
v
B. ulg H2
un atu
B.
if s
th
et B. orm
ai o is
ot va
ao tu
m
B. ic s
ca ron
cc
ae
M
ou
se

Figure S8.
100
80

Non-unique
Unique

60
40
20

C

0

Percentage

B

LF/HPP (E1)

80

HF/HS (E1)

Abundance, COPRO-Seq
Transcripts detected, GeneChip

60

Proteins detected, LC-MS/MS
40
20

B
Ba act
ct ero
er id
Ba
o
e
ct
er Bac ide s W
s
oi
de ter vu H2
s oid lga
t
e
Pa B het s o tus
ra ac aio va
ba te ta
tu
ct roi om s
e
d
ic
Ba roid es ron
ct es ca
R ero dis cca
um id
e
e tas
i
C noc s u oni
ol
n
lin occ ifo s
s
u rm
C ella s o is
lo
be
a
s
e
C tri
lo di rof um
st um ac
rid
i
iu sc ens
D m s ind
or
e
p
ea iro ns
lo for
ng m
Ba
ic e
at
ct
en
er
a
oi
de
B
Ba
a
s
ct Ba cte ca
er ct ro
e
o
i cc
Pa ide roi des ae
ra s t des W
ba he
H
ct ta vul 2
g
e
i
R roi ota atu
um de om s
in s d ic
oc is ro
Ba oc tas n
c cu o
C ter s o nis
lo oi
s
d be
Ba trid es um
ct ium ov
a
C ero
s tu
ol
lin ide cin s
C se s u den
lo lla ni
s
st
rid ae form
iu rof is
D m s aci
or
e
ea piro ns
lo for
ng m
ic e
at
en
a

0

1
0
−1
−3

●
●

−5
−4

−3

−2

−1

log2

(

0

1

)

LF/HPP
HF/HS

●

●

(

1

2

3

4

) [RNA]

●
●

r = 0.36
−4 −3 −2 −1

(

r = 0.53
3

[RNA]

4

5

●

●

●

−3

●

●

● ●

●

●

●

●
●

●

●

●
●
●●

●
● ●
● ●
●●
●
●

●●

●

●●
●

●

●
●
● ●

●
●●

●●

● ● ● ●
●
●
●
●

●

●
●

●

●

●
●

●●
●
●

r = 0.48
−4 −3 −2 −1

(

0

1

3

) [RNA]

log2 LF/HPP
HF/HS

168

2

2

3

4

) [RNA]

5

●
●

4

5

−5

●

●

●

●
●

●
● ●

●

● ●

●
●

●

●

●
●

●● ●
●

●
●

●
●

●
●●●
● ●● ●
●
●●●●●
●● ● ● ●
● ● ● ●
● ●
●
●
●
●● ●
●
● ●● ●●
● ● ● ●● ● ●
●●
●
●
●
●
●
●
●
●●
●
●●●
●
●● ●
●
●
●
●
●
●
●
●

−3

●

−5

1

Carbohydrate metabolism
6
5
4
3
2
1
0
−1

●

●

0

log2 LF/HPP
HF/HS

●
●

●

●

−5

5

Amino acid metabolism
6
5
4
3
2
1
0
−1

●● ●

●●
●
●
●
●● ●
● ●●
●
● ●
●
● ●
● ●●
●
● ●● ● ● ●
●● ●
●
●
● ● ●
●
●
● ●
●
●
●

log2 LF/HPP
HF/HS

●●

2

) [Protein]
r = 0.03

0

●

●

●

●

−3

−4 −3 −2 −1

●

●

●
●
●

(
−3
−5

●

●

●

(

●

● ●

●
●
●●●●
●
●
● ●●
●
●●
●
●●●●●●●● ●
●● ● ●
●
●
● ● ● ●
●
● ●
●● ●
●
●
●
●
●
●
●
●
●●
●
●

●

●

) [Protein]

2

●

●
●

●

●

●
●

(

3

●

●

●
●

Energy metabolism

6
5
4
3
2
1
0
−1

log2 LF/HPP
HF/HS

4

●

●

) [Protein]

● ●
●
●
●
●
●
●● ●
●
●
●
●
● ●
●
●
●
● ● ● ●
●
●
● ●●● ●
●
● ● ● ● ● ●● ● ●
●
● ●● ●
●
●●● ●●
● ● ●● ●●●
●●
●●● ● ●
●●●●●
●
●
●
●
●
● ●●●●●●● ●● ● ●●● ●● ● ● ●● ●● ●
●● ●● ●●● ● ●
●
●
●
●
●
●
●●
●●●●●● ● ● ●●●
●
●● ● ● ●●●● ●
● ●●● ● ●●
●●● ●● ●
● ● ●● ●●●●●●● ●●●
●● ● ●
● ●●● ●●●
● ●●●●
●
●●● ●●● ●●
● ●● ● ●
● ●● ●
● ● ● ●●●● ●● ●●●
●●●● ● ●●
●●● ●●●●●●●●●●● ●● ●●● ●●
● ● ●● ●
●
● ●● ●●●
●
● ●●●
●●
●
●
●●
●
●
●
● ●●●● ●
●●● ●
●
●●●●
●
● ●●● ●
● ●●●● ●● ● ●
●
●
● ●●
● ●●●●●●●●●●
● ● ●● ●●
●
●
●● ●● ● ●● ●
●
● ●● ●● ●●
●●
●
●●● ●●● ●●● ● ●
●
●
●
●
●
●●
● ● ●
●
●●
●
● ●
●● ●
●
● ●
●
●●
●●
●
●
●
●
● ●
●
●
●
●
●
●
●
● ●
●
●
●
●
●
●●
●●

(

) [Protein]

●
●

(

log2 LF/HPP
HF/HS

●

●

●

●

5

log2 LF/HPP
HF/HS

6

Translation

6
5
4
3
2
1
0
−1

log2 LF/HPP
HF/HS

All KEGG categories

log2 LF/HPP
HF/HS

) [Protein]

C

●

●

●

●

●

●

●

●

r = 0.69

●

−4 −3 −2 −1

(

0

1

2

3

) [RNA]

log2 LF/HPP
HF/HS

4

5

References
1.

Lozupone CA, Hamady M, Cantarel BL, Coutinho PM, Henrissat B, et al. (2008) The
convergence of carbohydrate active gene repertoires in human gut microbes. Proc Natl
Acad Sci U S A 105: 15076-15081.

2.

Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, et al. (2009) A core gut
microbiome in obese and lean twins. Nature 457: 480-484.

3.

Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA (2008) Polysaccharide utilization by
gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6: 121131.

4.

Roberfroid MB, Van Loo JA, Gibson GR (1998) The bifidogenic nature of chicory inulin
and its hydrolysis products. J Nutr 128: 11-19.

5.

Gibson GR, Macfarlane GT, Cummings JH (1993) Sulphate reducing bacteria and hydrogen
metabolism in the human large intestine. Gut 34: 437-439.

6.

Faith JJ, McNulty NP, Rey FE, Gordon JI (2011) Predicting a human gut microbiota’s
response to diet in gnotobiotic mice. Science 333: 101-104.

7.

Faith JJ, Rey FE, O’Donnell D, Karlsson M, McNulty NP, et al. (2010) Creating and
characterizing communities of human gut microbes in gnotobiotic mice. ISME J 4: 10941098.

8.

McNulty NP, Yatsunenko T, Hsiao A, Faith JJ, Muegge BD, et al. (2011) The impact of
a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and
monozygotic twins. Sci Transl Med 3: 106ra106.

9.

Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, et al. (2009) Characterizing
a model human gut microbiota composed of members of its two dominant bacterial phyla.
Proc Natl Acad Sci U S A 106: 5859-5864.
169

10.

Rey FE, Faith JJ, Bain J, Muehlbauer MJ, Stevens RD, et al. (2010) Dissecting the in vivo
metabolic potential of two human gut acetogens. J Biol Chem 285: 22082-22090.

11.

Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, et al. (2010) A human gut microbial gene
catalogue established by metagenomic sequencing. Nature 464: 59-65.

12.

(2012) Structure, function and diversity of the healthy human microbiome. Nature 486:
207-214.

13.

Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. (2005) Diversity of the
human intestinal microbial flora. Science 308: 1635-1638.

14.

Martens EC, Chiang HC, Gordon JI (2008) Mucosal glycan foraging enhances fitness and
transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 4: 447457.

15.

Benjdia A, Martens EC, Gordon JI, Berteau O (2011) Sulfatases and a radical S-adenosylL-methionine (AdoMet) enzyme are key for mucosal foraging and fitness of the prominent
human gut symbiont, Bacteroides thetaiotaomicron. J Biol Chem 286: 25973-25982.

16.

Koropatkin NM, Cameron EA, Martens EC (2012) How glycan metabolism shapes the
human gut microbiota. Nat Rev Microbiol 10: 323-335.

17.

Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, et al. (2007) Evolution of
symbiotic bacteria in the distal human intestine. PLoS Biol 5: e156.

18.

Martens EC, Lowe EC, Chiang H, Pudlo NA, Wu M, et al. (2011) Recognition and
degradation of plant cell wall polysaccharides by two human gut symbionts. PLoS Biol 9:
e1001221.

19.

Martens EC, Roth R, Heuser JE, Gordon JI (2009) Coordinate regulation of glycan
degradation and polysaccharide capsule biosynthesis by a prominent human gut symbiont.
J Biol Chem 284: 18445-18457.

170

20.

Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes
associated with obesity. Nature 444: 1022-1023.

21.

Pagani I, Liolios K, Jansson J, Chen IM, Smirnova T, et al. (2012) The Genomes OnLine
Database (GOLD) v.4: status of genomic and metagenomic projects and their associated
metadata. Nucleic Acids Res 40: D571-579.

22.

Cantarel BL, Coutinho PM, Rancurel C, Bernard T, Lombard V, et al. (2009) The
Carbohydrate-Active EnZymes database (CAZy): an expert resource for Glycogenomics.
Nucleic Acids Res 37: D233-238.

23.

Cantarel BL, Lombard V, Henrissat B (2012) Complex carbohydrate utilization by the
healthy human microbiome. PLoS One 7: e28742.

24.

Bjursell MK, Martens EC, Gordon JI (2006) Functional genomic and metabolic studies of
the adaptations of a prominent adult human gut symbiont, Bacteroides thetaiotaomicron, to
the suckling period. J Biol Chem 281: 36269-36279.

25.

Lynch JB, Sonnenburg JL (2012) Prioritization of a plant polysaccharide over a mucus
carbohydrate is enforced by a Bacteroides hybrid two-component system. Mol Microbiol
85: 478-491.

26.

Chu SH, Walker WA (1986) Developmental changes in the activities of sialyl- and
fucosyltransferases in rat small intestine. Biochim Biophys Acta 883: 496-500.

27.

Thomsson KA, Holmen-Larsson JM, Angstrom J, Johansson ME, Xia L, et al. (2012)
Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core
3-transferase-deficient mice highlights differences compared with human MUC2.
Glycobiology 22: 1128-1139.

28.

Katayama T, Sakuma A, Kimura T, Makimura Y, Hiratake J, et al. (2004) Molecular cloning
and characterization of Bifidobacterium bifidum 1,2-alpha-L-fucosidase (AfcA), a novel
inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 186: 4885-4893.
171

29.

Keller M, Hettich R (2009) Environmental proteomics: a paradigm shift in characterizing
microbial activities at the molecular level. Microbiol Mol Biol Rev 73: 62-70.

30.

Wilmes P, Bond PL (2006) Metaproteomics: studying functional gene expression in
microbial ecosystems. Trends Microbiol 14: 92-97.

31.

Bertin PN, Heinrich-Salmeron A, Pelletier E, Goulhen-Chollet F, Arsene-Ploetze F, et al.
(2011) Metabolic diversity among main microorganisms inside an arsenic-rich ecosystem
revealed by meta- and proteo-genomics. ISME J 5: 1735-1747.

32.

Verberkmoes NC, Russell AL, Shah M, Godzik A, Rosenquist M, et al. (2009) Shotgun
metaproteomics of the human distal gut microbiota. ISME J 3: 179-189.

33.

Dodd D, Mackie RI, Cann IK (2011) Xylan degradation, a metabolic property shared by
rumen and human colonic Bacteroidetes. Mol Microbiol 79: 292-304.

34.

Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, et al. (2009) Identifying genetic
determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6:
279-289.

35.

Robert C, Chassard C, Lawson PA, Bernalier-Donadille A (2007) Bacteroides cellulosilyticus
sp. nov., a cellulolytic bacterium from the human gut microbial community. Int J Syst Evol
Microbiol 57: 1516-1520.

36.

Backhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI (2005) Host-bacterial
mutualism in the human intestine. Science 307: 1915-1920.

37.

Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, et al. (2011) Extensive personal
human gut microbiota culture collections characterized and manipulated in gnotobiotic
mice. Proc Natl Acad Sci U S A 108: 6252-6257.

38.

Anders S, Huber W (2010) Differential expression analysis for sequence count data.
Genome Biol 11: R106.

172

39.

Chevreux B, Wetter T, Suhai S. Genome sequence assembly using trace signals and
additional sequence information; 1999; Hannover, Germany. pp. 45-56.

40.

Chevreux B, Pfisterer T, Drescher B, Driesel AJ, Muller WEG, et al. (2004) Using the
miraEST assembler for reliable and automated mRNA transcript assembly and SNP
detection in sequenced ESTs. Genome Res 14: 1147-1159.

41.

Tech M, Merkl R (2003) YACOP: Enhanced gene prediction obtained by a combination of
existing methods. In Silico Biol 3: 441-451.

42.

Eden PA, Schmidt TM, Blakemore RP, Pace NR (1991) Phylogenetic analysis of
Aquaspirillum magnetotacticum using polymerase chain reaction-amplified 16S rRNAspecific DNA. Int J Syst Bacteriol 41: 324-325.

43.

Lane DJ (1991) 16S/23S rRNA sequencing. In: Stackebrandt E, Goodfellow M, editors.
Nucleic Acid Technology in Bacterial Systematics. New York: John Wiley & Sons. pp.
115-175.

44.

Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, et al. (2010) QIIME
allows analysis of high-throughput community sequencing data. Nat Methods 7: 335-336.

45.

Chen VB, Davis IW, Richardson DC (2009) KING (Kinemage, Next Generation): a
versatile interactive molecular and scientific visualization program. Protein Sci 18: 24032409.

46.

Baldi P, Long AD (2001) A Bayesian framework for the analysis of microarray expression
data: regularized t -test and statistical inferences of gene changes. Bioinformatics 17: 509519.

47.

Ning Z, Cox AJ, Mullikin JC (2001) SSAHA: a fast search method for large DNA databases.
Genome Res 11: 1725-1729.

48.

de Hoon MJ, Imoto S, Nolan J, Miyano S (2004) Open source clustering software.
Bioinformatics 20: 1453-1454.
173

49.

Saldanha AJ (2004) Java Treeview--extensible visualization of microarray data.
Bioinformatics 20: 3246-3248.

50.

Eng JK, McCormack AL, Yates JR, 3rd (1994) An approach to correlate tandem mass
spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass
Spectrom 5: 976-989.

51.

Tabb DL, McDonald WH, Yates JR, 3rd (2002) DTASelect and Contrast: tools for
assembling and comparing protein identifications from shotgun proteomics. J Proteome
Res 1: 21-26.

52.

Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP (2003) Evaluation of multidimensional
chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale
protein analysis: the yeast proteome. J Proteome Res 2: 43-50.

53.

Elias JE, Gygi SP (2007) Target-decoy search strategy for increased confidence in largescale protein identifications by mass spectrometry. Nat Methods 4: 207-214.

54.

Lockhart WR (1953) A single tube method for anaerobic incubation of bacterial cultures.
Science 118: 144.

55.

Pruesse E, Peplies J, Glockner FO (2012) SINA: accurate high-throughput multiple
sequence alignment of ribosomal RNA genes. Bioinformatics 28: 1823-1829.

56.

Price MN, Dehal PS, Arkin AP (2010) FastTree 2--approximately maximum-likelihood
trees for large alignments. PLoS One 5: e9490.

57.

Brosius J, Palmer ML, Kennedy PJ, Noller HF (1978) Complete nucleotide sequence of a
16S ribosomal RNA gene from Escherichia coli. Proc Natl Acad Sci U S A 75: 4801-4805.

174

Chapter 4

Future directions

175

Introduction
The experimental system and molecular tools developed over the course of this dissertation provide a means of addressing any number of questions about how the human gut microbiota assembles, operates, and responds to environmental changes over time. Our studies of the effects
of introducing probiotic strains into an established microbiota (discussed in Chapter 2) provide a
framework for identifying and characterizing future probiotic strains, probiotic consortia, prebiotics, and synbiotics (combinations of pre- and probiotics). We expect that data from studies using
model communities to dissect the mechanisms by which probiotic strains influence host physiology will significantly impact the ways we treat individuals suffering from malnutrition, metabolic
syndrome, inflammatory disorders, and other pathophysiological states that have been linked to
the gut microbiota/microbiome [1-3]. Our studies of the influence of diet change over time on
the microbiota (discussed in Chapter 3) provided many valuable insights about how communities
are reconfigured in terms of both their structure and function in response to an altered nutrient
landscape, as well as how prominent taxa (e.g., B. cellulosilyticus WH2) adjust their substrate
utilization strategies. Follow-up future studies can adopt a similar strategy to identify the specific
components of diets that drive desirable or undesirable reconfigurations in microbiota of different
human populations. At least three additional areas of research and development building on the
findings reported in Chapters 2 and 3 could and should be pursued, as described below.
Creating more representative models of the human microbiota
Culturing the ‘unculturable’
Although research performed in our laboratory has recently demonstrated that a significant number
of the microbes residing in a human gut microbiota represent lineages that can be cultured using
traditional methods [4], the fact remains that the human gut also harbors many species that are
recalcitrant to growth in the laboratory [5]. One example is the bacterial phylum TM7. Representatives from this as-yet ‘unculturable’ group were first identified by sequencing the 16S rRNA
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gene in environmental samples from a German peat bog [6]. Since then, they have been found in
many other habitats, including the human intestine [7]. Unculturable gut bacteria also come from
phyla (divisions) with many cultured representatives. For example, some families from two of the
best-studied intestinal phyla, the Firmicutes (e.g., Lachnospiraceae) and the Bacteroidetes (e.g.,
Porphyromonadaceae, Prevotellaceae, Rickenellaceae) are comprised of many species we cannot
yet study in isolation. The defined communities of human gut bacteria characterized in this dissertation have been comprised exclusively of sequenced, culturable organisms. If monocultures of
a microbe cannot be prepared or if a microbe’s genome cannot be sequenced, it is not eligible for
inclusion in model community studies of the type described here. Because we know or infer from
culture-independent metagenomic studies that currently unculturable organisms can play important roles in the human gut [8], finding ways to expand our inventory of culturable gut microbes
will be critical as we aim to develop even more functionally and structurally representative models
of human gut communities.
Some ‘unculturable’ organisms may not be amenable to being grown in isolation because
their metabolism requires inputs (e.g., nutrients, signaling cues) from other microbial partners, and/
or researchers may not be sufficiently replicating essential aspects of their natural gut environment
[9]. Model communities such as those employed here offer one avenue for characterizing the nature of such mutualistic relationships through in vivo coculture experiments. In theory, a researcher
could use gnotobiotic mice colonized with defined and representative model communities as a type
of culturing vessel or in vivo ‘test tube’ into which difficult or impossible-to-culture organisms
could be introduced. Such organisms could come from samples where species diversity has been
artificially depressed to enrich the target species population, for example through the administration of antibiotics. These low-complexity consortia could then be introduced into gnotobiotic mice
harboring model communities with the aim of establishing the unculturable organism in a more
defined setting. Studies of environments with low levels of species complexity, such as acid mine
drainage sites, have shown that the genomes of the organisms comprising simple communities can
be reconstructed from metagenomic data [10]. We anticipate that if an unculturable organism (and
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a small number of other accompanying species) could be established in a gnotobiotic mouse colonized beforehand with species whose genomes are sequenced, it should be possible to reconstruct
the genomes of the newly introduced organisms. Further, establishment of the target species in a
model ecosystem would allow us to study its metabolic lifestyle with the same metatranscriptomic
(RNA-Seq) and high-resolution metaproteomic methods used in this dissertation to characterize
microbe-microbe and diet-microbe interactions, offering important insights not provided by the
inspection of its genome sequence alone [11].
Personal culture collections
The studies carried out over the course of this dissertation have made use of carefully constructed
models meant to be representative of a healthy human gut microbiota in terms of its phylogenetic
structure, gene content, and functional capacity. As we strive to assemble even more representative
models of the microbiota, we must account for that the fact that the way in which assemblages of
organisms operate may be dictated by their composition, their co-evolution within an individual,
family or population representing a given lifestyle (cultural tradition), as well as the physiological
status of an individual host. Thus, a ‘one size fits all’ model community may not always be appropriate or most effective for addressing particular biological questions. For this reason, we anticipate a move in the future towards greater study of ‘personal culture collections’ [4] comprised
of clonally arrayed, culturable microbes isolated from single individuals. These personal culture
collections would each be constructed using a sample (e.g., feces) from an individual possessing
particular age, physiological state, cultural tradition, or disease state. Armed with our current and
future (see above) understanding of the culturing requirements of gut microbes, we would isolate
the majority of taxa from a human subject’s microbiota and archive them as a subject-specific
model microbiota. Transplantation of these culture collections into germ-free mice would then be
performed to determine if consortia faithfully recapitulate (transmit) microbiota-mediated human
donor phenotypes in gnotobiotic animals. Should our attempts at transferring human phenotypes to
germ-free hosts using culture collections prove effective, further characterization of the microbes
driving particular phenotypes could be conducted. Such follow-up studies could include the se178

quencing of isolate genomes to gain insight about their metabolic potential and nutrient requirements, introduction of subsets of the community, mutagenesis of individual isolates prior to their
inclusion in a model community, and/or replacement of a given member with by closely-related
species to determine how general or specific important traits might be within a specific lineage.
Developing new and improved tools and techniques for characterizing model communities
Construction of more representative models of the human gut microbiota should also be accompanied by development of new and improved methods for characterizing these communities; this
would allow us to interrogate their structure and operations in more detailed (comprehensive) as
well as more holistic ways. Some of the methods that were developed or improved over the course
of this dissertation can be scaled to characterize highly diverse model communities fairly easily.
For example, COPRO-Seq can accommodate communities of nearly any complexity, provided
they are comprised exclusively of sequenced species whose genomes can be differentiated from
one another. Microbial RNA-Seq is also scalable and can be used to characterize complex communities if financial resources are available to sequence the metatranscriptome deeply. Although the
structure and function of model communities can be probed readily with current techniques, there
are also many biological parameters of the gut ecosystem that we are not yet capable of measuring
with sufficient accuracy or throughput. This includes, for example, the spatial relationship between
microbes and the gut’s cellular and luminal contents (the latter includes its mucus layer as well as
partially digested food particles). Future efforts to develop methods for measuring some of these
parameters are described below.
Absolute quantitation of microbial biomass and taxon abundance
In earlier chapters, we demonstrated that COPRO-Seq provides precise and accurate measurements of the proportional representation of each species within a model community. When interpreting changes in a species’ proportional abundance over time, it is important to consider that
such changes can be driven by at least two factors: (i) an increase/decrease in the absolute abun179

dance of that species within the community, and (ii) an increase/decrease in the absolute abundance of other species within the community. Currently, COPRO-Seq is not capable of providing
the researcher with precise measurements of absolute abundance unless additional data (e.g., measurements of total microbial cell concentrations, total community biomass) are provided. In cases
where the proportional abundance of an organism is impacted to a significant degree by a perturbation, the direction of the perturbation’s effect on a particular species can be inferred with strong
confidence. However, subtle changes can be much more difficult to interpret. We have therefore
begun investigating approaches that can complement COPRO-Seq by providing measures of total
cell concentrations or total community biomass over time, so that the absolute abundance of each
species in a community can be calculated. In the simplest method, total community DNA is used
as a proxy for community biomass. Experimental data suggest, however, that measurements of fecal DNA concentrations are noisy from sample-to-sample, and we cannot rule out the possibility
that the composition of the diet fed to a gnotobiotic host might affect DNA extraction yields. A
second method involves using fluorescence activated cell sorting (FACS) to ‘count’ the number
of bacterial cells in a gut sample (e.g. feces). This approach uses DNA-specific dyes and the light
scattering properties of bacterial cells to differentiate microbes in a sample from all other particles.
By counting labeled cells and comparing their concentration to that of a spiked-in bead standard
of known size, a reliable estimate of the total bacterial cell count in a sample can be obtained. It is
also possible that the addition of other reagents might allow for the discrimination of live and dead
cells. Although the latter approach for quantifying the absolute abundance of the species within a
model community is still under investigation, we anticipate that it will ultimately serve as an important element of the molecular tool kit used by those studying model gut communities.
An expanded role for INSeq in model community studies
In Chapter 3, INsertion Sequencing (INSeq; [12,13]) was used to confirm that certain highly-expressed loci within the genome of Bacteroides cellulosilyticus WH2 act as important diet-specific
fitness determinants in vivo. This approach, which was developed as part of the study described
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in Appendix A, provides the researcher with a powerful tool for identifying fitness determinants
in any microbial species that can be transformed with a sequencing-adapted mariner transposon
delivery vector. Recently, members of our laboratory developed a version of this delivery vector
that incorporates specific barcodes that, when sequenced along with captured chromosomal DNA
located adjacent to an inserted transposon, can be used to distinguish different mutagenized populations of cells. This improvement on the original pSAM vector allows us to mutagenize and pool
multiple species of gut bacteria when constructing model communities so that rather than identifying the genetic determinants of fitness in one species at a time, many different species can be
evaluated simultaneously. Future studies leveraging this technical innovation should be performed
to identify genes that are broadly important for microbial success/persistence within the gut. Such
studies, identifying ‘general’ fitness determinants shared among members of a particular microbial
lineage, could serve as a foundation for experiments that seek to identify other shared suites of
genes needed for fitness in particular contexts (e.g., specific host physiological/pathological states
or diets). Given their dominance in the human gut, role in human health [14] and the breakdown of
macronutrients [15], and their genetic tractability, we see members of the Bacteroidetes as prime
candidates for such studies going forward.
New imaging techniques for evaluating gut biogeography
Although metagenomic surveys have taught us much about the overall composition of the distal
human gut microbiota, we still know surprisingly little about the microhabitats occupied by individual lineages and how the spatial distribution of a particular species is impacted by variables
such as diet and invasion of the ecosystem by new taxa. Fluorescence in situ hybridization (FISH)
has been used for years as a method for quantifying [16] and visualizing [17,18] microbes in a variety of ecosystems; the method is based on short, fluorescently-labeled oligonucleotide probes that
hybridize to small subunit ribosomal RNAs (e.g.,16S rRNA). One of the drawbacks of traditional
FISH-based methods is the inability of fluorescence microscopes to differentiate more than a handful of fluorophores simultaneously. This limitation prevents those studying microbial communities
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from using more than two or three labeled oligonucleotide probes at once. Therefore, these studies typically involve low-resolution visualization of bacteria using ‘universal’ probes which label
most or all bacteria, or probes designed to label taxonomically-related species (e.g., those of the
same genus or class). In collaboration with researchers at the Marine Biological Laboratory, we
have begun to apply a new variation of FISH to the study of defined model human gut communities in gnotobiotic mice. This method, known as combinatorial labeling and spectral imaging fluorescence in situ hybridization (CLASI-FISH; [19,20]) allows the researcher to visualize at least 15
and as many as hundreds of different species simultaneously. Our initial experiments have shown
that the method is tractable in samples collected from mice, and that spatial relationships between
all taxa in a model community can be quantified simultaneously. As these methods are developed
further and applied to defined communities of increasing complexity, we expect to delineate new,
previously unappreciated syntropic relationships between taxonomic groups and develop a greater
understanding of how microbes compete and cooperate to achieve stable community configurations within the gut.
Further study of specific taxa and ecological guilds
Focused studies characterizing widely distributed gut taxa are important for understanding how
particular lineages influence the operations of larger gut communities, and help us understand the
role of keystone species within these systems. For instance, decades of research on Bacteroides
thetaiotaomicron, whose genome was first sequenced in 2003 [21], have helped us better understand how gut microbes utilize polysaccharides [22,23], interact with the mucosal immune system
[24], and adapt metabolically during postnatal host development [25]. In another example, extensive microbiological studies of Faecalibacterium prausnitzii and the Roseburia have revealed the
important role these species play in the production of butyrate, an important source of energy for
colonocytes [26]. Studies focused on different ecological guilds of intestinal microbes (i.e., those
that exploit the same resources, often in related ways) have also taught us a about their roles in gut
food webs. Examples of such guilds are the methanogenic archaea [27] and acetogenic bacteria
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[28]. As our appreciation grows for the diversity of functional niches occupied by intestinal bacteria, so too will our need to better characterize the roles and capabilities of individual members of
the gut microbiota.
Based on the experimental results described in Chapter 3, we would advocate strongly for
further characterization of B. cellulosilyticus WH2, both in vitro and as a component of defined
model human gut communities. Our draft sequence of this microbe’s genome reveals it to be the
largest of any Bacteroides species to date. More importantly, it is also the most replete in carbohydrate active enzymes (CAZymes) and polysaccharide utilization loci (PULs) of any member of the
Bacteroidetes sequenced so far. Though the link between its substantial carbohydrate utilization
armamentarium and its strong fitness on disparate diets is still somewhat speculative, our data do
suggest that this species utilizes multiple carbohydrates in vivo, perhaps indicative of a diversified
nutrient utilization strategy. Such a strategy is likely to provide a fitness advantage to a bacterium
colonizing the gut of a host whose diet is far from monotonous.
While the studies outlined in this dissertation have greatly expanded our understanding of
this bacterium, further efforts to ‘crack the code’ of its carbohydrate utilization strategy are needed.
Our efforts thus far have successfully identified one or more substrates that trigger the expression
of at least 30 susC/D gene pairs (the core elements of PULs) in its genome and have revealed that
its metabolic strategy focuses largely on the catabolism of diet-derived xylans. However, the substrates capable of triggering the expression of over two-thirds of this organism’s 113 PULs remain
unidentified. Furthermore, we know little about the regulatory mechanisms and exact molecular
moieties that control the expression of individual PULs. Delineating these regulatory networks
should help us understand how gut microbes ‘decide’ what carbon sources to compete for and
utilize, and which receive low priority from a metabolic perspective. INSeq-based analyses have
shown that the ability to utilize xylan is critically important to B. cellulosilyticus WH2 in vivo.
However, the degree to which disrupting key components of PULs required for the utilization of
other substrates and the impact of disrupting the normal regulation of these loci are areas deserving
of further attention.
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Finally, though further characterization of carbohydrate utilization mechanisms in this
prominent Bacteroides will be instructive, even greater insight might be gained by characterizing
multiple other Bacteroides spp. using the same strategies employed here. Identifying the genes
required for the utilization of particular glycans in a number of lineages should allow us to begin describing different PUL ‘families’ (i.e., clusters of genes with non-identical configurations/
compositions that confer similar substrate utilization capabilities). Theoretically, the presence of
genetic elements known to be associated with a particular PUL family could even be used as a
metagenomic biomarker to indicate whether or not a given individual’s microbiota harbors the
capacity to utilize particular dietary substrates. Such information could be incredibly useful as
researchers begin to develop microbiome-directed therapeutics tailored to ‘supplement’ deficient
activities using probiotic strategies, or ‘boost’ the representation of important lineages using prebiotic compounds. Finally, as more knowledge is acquired about the carbohydrate utilization capabilities of different species, we anticipate the development of quantitative models that allow us to
predict which bacteria will prosper (or perish) under particular dietary regimens and to prescribe
diets that improve the nutritional status of humans representing different cultural traditions, at various stages of their lifecycle.
Concluding statements
As our appreciation grows for the many ways in which our gut microbes impact human health,
we must be judicious and thoughtful in the ways we address the many outstanding questions that
remain. Certainly, gut microbiota studies in human subjects will continue to yield new insights
about the nature of our relationship with our intestinal symbionts. However, a greater focus on the
careful characterization of representative models of this complex system under controlled conditions is also warranted, and necessary, if we are to develop generalizable principles and ‘rules’ for
how this important ‘microbial organ’ operates.
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SUMMARY

The human gut microbiota is a metabolic organ
whose cellular composition is determined by a
dynamic process of selection and competition. To
identify microbial genes required for establishment
of human symbionts in the gut, we developed an
approach (insertion sequencing, or INSeq) based
on a mutagenic transposon that allows capture of
adjacent chromosomal DNA to define its genomic
location. We used massively parallel sequencing to
monitor the relative abundance of tens of thousands
of transposon mutants of a saccharolytic human
gut bacterium, Bacteroides thetaiotaomicron, as
they established themselves in wild-type and
immunodeficient gnotobiotic mice, in the presence
or absence of other human gut commensals. In vivo
selection transforms this population, revealing functions necessary for survival in the gut: we show how
this selection is influenced by community composition and competition for nutrients (vitamin B12).
INSeq provides a broadly applicable platform to
explore microbial adaptation to the gut and other
ecosystems.
INTRODUCTION
Our indigenous microbial communities play critical roles in
shaping myriad features of our biology. The distal gut hosts the
majority of our microbes; these include representatives of all
three domains of life, plus their viruses. The density of organisms
occupying this habitat is astonishing, exceeding 1012 cells/mL.
Most phylogenetic types (phylotypes) observed in the guts of
humans and other mammals belong to just two bacterial divisions (phyla)—the Firmicutes and the Bacteroidetes (Ley et al.,
2008). Microbial community (microbiota) exchange experiments
indicate that gut community members are dynamically selected:
for example, transplantation of a Proteobacteria-dominated
zebrafish gut microbiota into germ-free mice transforms this
community so that it comes to resemble a mouse gut microbiota,
while transplantation of a mouse microbiota into germ-free
zebrafish has the opposite effect, yielding a community that
has the phylum-level characteristics of the native zebrafish
microbiota (Rawls et al., 2006).

Within the Firmicutes and Bacteroidetes, hundreds to thousands of phylotypes partition available niches (professions) to
create a community able to maintain itself in this continuously
perfused ecosystem despite shifts in host diet, regular ingestion
of foreign bacteria, intense resource competition, high bacteriophage levels, and immune surveillance. Comparisons of the
sequenced genomes of cultured representatives of major gut
phylogenetic lineages provide a means for identifying genomic
features potentially important for colonization and competition
in the gut. However, the recent surge in microbial genome
sequencing projects has far outpaced development of broadly
applicable tools for directly testing the role of genes in determining fitness in this habitat. The paucity of tools is unfortunate,
as fundamental questions connecting genome content to function remain unexplored. For example, how are the determinants
of fitness related to nutrient availability, and how closely do the
genes required for fitness in vivo mirror those required for maximizing growth rate in vitro? Does community structure influence
this map of genetic requirements, or is competition largely
‘‘within species’’? Do the major recognized components of the
host immune system play a dominant role in determining which
genes are critical for symbiont fitness in vivo? To address these
questions, we integrated a simple and broadly applicable
genetic tool with second-generation DNA sequencers and
gnotobiotic mouse models to identify fitness determinants in
the genome of a human gut mutualist.
Mariner transposon mutagenesis is an attractive forward
genetic strategy for connecting phenotype to gene because
stable random insertions can be generated in a recipient genome
without specific host factors: the ability of these transposons to
serve as mutagenic agents is well established in members of all
three domains of life (Lampe et al., 1996; Mazurkiewicz et al.,
2006). After alignment of the inverted repeat (IR) sequences
that delimit mariner family transposons, we noted that a single
G-T transversion at a nonconserved position would create
a recognition sequence for the type IIs restriction enzyme
MmeI. When directed to this location, MmeI would cleave 16 bp
outside of the transposon, capturing a genomic fragment that
identifies the insertion site. Moreover, if the genome sequence
of the recipient organism were known, the short genomic
DNA sequences captured by this MmeI digestion would be sufficient to uniquely map transposon location. We reasoned that
in a mixed population of transposon mutants produced in a
given recipient bacterial species, the relative abundance of
each MmeI-liberated genomic fragment, identified after limited
PCR amplification and massively parallel sequencing, would in
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Figure 1. Mapping and Quantifying Tens of
Thousands of Transposon Insertion Strains
by High-Throughput INSeq
(A) A negative selection scheme for identification
of genes required for colonization in vivo. Mutants
in genes important for competitive growth (red) are
expected to decrease in relative abundance in the
output population.
(B) Preparation of an INSeq library. Genomic DNA
is extracted from the mutagenized bacterial
population, digested with MmeI, and separated
by polyacrylamide gel electrophoresis (PAGE).
Transposon-sized fragments are appended with
double-stranded oligonucleotide adapters by ligation. Limited cycles of PCR create the final library
molecules for sequencing.
(C) Map of insertion sites in the B. thetaiotaomicron genome. An arrow marks the origin of
replication.
(D) Reproducibility of library preparation and
sequencing protocols. Technical replicates were
prepared and sequenced from a single transposon
mutant population. Each point represents the
abundance of insertions in a single gene; the
coefficient of determination, R2, on log-transformed abundance values is 0.92.

principle mirror the abundance of each mutant in the population.
Putting this population under potentially selective conditions
(e.g., colonization of the intestines of gnotobiotic mice) could
then be used to highlight mutants that change in relative abundance, and thereby identify genes and pathways critical for
fitness under these conditions (Figure 1A).
Using this insertion-sequencing (INSeq) approach, we subjected a mutagenized population of the prominent human gut
symbiont, Bacteroides thetaiotaomicron, to varying selective
pressures: in vitro growth in continuous flow chemostats, monoassociation of wild-type and knockout germ-free mice lacking
major branches of their innate or acquired immune systems,
and as one component of several defined in vivo communities
of human gut-derived microbes. The results provide evidence
that human gut symbionts, like their pathogenic counterparts,
possess dedicated mechanisms critical for interaction with their
host and each other. The relative importance of these mechanisms is not static but instead is shaped by other members of
the microbiota. As a strategy for functional characterization of
newly sequenced genomes in general, and of the human gut
microbiome in particular, INSeq extends existing techniques in
several important aspects.
RESULTS
We constructed pSAM, a sequencing-adapted mariner transposon delivery vector with three major features: an antibiotic
resistance cassette flanked by MmeI-modified mariner IRs,
a multiple cloning site immediately upstream of the himar1C9
mariner transposase (Lampe et al., 1999), and machinery for
replication in the donor strain and transfer by conjugation (see
Figures S1A–S1C available online). B. thetaiotaomicron was
chosen as the recipient species to test this approach for several
reasons (Figure S2A). First, it is highly adapted to life in the distal

human gut (Zocco et al., 2007). A prominent member of the
gut microbiota, this mutualist is richly endowed with a broad
arsenal of genes encoding glycoside hydrolases and polysaccharide lyases not represented in the human genome (Xu et al.,
2003). These genes are incorporated together with genes
encoding nutrient sensors and carbohydrate transporters into
88 polysaccharide utilization loci (PULs) representing 18% of
the organism’s genome (Martens et al., 2008). Thus equipped,
B. thetaiotaomicron functions as a flexible forager of otherwise
indigestible dietary glycans, as well as host glycans when
dietary polysaccharides are not available (Martens et al., 2008).
Second, >200 GeneChip data sets of B. thetaiotaomicron’s
transcriptome have been collected during growth in vitro under
a variety of conditions, after monocolonization of germ-free
mice fed different diets, as well as after cocolonization with
another human gut bacterial or archaeal species (NCBI GEO
archive). Third, functional genomic studies conducted in gnotobiotic mice have shown that monoassociation with B. thetaiotaomicron can recapitulate a number of host responses evoked
by a complete mouse gut microbiota. Fourth, a limited number
of in vivo competition experiments conducted in gnotobiotic
mice colonized with isogenic wild-type and mutant B. thetaiotaomicron have identified a few fitness determinants that could
serve as reference controls for the present study (Peterson
et al., 2007).
Construction and Characterization of a Transposon
Mutant Population by INSeq
We found that transfer of the MmeI-modified mariner transposon
into the genome of B. thetaiotaomicron occurs with high efficiency (Figure S2). To identify the site of transposon insertion
and the relative abundance of each mutant in an otherwise
isogenic population, we developed a straightforward procedure
to extract the two 16 bp genomic sequences adjacent to each
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transposon, append sequencing adapters to these fragments,
and separate the desired molecules from genomic background
(Figure 1B and Supplemental Experimental Procedures).
Sequencing these tags using an Illumina Genome Analyzer II
produced 8 million raw reads from a single flow cell lane:
90% of these reads contained the transposon (Figure S2D).
We designed a software package, MapSAM, to filter out lowquality sequences, quantify and pair reads generated from either
side of an insertion, and assign these paired reads to a specific
location in the target genome (Figure 1C). Examination of
technical replicates indicated that the library preparation,
sequencing, and mapping strategies were highly reproducible
(Figure 1D and Figure S3). The proportion of reads that were
unambiguously mapped (98%) matched predictions from an
in silico model of random transposon insertion (Figure S4A);
no insertion sequence bias beyond the known ‘‘TA’’ dinucleotide
requirement (Bryan et al., 1990) was apparent (Figures S4B
and S4C).
We first characterized a mutant population containing
35,000 B. thetaiotaomicron transposon insertion strains. Insertions were well distributed across the genome at an average
density of 5.5 insertions/kb (Figure 1C). After filtering out insertions in the distal (30 ) 10% of any coding region (because such
insertions could possibly still permit gene function), we found
that 3435 of the 4779 predicted open reading frames in the
genome (72%) had been directly disrupted in the mutant
population. Inclusion of genes disrupted by upstream (polar)
mutations in a predicted operon increased this number to 78%;
rarefaction analysis suggested that this population is approaching saturation (Figure S4D).
To identify B. thetaiotaomicron genes unable to tolerate transposon insertion, we generated and mapped a second, independent mutant population. We combined both data sets and
applied a Bayesian model to account for the number of informative insertion sites in each gene (Lamichhane et al., 2003). The
results yielded a conservative list of 325 candidate essential
genes for growth under anaerobic conditions when plated onto
rich (tryptone-yeast extract-glucose; TYG) medium (Table S1).
These genes were significantly enriched (Benjamini-Hochberg
corrected p < 0.05) for Clusters of Orthologous Groups (COG)
categories representing cell division (category D), lipid transport/metabolism (I), translation/ribosomal structure/biogenesis
(J), and cell-wall/membrane biogenesis (M). This is consistent
with genome-wide mutagenesis studies of Escherichia coli and
Pseudomonas aeruginosa (Baba et al., 2006; Jacobs et al.,
2003). For nonessential genes, insertion frequency showed
some correlation (R2 of log-transformed values = 0.33) with
GeneChip-defined expression levels during mid-log phase
growth of the parental wild-type strain in batch fermentors
containing TYG medium (Figure S4E). The reason for this relationship is not known, although studies of mariner transposition
in vitro suggest that the enzyme has a preference for bent or
bendable DNA (Lampe et al., 1998).
Combinatorial Mapping of Individual Insertion Strains
from an Archived Mutant Collection
A mutant population of this complexity contains insertions in
most of the coding potential of the genome and can facilitate
forward genetic approaches for identifying genotypes con-

nected with a phenotype of interest. These mixed populations,
however, are less amenable to reverse genetics: specific genotypes are not individually retrievable. Arrayed transposon mutant
collections, in which strains of known genotype are archived
individually, provide an important avenue for retrieval and further
study of specific strains of interest. To date, such collections
have been created by using a strain-by-strain procedure that
typically consists of cell lysis, removal of cellular debris, multiple
rounds of semirandom or single-primer PCR, DNA cleanup, and
individual Sanger sequencing of each amplicon. As an alternative, we developed a combinatorial technique for simultaneously
mapping thousands of individually archived transposon mutant
strains in parallel (Figure 2A, Figure S5, and Supplemental Experimental Procedures).
This approach consists of three basic steps: (1) culturing and
archived storage of randomly picked mutant colonies in individual wells of 96-well (or higher density) plates, (2) placement
of each of these strains into pools in unique patterns, and (3)
sequencing of these pools by INSeq in order to associate
each transposon insertion location with a strain in the original
arrayed multiwell plates. Because n pools can contain 2n unique
presence/absence patterns, a small number of pools can
uniquely identify a large number of strains. To this end, a benchtop liquid-handling robot was used to distribute archived
transposon mutant strains across a subset of pools in a pattern
selected to minimize the likelihood of mistaking one strain for
another or incorrectly mapping clonal strains (Figure 2B and
Supplemental Experimental Procedures). Libraries were then
prepared from each pool using the same method described in
Figure 1B, except that a pool-specific, barcoded adaptor
(Table S2) was used in the ligation step. These libraries were
combined into a single sample that can be sequenced with an
Illumina Genome Analyzer II using just one lane of the instrument’s eight-lane flow cell. Reads were first mapped to the
reference B. thetaiotaomicron genome to determine insertion
sites; to assign an insertion site to a specific archived strain,
the pool-specific barcodes associated with a given insertion
location on the chromosome were then matched with the
patterns assigned to the strains in the original archived set of
plates.
Using this strategy, we were able to identify the insertion coordinates for over 7000 individually archived B. thetaiotaomicron
transposon mutant strains in parallel (Table S3). To verify the
accuracy of these assignments, we first used ELISA to test
strains predicted to have lost reactivity to two monoclonal antibodies of known specificity (Peterson et al., 2007). We also
amplified transposon-genome junctions of test strains by semirandom PCR and sequenced the amplicons. In total, 179 of
183 strains tested (98%) produced the anticipated results
(Figure 2C), confirming that combinatorial barcoding and INSeq
can be used to efficiently and economically generate archived,
sequence-defined, mutant collections.
Identification of Genes Required for Fitness In Vitro
To identify genes that contribute to exponential growth in
nutrient-rich conditions in vitro, we maintained a 35,000-strain
mutant population in this growth phase (OD600 0.1–0.4), under
anaerobic conditions, in chemostats that were continuously
supplied with fresh TYG medium. Output populations were
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Figure 2. Mapping an Archived Strain
Collection by Combinatorial Pooling and
High-Throughput Sequencing
(A) Individual strains are archived in a 96-well
format and then placed into a subset of 24 pools
according to a unique 24-bit binary string assigned to each strain. Libraries are prepared
from each of these pools using the workflow
shown in Figure 1B, except that one of 24 poolspecific barcoded dsDNA adaptors is employed
in the ligation step. Libraries are then combined
and sequenced in a single run. Reads mapping
to a specific insertion location are compiled and
the associated pool-specific barcodes are identified to recreate the 24-bit string and, with it, the
physical location of the corresponding strain in
the archived collection. For details, see the
Supplemental Experimental Procedures.
(B) Sample pool distribution patterns for archived
strains. A given strain (row) is placed in pools
(columns) designated with white boxes and
omitted from pools marked with black boxes.
The patterns generated are each distinct in at
least six positions and do not overlap to produce
another pattern in the set. For details, see the
Supplemental Experimental Procedures.
(C) Confirmation of strain-insertion assignments.

sampled from four independent chemostats; two after 15 hr
of continuous exponential growth and two after 45 hr of
growth. DNA was prepared from each of these populations,
and transposon-adjacent genomic fragments were identified
by INSeq. After removing insertions in the 30 10% of each
gene, a z test was applied to identify genes that show a significantly altered representation from the overall distribution of
output:input abundance ratios after q value correction for
multiple hypothesis testing (q < 0.05; see the Supplemental
Experimental Procedures). To test this approach for identifying
fitness determinants, we also examined insertions in intergenic
‘‘neutral loci’’ (Figure S6A). None of these 80 control regions
passed the statistical cutoff for underrepresentation (three
increased in abundance). In contrast, 477 genes (14% of
the genes represented in the input population) showed a
statistically significant change in abundance after in vitro selection (265 underrepresented/212 overrepresented; Figure S6B
and Table S4). Consistent with selection for maximal growth
rate in rich medium, the list of factors important for fitness
under these conditions was significantly enriched in genes
annotated as being in COG category C (energy production
and conversion).
As a proof of principle, we asked whether an observed
enrichment in a broad functional group (COG category), represented among genes required for fitness, could be altered by
manipulating environmental conditions. To do so, we harvested
exponentially growing cells from mutant populations grown in
minimal defined medium in the presence or absence of exogenous amino acids and quantified the abundance of transposon

mutants by INSeq (n = 4 replicate populations, each assayed
independently). Gratifyingly, the set of genes required for fitness
specifically in the amino acid-depleted condition was most
highly enriched (p < 0.0005) in COG category E (amino acid
transport/metabolism) (Figure S7 and Table S5).
Genes Required for Establishment
of B. thetaiotaomicron within the Distal Gut
of Monoassociated Gnotobiotic Mice
To survey the B. thetaiotaomicron genome for genes critical for
fitness in a mammalian gut ecosystem, we colonized germ-free
mice with a single gavage of approximately 108 colony-forming
units (CFUs) of the 35,000-strain mutant population (n = 15
animals representing three independent experiments, each
involving a cohort of five 8- to 12-week old C57BL/6J males;
experiments were performed 3 months apart). The five animals
in each cohort were caged individually in a shared gnotobiotic
isolator and fed a standard, autoclaved, polysaccharide-rich,
low-fat chow diet ad libitum. The relative abundance of each
mutant strain in the cecal bacterial population was defined at
the time of sacrifice 14 days after gavage; this interval between
gavage and sacrifice encompassed several cycles of turnover
of the mucus layer and the underlying gut epithelium, and is
sufficient to allow mobilization of innate and adaptive immune
responses (Peterson et al., 2007).
All recipients of the gavage harbored equivalent levels of
B. thetaiotaomicron at the time of sacrifice (1011–1012 CFU/
mL cecal contents as quantified by plating and by qPCR). Moreover, the relative representation of mutants was consistent
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Figure 3. Identification of Genetic Determinants of Fitness In Vivo
(A) The transposon mutant population is largely
stable in vivo. The relative abundance of mutations
in each gene (points) was compared between
input and output (median from wild-type monoassociated mice, n = 15) populations. Genes that
show a statistically significant change (q < 0.05)
in representation in all three cohorts of mice are
shown in red, others in gray. The relative abundances of 80 gene-sized neutral loci are shown
in black (no significant change) and green (three
neutral loci that pass the significance criteria).
(B) Individual strains retrieved from the archived
collection demonstrate that genes critical for
fitness in vivo are dispensable in vitro. Each
strain was cultured individually in TYG medium,
and doubling time was calculated from OD600
measurements; error bars represent one standard
deviation based on triplicate experiments. Mutants predicted by INSeq to have in vitro growth
defects are marked with arrows. N/D, no growth
detected. rnf, Na+-transporting NADH:ubiquinone
oxidoreductase (BT0616-22); S layer, putative S
layer locus (BT1953-7); nqr, Na+-translocating
NADH-quinone reductase (BT1155-60); hly, hemolysin A (BT3459).
(C) Insertions in the CPS4 locus (BT1338-58) show
a consistent in vivo fitness defect. Individual insertion locations (open arrowheads) in a representative gene (BT1346; green arrow) are shown at
top. Read counts for input (black) and output
(orange) samples at each insertion location are indicated (output counts represent the median from the ceca of wild-type monoassociated mice, n = 15). Median
output:input ratios for each gene (black/green arrows) across the CPS4 locus are shown below. Asterisks indicate the average FDR-corrected p value (q) across
three experimental cohorts (n = 5 mice/cohort): *q < 0.05; **q < 0.01.

between the ceca of individual mice (Tables S9–S11) and for
most genes reflected their abundance in the input population
(Figure 3A). However, compared to the input population, mutants
in 370 genes showed significantly (q < 0.05) altered representation (90 overrepresented/280 underrepresented) in all three
cohorts of mice (Table S6; note that the largest category of genes
identified in this screen encode hypothetical or conserved hypothetical proteins). Only one of the 80 ‘‘neutral intergenic’’ controls
described above was significantly underrepresented in these
populations (two were overrepresented).
While the smaller group of 90 genes that produce a competitive
advantage in the cecum when mutated (highlighted in Table S6
in blue and green) are not significantly enriched in any broad
predicted functional (COG) categories, only half can be
explained by corresponding behavior in chemostats containing
rich medium. The underrepresented genes show a similar trend:
half (146) of the 280 genes critical for in vivo fitness can be
predicted from growth defects in rich medium; the remainder
(134/280), which are highlighted in Table S6 in yellow, do not
show a defect after prolonged exponential growth in vitro. These
include loci with diverse predicted functions, including assembly of polysaccharide- and protein-based surface structures
(BT1339-55, BT1953-7), synthesis and utilization of vitamin
B12-dependent cofactors (BT2090-1, BT2760), and an rnf-like
oxidoreductase complex (BT0616-22) (e.g., Figure S8).
To confirm that the requirement for these genes in vivo
could not be explained by general growth defects, we analyzed

individual mutant strains retrieved from the archived strain
collection. This collection contained sequence-defined, singleinsertion transposon mutants in 70% of the genes designated
as critical for survival in the distal gut in vivo (80% if predicted
polar effects are included) (Table S3). After validating the site of
selected transposon insertions by semirandom PCR and Sanger
sequencing, we determined the exponential doubling time of
representative strains individually (Figure 3B). Strains carrying
transposon insertions in genes uniquely required in vivo had an
in vitro growth rate similar to wild-type B. thetaiotaomicron,
further suggesting that the critical function of these genes
in vivo cannot be simply explained by a necessity for sustaining
exponential growth in rich medium. In contrast, mutants that
exhibited a competitive defect in the 35,000-strain population
both in vitro and in vivo had a slower doubling time when cultured
individually, suggesting that these genes play a basic role in
bacterial cell physiology.
An earlier report from our group used a targeted mutagenesis
strategy to disable expression of genes encoding capsular polysaccharide (CPS) 4 in this organism; this strain was rapidly displaced by wild-type B. thetaiotaomicron after initial inoculation
as a 1:1 mixture into germ-free mice (Peterson et al., 2007).
The 35,000-strain transposon mutant population recapitulated
this observation (Figure 3C and Figure S9). The transposon
mutant population included over 1100 independent insertions
across 143 genes that span all eight CPS loci encoded in the
B. thetaiotaomicron genome. None of the other CPS loci
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Figure 4. Identification of Environmental
and Microbial Factors that Determine the
Fitness Landscape for B. thetaiotaomicron
(A) The relative abundance of each mutant in
the B. thetaiotaomicron population was evaluated
in multiple host genotypes (wild-type C57Bl/6;
Rag1/; Myd88/) and microbial contexts.
(B) qPCR assays of cecal microbial community
composition in gnotobiotic mice at the time of
sacrifice. The 35,000-strain B. thetaiotamicron
population is indicated with arrows.

were required for fitness in vivo, indicating that CPS4 plays
a unique role for B. thetaiotaomicron in the gut environment of
monoassociated gnotobiotic mice fed a standard plant polysaccharide-rich chow diet. Moreover, our observation that transposon inactivation of genes in any single PUL did not confer
a competitive disadvantage in vivo is consistent with B. thetaiotaomicron’s capacity for adaptive foraging of a broad range of
glycans present in this diet (a total of 5137 distinct transposon
mutants, involving 810 genes in all 88 PULs).
The Impact of Host Genotype and Community Structure
on Selection In Vivo
We next asked whether a broad view of the mutant population as
a whole could help address some basic questions in mammalian
gut microbial ecology described in the Introduction: are the
genetic determinants of fitness influenced by the bacterial
community (microbiota) context; do inter-specific competition
and intra-specific competition play distinct roles in shaping the
selective pressures on a genome; is this selection primarily maintained by elements of the host immune system?
To explore these questions, we manipulated two features
of the host habitat: (1) the immune system, by introducing the
B. thetaiotaomicron mutant population into germ-free mice with
genetically engineered defects in innate or adaptive immunity
(Myd88/ and Rag1/, respectively); or (2) microbial composition, by including this mutant population as one component of
three different types of defined communities, one consisting of
six other sequenced human gut-associated Bacteroidetes,
another composed of eight sequenced human gut-associated
Firmicutes and Actinobacteria, and a third consisting of all 14

of these representatives of the human
distal gut microbiota (n = 4–5 animals per
treatment group per experiment; Figure 4A
and Table S7). Animals were sacrificed 14
days after gavage and their cecal contents
harvested. qPCR assays of cecal DNA,
using species-specific primers, revealed
that gavage with a given multispecies
input community yielded consistent
cecal ‘‘output’’ community compositional
profiles (Figure 4B and Table S8).
Each of these treatments shifted the
B. thetaiotaomicron population from its
input distribution (Tables S9–S12). To
search for functional trends in these shifts,
we assigned the genes underrepresented
in output populations to functional (COG) categories. The in vivo
fitness determinants were significantly enriched in different predicted functions compared to essential genes, or to the genes
required for maximal exponential growth in rich medium in vitro
(Figure 5). For example, the predicted essential genes are most
prominently enriched in COG categories J (translation, ribosome
structure/biogenesis) and D (cell-cycle control and cell division),
neither of which is enriched among the in vivo fitness determinants. Instead, the genes required in vivo are biased toward
energy production/conversion (category C) and amino acid and
nucleotide transport/metabolism (COG categories E and F,
respectively). This represents an expansion beyond the single
category (C) enriched after selection for maximal growth rate
in vitro and is consistent across all in vivo treatment groups.
Closer examination of enriched COGs and carbohydrateactive enzyme (CAZy) families highlights the role of polysaccharide synthesis for competitive fitness in this environment;
overrepresented functions include UDP-glucose-4-epimerases
and glycosyltransferases (specifically, GT2 and GT4 families
[Cantarel et al., 2009]) (Table S13). Together, these observations
suggest that at the level of statistical enrichment of broad functional groups, the in vivo fitness requirements were distinct from
those derived in vitro but that these enrichments were consistent
across in vivo treatment conditions. Many of the annotated
fitness determinants (e.g., CPS4 and the rnf-like oxidoreductase)
followed this pattern: dispensable in vitro but critical across all
in vivo conditions tested.
This functional category enrichment analysis depends
critically on genome annotation (50% of genes were not
assignable to COG categories), while not accounting for
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Figure 5. COG Category-Based Classification of Genes Critical for
Fitness In Vitro and In Vivo
Percent representation was calculated as (number of genes in a COG category/number of genes underrepresented in output population). Significant
enrichments in specific COG categories, assessed by comparing these
percentages to a null expectation based on the size of the list of selected
genes and the representation of a given category in the genome, are marked
with asterisks (Benjamini-Hochberg corrected, p < 0.05).

differences in selection magnitude between treatments. To
circumvent these limitations, we used unsupervised hierarchical
clustering to evaluate the relationships between all in vitro and
in vivo output populations (48 samples in total). In this analysis,
samples are clustered based on the relative abundance of
mutants in each gene independent of annotation. A dendrogram
of the clustering results separates the in vitro populations
from those shaped by in vivo selection (Figure 6A). The populations recovered from monoassociated wild-type, Rag1/, and
Myd88/ mice formed shared branches on this tree of mutant
population structures, suggesting that B. thetaiotaomicron may
have multiple, redundant pathways for countering immune pressures, at least under the conditions of these experiments. In
contrast, the transposon mutant populations recovered from
mice that also harbored other Bacteroidetes species were fully
separable from the population structures selected in B. thetaiotaomicron monoassociations or those resulting from the presence of a Firmicutes+Actinobacteria consortium. These patterns
were recovered in >99% of bootstrapped dendrograms and also
by unsupervised hierarchical clustering of samples based only
on the genes that showed a significantly altered output:input
ratio by z test (data not shown).

To further evaluate the robustness of the clustering algorithm,
we conducted a principal coordinates analysis on these 48
transposon mutant populations (Figure 6B and Figure S10).
Similar to the hierarchical clustering dendrograms, the first principal coordinate separates in vitro from in vivo mutant populations. The second coordinate separates these populations by
microbial context: Bacteroidetes-containing communities shape
a B. thetaiotaomicron mutant population that is distinct from that
produced in monoassociations, or in the Firmicutes+Actinobacteria consortia, further indicating that although the same broad
functional categories are enriched among B. thetaiotaomicron
fitness determinants under a range of in vivo conditions, these
mutant populations are additionally shaped by changes in microbial community composition.
We applied a random forest classifier (Breiman, 2001) to identify genes that were responsible for the observed separation of
mutant populations in monoassociated mice from those mutant
populations present in Bacteroidetes cocolonized mice. This
machine-learning algorithm serves to estimate the importance
of predictor variables (i.e., genes) for differentiating between
classes (i.e., the monoassociation versus Bacteroidetes
cocolonized groups, which were distinguished by unsupervised
clustering and principal coordinates analysis). This approach
identified a total of 220 genes as important for differentiating
these groups (Table S14). Mutants in 144 of these predictor
genes had lower output:input ratios in the monoassociations:
in other words, these genes were more important when other
Bacteroidetes were not present. Mutants in 76 genes had lower
output:input ratios in mice cocolonized with other Bacteroidetes.
These 76 genes, which provide a signature of functions under
increased selection for B. thetaiotaomicron in the presence of
other Bacteroidetes, are enriched for components of amino
acid biosynthetic pathways, suggesting that although these
functions are required in all in vivo conditions, other Bacteroidetes may outcompete B. thetaiotaomicron for exogenous
amino acids.
The Functional Requirement for a Vitamin
B12-Regulated Locus Is Modulated by Community
Composition
We identified 165 independent transposon insertions, mapping
to five adjacent genes (BT1957-53), that conferred a drastic
fitness disadvantage during monoassociation of germ-free
mice yet had no impact on exponential growth in vitro. Moreover,
their effect on fitness was influenced by community context: the
Bacteroidetes-only community exacerbated the competitive
defect, while the Firmicutes+Actinobacteria consortium fully
nullified the requirement for these genes. Introducing all 14 of
these species resulted in an intermediate phenotype (Figures
7A and 7B).
Examination of B. thetaiotaomicron transcriptional profiles
(NCBI GEO archive) disclosed that expression of genes in this
locus (spanning BT1957–BT1949) is strongly upregulated
in vivo compared to growth in vitro under a variety of conditions.
Moreover, in two closely matched experiments conducted in
defined minimal medium that differed in five components,
expression was modulated >10-fold (Table S15). This observation was validated by qRT-PCR assays of BT1954 and BT1956
(data not shown). Systematic addition of each variable
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Figure 6. Clustering of B. thetaiotaomicron
Mutant Population Structures after Manipulation of Host Environment or Microbial
Context
(A) Unsupervised hierarchical clustering of
B. thetaiotaomicron mutant population structures
in vitro and in vivo. Branches are colored by treatment. Pie charts indicate the microbial context of
the mutant population in samples from different
branches of the tree. Bootstrap support is indicated by a square at each node: >50% (white),
>90% (yellow), >99% (black/unmarked).
(B) Principal coordinates analysis based on the
representation of transposon-disrupted genes.

DISCUSSION

component revealed that locus transcription is induced in
response to reduced levels of vitamin B12 (Figure 7C). Moreover,
the ABC transporter encoded by BT1952-50 shares homology
with the BtuFCD B12 acquisition system of S. typhimurium LT2
(23%, 35%, and 25% identity, respectively).
Vitamin B12 is critically involved in normal mammalian physiology yet is synthesized exclusively by microbes (Krautler,
2005). Because the complete genome sequence of each member
of the defined microbial communities used in our experiments was
known, we were able to use BLAST to identify homologs to known
B12 synthesis, transport, or utilization genes in the synthetic
human gut microbiomes (Tables S16 and S17). As described for
the related species Porphorymonas gingivalis (Roper et al.,
2000), members of the Bacteroidetes community (including
B. thetaiotaomicron) were missing some or all of the genes necessary for synthesis of B12 or its direct precursors but encoded predicted transporters and likely have an obligate B12 requirement for
growth. In contrast, the Firmicute/Actinobacteria group contained
several members that harbored complete B12 biosynthetic pathways. To test these predictions, we attempted to culture each
species on defined medium in the presence and absence of
vitamin B12. R. obeum, a Firmicute that encodes a complete B12
biosynthetic pathway and is predicted to require the vitamin for
methionine synthesis, grew robustly without B12 in the medium,
while the Bacteroidetes were auxotrophic (Table S16). These
observations suggest that the capacity for vitamin B12 biosynthesis is determined by community structure (Figure 7D) and
that B. thetaiotaomicron responds to changes in community
membership via the gene products encoded by BT1957-49.
Consistent with this observation, the fitness defect of BT1957-3
mutants correlated well with variation in R. obeum levels between
mice in vivo (R2 of log-transformed values = 0.77; Figure 7E).

By simultaneously profiling the relative
abundance of tens of thousands of
B. thetaiotaomicron mutants across
multiple conditions, we identified hundreds of genes that are critical for the
fitness of this prominent human gut
symbiont in vivo. A large number of these
genes are not determinants of exponential growth in nutrient-replete medium
in vitro.
This approach (INSeq) for functional genome-wide analysis of
organisms for which a genome sequence (and possibly little else)
is known is generally applicable and extends existing techniques
in several important ways. First, a single transposon replaces
the sets of individually barcoded variants needed for signaturetagged mutagenesis (Hensel et al., 1995). Second, highthroughput sequencing provides a general alternative to the
species-specific DNA microarrays required for hybridizationbased mutant profiling (Mazurkiewicz et al., 2006). Third, this
sequencing-based strategy identifies the precise genomic location and provides a ‘‘digital’’ count-based abundance readout of
individual insertions in both coding and noncoding regions. In
this way, independent insertions with shared behavior serve to
validate gene-level fitness effects. Finally, because mariner
family transposon activity has been demonstrated in Bacteria,
Archaea, and Eukarya, this method is generalizable. Further,
the barcoded pooling strategy used to create a sequencedefined archived strain collection allows for retrieval of individual
strains of interest for follow-up studies of the impact of individual
gene disruptions on various microbial functions and adaptations.
In this way, a forward genetic tool (a mutagenized cell population
that can be screened for phenotypes en masse) can also serve
as a platform for reverse genetics (a collection of isogenic,
sequence-defined mutations in most of the coding potential of
the target genome).
Surprisingly, mice lacking major branches of the immune
system did not exhibit noticeably restructured B. thetaiotaomicron mutant populations compared to wild-type animals. It is
possible that examination of microbial populations in closer
contact with the host mucosa, or populations from host animals
exposed to intentional immune stimulation, would aid the identification of genes differentially required for fitness in response to
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Figure 7. Community Context Modulates
the Fitness Requirement for a Vitamin B12Regulated Locus in B. thetaiotaomicron
(A) Genetic organization and predicted annotation
of the BT1957-49 locus.
(B) The relative abundance of transposon insertion
mutants in input and output mutant populations is
dependent on community context. Asterisks indicate FDR-corrected p value (q) for each cohort:
*q < 0.05; **q < 0.01. Note that few insertions/
reads were identified in the input community for
BT1952-49 (Table S9); therefore, these genes are
not included in the analysis shown in this panel.
(C) BT1956 gene expression is regulated by
vitamin B12. Error bars represent one standard
deviation based on triplicate qRT-PCR experiments. Similar results were observed for BT1954
(data not shown). Interestingly, BT1956 insertion
mutants do not exhibit growth defects in medium
containing either 37 or 0.37 nM B12, suggesting
that multiple loci are involved in acquisition of
this vitamin in vitro (data not shown). Consistent
with this observation, other loci annotated as
being potentially involved in B12 uptake were
coordinately upregulated with BT1957-49 in
genome-wide transcriptional profiling experiments.
(D) Pie charts showing that the defined microbial
communities characterized in this study vary in
their capacity for vitamin B12 biosynthesis. Color
codes are as follows: dark blue, species with a predicted complete biosynthetic pathway (see Tables
S16 and S17 for annotations) that are able to grow in defined medium lacking B12 (‘‘demonstrated prototrophs’’); light blue, organisms with a predicted complete
biosynthetic pathway able to grow on rich medium but not on defined medium with or without B12 (‘‘predicted prototrophs’’); dark green, species without
a complete pathway whose growth in defined medium requires B12 (‘‘demonstrated auxotrophs’’); light green, species without a complete biosynthetic pathway
unable to grow on defined medium with or without B12 (‘‘predicted auxotrophs’’); black, species that do not grow on defined medium with or without B12 but that
possess a B12-independent methionine synthase (the presence of such an enzyme implies the absence of a B12 requirement). The relative proportions of prototrophs and auxotrophs shown represent the average in each community in vivo as determined by species-specific qPCR of cecal contents.
(E) The B. thetaiotaomicron fitness requirement for BT1957-3 correlates with levels of the B12-prototrophic species Ruminococcus obeum in the microbial
community. Each point represents an individual mouse containing a defined multispecies microbiota in addition to the B. thetaiotaomicron transposon mutant
population. Color code is as follows: blue, Firmicutes+Actinobacteria community; pink, Bacteroidetes+Firmicutes+Actinobacteria. The relative abundance of
R. obeum (determined by qPCR analysis of cecal contents at the time of sacrifice) is plotted against the average output:input ratio of B. thetaiotaomicron transposon mutants in genes BT1957-3 in each individual.

host immune surveillance. INSeq already can be applied to relatively small amounts of starting material: further decreases
should help address the largely unexplored question of the relationship between the activities of the innate and/or adaptive
immune systems and the biogeography of the microbiota.
Our study underscores how selection is shaped by microbial
context. Because the INSeq strategy specifically targets
transposon-adjacent chromosomal fragments, it is possible to
monitor changes in the structure of a mutagenized population
(in either wild-type or genetically manipulated gnotobiotic
mice) even if this population constitutes a small fraction of
a larger microbial community. For example, using unsupervised
hierarchical clustering and principal coordinates analysis to evaluate the relationships between B. thetaiotaomicron mutant
population structures in defined microbial communities in vivo,
we observed that the presence of other Bacteroides was an
important determinant of the selective pressures acting on the
B. thetaiotaomicron genome. Additionally, we identified a mechanism by which B. thetaiotaomicron senses and responds to
changes in gut microbial community structure: this species

employs the products of BT1957-49 in response to variations
in vitamin B12 levels that result from changes in community
composition. These genes are dispensable in rich medium
in vitro and become increasingly critical for fitness in vivo as
the levels of B12 prototrophic species (such as R. obeum) are
reduced. The mechanism by which R. obeum relieves this selective pressure, the role of the surface (S layer) proteins encoded
by this locus, and the consequences of microbial B12 competition on host physiology await further study.
In principle, INSeq can be extended to an analysis of communities of defined species composition introduced into gnotobiotic mice together with, before, or after introduction of one or
more transposon-mutagenized species. Subsequent INSeqbased time series studies of these deliberately constructed
microbial populations offer the opportunity to address a wide
range of unanswered questions about properties of our gut
microbiota, ranging from the characteristics, determinants, and
ecologic principles underlying its initial assembly, to the genomic
correlates of niche partitioning among its members, to the
genetic and metabolic factors that determine the persistence
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and impact of various probiotic and enteropathogen species
(and degree to which the functions required for persistence of
gut mutualists overlap with those of pathogens [Hendrixson
and DiRita, 2004; Lalioui et al., 2005; Liu et al., 2008; Shea
et al., 2000]).
In summary, INSeq can be applied to a variety of phylotypes to
identify factors that shape their adaptations to myriad environments, and further, to readily retrieve mutants in the genes
encoding such factors. As such, INSeq, and the rapidly evolving
capacity for massively parallel DNA sequencing that supports its
application, should be a useful platform for microbial genetics,
genomics, and ecology.
EXPERIMENTAL PROCEDURES
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Bacterial Culture Conditions
Escherichia coli S-17 l pir strains (Cowles et al., 2000) were grown at 37 C in LB
medium supplemented with carbenicillin 50 mg mL1 where indicated in the
Supplemental Experimental Procedures. B. thetaiotaomicron VPI-5482
(ATCC 29148) was grown anaerobically at 37 C in liquid TYG medium (Holdeman et al., 1977) or on brain-heart-infusion (BHI; Becton Dickinson) agar
supplemented with 10% horse blood (Colorado Serum Co.). Antibiotics (gentamicin 200 mg mL1 and/or erythromycin 25 mg mL1) were added as indicated in
the Supplemental Experimental Procedures. Other human gut-derived species
were cultured in supplemented TYG (TYGs: see the Supplemental Experimental
Procedures).
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Predicting a Human Gut Microbiota’s
Response to Diet in Gnotobiotic Mice
Jeremiah J. Faith, Nathan P. McNulty, Federico E. Rey, Jeffrey I. Gordon*
The interrelationships between our diets and the structure and operations of our gut microbial
communities are poorly understood. A model community of 10 sequenced human gut bacteria
was introduced into gnotobiotic mice, and changes in species abundance and microbial gene
expression were measured in response to randomized perturbations of four defined ingredients
in the host diet. From the responses, we developed a statistical model that predicted over 60%
of the variation in species abundance evoked by diet perturbations, and we were able to identify
which factors in the diet best explained changes seen for each community member. The approach
is generally applicable, as shown by a follow-up study involving diets containing various
mixtures of pureed human baby foods.
wing to its many roles in human health
(1–3), there is great interest in deciphering the principles that govern the operations of an individual’s gut microbiota. Current
estimates indicate that each of us harbors several
hundred bacterial species in our intestine (4, 5),
and different diets lead to large and rapid changes
in the composition of the microbiota (6, 7). Given
the dynamic interrelationship between diet, the
configuration of the microbiota, and the partitioning of nutrients in food to the host, inferring
the rules that govern the microbiota’s responses
to dietary ingredients represents a challenge (8).
Gnotobiotic mice colonized with simple, defined collections of sequenced representatives of
the various phylotypes present in the human gut
microbiota provide a simplified in vivo model
system in which metabolic niches, host-microbe,
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and microbe-microbe interactions can be examined by using a variety of techniques (9–12).
These studies have focused on small communities exposed to a few perturbations. We used
gnotobiotic mice harboring a 10-member community of sequenced human gut bacteria to model the response of a microbiota to changes in host
diet. We aimed to predict the absolute abundance
of each species in this microbiota on the basis of
knowledge of the composition of the host diet.
Furthermore, we wanted to gain insights into the
niche preferences of members of the microbiota
and to discover how much of the response of the
community was a reflection of their phenotypic
plasticity.
The 10 bacterial species were introduced into
germ-free mice to create a model community
with representatives of the four most prominent
bacterial phyla in the healthy human gut microbiota (fig. S1A) (13). Their genomes encode major
metabolic functions that have been identified in
anaerobic food webs, including the ability to break
down complex dietary polysaccharides not acces-
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any XMRV isolates with the same or nearly the
same sequences identified elsewhere originated
from this event (23).

sible to the host (Bacteroides thetaiotaomicron,
Bacteroides ovatus, and Bacteroides caccae);
consume oligosaccharides and simple sugars
(Eubacterium rectale, Marvinbryantia formatexigens,
Collinsella aerofaciens, and Escherichia coli);
and ferment amino acids (Clostridium symbiosum
and E. coli). We also included two species capable of removing the end products of fermentation:
a H2-consuming, sulfate-reducing bacterium
(Desulfovibrio piger) and a H2-consuming acetogen
(Blautia hydrogenotrophica).
To perturb this community, we used a series
of refined diets in which each ingredient represented the sole source of a given macronutrient (casein = protein, corn oil = fat, cornstarch =
polysaccharide, and sucrose = simple sugar) and
in which the concentrations of these four ingredients were systematically varied (fig. S1, B
and C, and table S1). Each individually caged
male C57Bl/6J mouse was fed a randomly selected diet, with diet switches occurring every
2 weeks (n = 13 animals; fig. S1D shows the
variation of diet presentation between animals).
Shotgun sequencing of total fecal DNA allowed
us to determine the absolute abundance of each
community member, based on assignment of
reads to the various species’ genomes, in samples
obtained from each mouse on days 1, 2, 4, 7, and
14 of a given diet period (13).
To predict the abundance of each species in the
model human gut microbiome given only knowledge of the concentration of each of the four perturbed diet ingredients, we used a linear model
yi ¼ b0 þ bcasein Xcasein þ bstarch Xstarch þ
bsucrose Xsucrose þ boil Xoil

ð1Þ

where yi is the absolute abundance of species i;
Xcasein, Xstarch, Xsucrose, and Xoil are the amounts
(in grams per kilogram of mouse diet) of casein,
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cornstarch, sucrose, and corn oil, respectively, in
a given host diet; b0 is the estimated parameter
for the intercept; and bcasein, bstarch, bsucrose, and
boil are the estimated parameters for each of the
perturbed diet components. Because each mouse
underwent a sequence of three diet permutations
presented in different order, and each of the diet
periods covered all of the 11 possible diets (fig.
S1D), we were able to use two of these three diet
intervals to fit the model for Eq. 1 (13 mice × 2
diets per mouse = 26 samples per bacterial species); we then measured our ability to predict
the abundance of each bacterial species for the
13 samples in the remaining (third) diet (13).
Averaging this cross-validation from all three
subsets, the model explained over 61% of the
variance in the abundance of the community members (abundance-weighted mean R2 = 0.61; see
table S2 for species-specific R2).
Although the cross-validation provided evidence that the response of this microbiota was
predictable from knowledge of these diet ingredients, a more conclusive validation of the model would be its ability to make predictions for
new diets. Therefore, we designed six additional diets with new combinations of the four refined ingredients. Using a design similar to the
first experiment, eight different 10-week-old
gnotobiotic male C57Bl/6J mice harboring the
10-member community were each given a randomized sequence of diets selected from the
six new diets (shaded diets L to Q in fig. S1B)
or one of the previous diets (fig. S1E). Fitting
the model parameters with the data from the
first experiment, we were able to explain 61%
of the variance in the abundance of the community members on the new diets, showing virtually
equivalent results to the cross-validation procedure (table S2).
These results indicate that the linear model
explains the majority of the variation in abundance of each organism by using only a knowledge of the species in the community and the
concentrations of casein, cornstarch, sucrose,
and corn oil in the diet, without having to ex-
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from the first and second set of mice given the refined diets (fig. S1, D and E)
are shown in purple and green, respectively, and the mean and standard error
for all diets at a given concentration of casein are shown in red and tan,
respectively.
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Fig. 1. Total community abundance (biomass)
and the abundance of
each community member
can best be explained by
changes in casein. (A)
The total DNA yield per
fecal pellet increased as
the amount of casein in
the host diet increased
(shown are mean T SEM
for each tested concentration of casein). (B) Changes
in species abundance as
a function of changes in
the concentration of casein in the host diet were also apparent for all
10 species; seven species (such as B. caccae) were positively correlated
with casein concentration, whereas the remaining three species (such as
E. rectale) were negatively correlated with casein concentration. Data points

Fig. 2. Mean community member abundance for each diet. The height of each bar indicates the total
DNA yield/biomass for a given diet. Casein concentrations (grams per kilogram) for each diet are
displayed in gray above each bar. See fig. S1 and table S1 for a description of diets A to Q.
plicitly consider the effects of microbe-microbe
or microbe-host interactions or diet order. We
also tested several other models, including
adding interactions between the variables, quadratic terms, and interactions with quadratic
terms (13). After correcting for the number of
parameters in the model by using Akaike infor-
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mation criterion, the linear model was still the
best-performing.
To further dissect the community response to
these diet perturbations, we needed to infer which
set of diet ingredients is associated with the
abundance of each community member. Feature
selection algorithms assume that the response
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variable (in this case, the abundance of each organism) is potentially affected by only a fraction
of the variables in the model and use statistical
methods to choose the subset of variables that
most informatively predict the abundance of each
species. Using stepwise regression as a feature
selection procedure with the equation above, all
species in our 10-member community had the
diet variable Xcasein significantly associated with
their abundance (table S3).
E. coli and C. symbiosum were the only bacteria with more than one variable significantly
associated with their abundance (casein and
sucrose for E. coli, and casein and starch for
C. symbiosum). Further exploring this finding,
we found casein highly correlated with the yield
of total DNA per fecal pellet across all diets
(Figs. 1A and 2). A component of casein, presumably amino acids and/or nitrogen, limits
the biomass of the community: This resource
limitation was observed even for combinations
of three additional refined protein and two
additional fat sources (soy, lactalbumin, eggwhite solids, olive oil, and lard; n = 9 different
diets given to another group of 9 C57Bl/6J
male mice) (fig. S2 and table S4). However,
the observed changes in species abundance are
not a simple consequence of a constant relative
abundance of each community member that is
scaled upwards as casein is increased: Three
community members (E. rectale, D. piger, and
M. formatexigens) decreased in absolute abundance by –25 to 50% from the low- to high-casein
diets, even though total community biomass
tripled (Fig. 1B, fig. S3, and table S5). Similar
changes in species abundance and total com-

munity DNA levels were observed when casein
concentrations were altered in gnotobiotic mice
harboring a nine- or eight-member subset of the
original community (minus B. hydrogenotrophica
or minus D. piger and B. hydrogenotrophica)
(table S6).
Microbial RNA-seq was used on fecal RNA
samples—prepared from mice on each diet (mean =
2.1 T 0.7 replicates per diet) (table S7) (13)—to
determine whether perturbations in diet ingredients correlated with underlying changes in mRNA
expression by community members. Each of the
36 RNA-seq data sets was composed of 36nucleotide-long reads (3.20 T 1.35 × 106 mRNA
reads per sample). Transcript abundances were
normalized for each of the 10 species to reads per
kilobase per million (RPKM) (14). After correcting for multiple hypotheses, we found no statistically significant changes in gene expression within
a given bacterial species as a function of any of
the diet perturbations (13). Although community
members do not appear to significantly alter their
gene expression, they do respond by increasing
or decreasing their absolute abundances (Fig. 2),
adjusting the total available transcript pool in the
microbiota for processing dietary components.
For example, as casein levels are increased across
the diets B. caccae increases its contribution to
the gene pool/community transcriptome; so, the
number of transcripts per unit of casein remains
roughly constant.
Because RNA-seq provides accurate estimates of absolute transcript levels (15), we used
transcript abundance information as a proxy to
predict the major metabolic niches occupied
by each community member. For species posi-
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Fig. 3. Example of community member responses
to complex human foods. Changes in species
abundance as a function of diet ingredients were
apparent for all 10 species (table S9). (A) B. ovatus
increased in absolute abundance with increased concentration of oats in the diet, whereas (B and C) most
of the 10 bacterial species (including E. rectale and
C. aerofaciens) responded to multiple ingredients. The mean and standard error for all diets are plotted
(no error bars are shown when replicate points are not available). The colored z axis mesh grid on the
three-dimensional plots is a triangle-based linear interpolation of the data, with color changes corresponding to the values in the color bar on the right.

tively correlated with casein, we found high
expression of mRNAs predicted to be involved
in pathways using amino acids as substrates
for nitrogen, as energy and/or as carbon sources.
In contrast, the three species that negatively correlated with dietary casein concentration showed
no clear evidence of high levels of expression
of genes involved in catabolism of amino acids
(13). The changes in abundance of the negatively correlated species (such as E. rectale) can be
explained by competition with another member
of the community that increases with casein (fig.
S4) (13, 16).
The power of the refined diets we used lies
in the capacity to precisely control individual
diet variables and to aid data interpretation from
more complex diets. To test whether the modeling framework we used generalizes to diets
containing food more typically consumed in
human diets, we created 48 meals consisting
of random combinations and concentrations
of four ingredients selected from a set of eight
pureed human baby foods (apples, peaches, peas,
sweet potatoes, beef, chicken, oats, and rice)
(table S8). The meals were administered for
periods of 7 days to the same eight gnotobiotic
mice that we used for the follow-up refined diet
experiments described above and in fig. S1E
(13). Each mouse received a sequence of six
baby-food diets. The order of presentation of
the baby-food diets was varied between animals (table S8) (13). We measured the absolute abundance of each bacterial community
member on days 1, 5, 6, and 7 for each diet.
Using the linear modeling approach described
above (13), we were able to explain over half
of the variation in species abundance using only
knowledge of the concentrations of the pureed
foods present in each meal (R2 = 0.62). We
used stepwise regression to identify the type of
pureed food (or foods) present in a given mixed
meal that was most significantly associated with
changes in each bacterial species (Fig. 3 and
table S9).
Defining the interrelationship between diet
and the structure and operations of the human gut
microbiome is key to advancing our understanding of the nutritional value of food, for creating
new guidelines for feeding humans at various
stages of their life span, for improving global
human health, and for developing new ways to
manipulate the properties of the microbiota so
as to prevent or treat various diseases. The experiments and model described above highlight
the extent to which host diet can explain the
configuration of the microbiota, both for refined
diets in which all of the perturbed diet components are digestible by the host and for human
diets whose ingredients are only partially known.
These models can now be tested by using larger
defined gut microbial communities representing
those of humans living in different cultural settings, and with more complex diets, including
various combinations of food ingredients that
they consume.
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Oxytocin Selectively Gates Fear
Responses Through Distinct Outputs
from the Central Amygdala
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Central amygdala (CeA) projections to hypothalamic and brain stem nuclei regulate the
behavioral and physiological expression of fear, but it is unknown whether these different
aspects of the fear response can be separately regulated by the CeA. We combined fluorescent
retrograde tracing of CeA projections to nuclei that modulate fear-related freezing or
cardiovascular responses with in vitro electrophysiological recordings and with in vivo
monitoring of related behavioral and physiological parameters. CeA projections emerged from
separate neuronal populations with different electrophysiological characteristics and different
response properties to oxytocin. In vivo, oxytocin decreased freezing responses in fear-conditioned
rats without affecting the cardiovascular response. Thus, neuropeptidergic signaling can
modulate the CeA outputs through separate neuronal circuits and thereby individually steer
the various aspects of the fear response.

F

ear can be severely immobilizing but can
also be a major driving force for some of
humans’ most heroic acts. In both cases,

the internal emotional experience may be similar,
although it may lead to substantially different
behavioral outcomes (1–3). Studies on human
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emotions often use autonomic nervous system
parameters to assess arousal, because of the role
of our internal organs in the emotional state
(4, 5). Projections from the central nucleus of the
amygdala (CeA) to the hypothalamus and different brain stem nuclei coordinate behavioral
and physiological fear expression (6). It has been
postulated that different fear responses, characterized by more active or passive behavioral coping strategies, can be triggered by a neuronal
switch within the CeA (7). The question thus
arises whether fear responses only vary in intensity, or whether different qualities of fear responses exist, reflected in different associations
between behavioral and physiological components. We investigated whether a neurophysiological basis for such a distinct regulation could
be found in the CeA.
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Fig. 1. Distinct neuronal populations of the CeM project to
PAG and DVC. (A and B) Coronal views of injection sites (A) in
PAG of fluorescent green and
(B) in DVC of red microspheres
(left), corresponding CeM labeling (right). Scale bars: left, 1 mm;
right, 500 mm. lPAG, lateral PAG;
vlPAG, ventrolateral PAG; sp5,
spinal trigeminal tract. (C) Separately labeled CeM neurons after coinjections of green and red
microspheres in respective PAG
and DVC (left) versus colabeled
neurons after injections of both
microspheres in DVC (right, scale
bar, 50 mm). (D) Quantification
of colabeled (coloc) CeM neurons (see also table S2). (E)
Electrophysiological characteristics of CeM→PAGs, “PAG” and
CeM→DVCs “DVC.” (*P < 0.05; **P < 0.01, n = 22 to 43 neurons) Error bars indicate SEM.
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